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xi
There is strong epidemiological evidence o f association between PMi0 (particulate matter with an 
aerodynamic diameter less than or equal to 10 microns) and adverse health outcomes including death 
and increased hospital admissions for cardio-pulmonary conditions. Ambient PM10 surrogates such as 
diesel exhaust particles (DEP), a common component o f UK PMi0, have been shown to induce lung 
inflammation in both humans and rodents. To date, few studies have reported on the toxicological 
response o f UK PM]0 in experimental animals.
This thesis summarises the characterisation o f the pulmonary toxicity o f Cardiff urban PM10. Firstly, 
the pulmonary toxicological responses in male Sprague Dawley rats following the intratracheal 
instillation o f Cardiff urban PM]0 were examined. A mild, but significant, change in lung permeability 
was observed in the lung post instillation o f a high (10 mg) dose o f the whole PM10 as adjudged by 
increases in lung to body weight ratio and total acellular lavage protein. Such effects were less marked 
following instillation o f a water-soluble fraction (80% o f the total mass) but histological examination 
showed that lung capillaries were swollen in size with this treatment. Secondly, expression profiling of 
PM exposed lung tissue identified distinct genes differentially expressed as a consequence o f  exposure 
to a high dose (10 mg) o f whole PM and equivalent dose o f  water soluble component o f PM. Such 
changes were linked to different histopathological events within the lung. In conclusion, conventional 
toxicological, histological and toxicogenomic studies have indicated that Cardiff PM10 exhibits low 
bioreactivity in the form o f mild permeability changes.
In vitro toxicological assessment o f the bio reactivity o f the PM sample using primary cultures o f 
epithelial type II and alveolar macrophage cells were used to identify the relative contribution o f the 
different fractions (whole, washed “durable” fraction and water soluble component) to the overall PM 
toxicity. Correlations with total metal content and particle size were identified in the different cell 
types. Cellular analysis using advanced fluorescence labelling and microscopy identified the ability o f 
the PM to induce subtle changes in cell and nuclear morphology that may result in increased cell death 
and apoptosis even at low particulate doses. Expression profiling o f the PM exposed cells proved 
difficult and realised limited information regarding the cellular responses to the toxicant. This 
approach failed to identify the same gene changes reported in the lung tissue profiling, illustrating the 
importance o f the different cell types within the lung to orchestrate a pulmonary response.
In conclusion, the use o f toxicogenomics and gene expression arrays in toxicological is still relatively 
novel approach to the assessment o f lung injury. The study addresses initial problems and offers some 
possible solutions regarding the use o f macro arrays and expression profiling in toxicology research. 
Expression arrays offer considerable scope as a research tool and in future will provide a powerful 
insight into gene changes on a global scale.
Chapter 1.0 
General Introduction
1.0 General Introduction
1.1 The Lungs
The primary function of the lung is the exchange of respiratory gases, it is also 
responsible for the synthesis and turnover of connective tissue matrix. The nature of 
the lung, with its extensive surface area and immense capillary network renders the 
lung highly susceptible to both blood and air borne toxicants and is known to be a 
specific target for and accumulate many toxins and drugs including the anti-neoplastic 
cancer drug, bleomycin and the herbicide paraquat. Thus the lung is at the frontline 
of defence to many air- and blood- borne toxins and has an important role in 
detoxification to prevent tissue and systemic toxicity. The lung is responsible for the 
synthesis and turnover of protective epithelial lining fluid, including surfactant and 
contributing to the repertoire of enzymes providing front line defence from inhaled 
foreign objects.
The lungs (Figure 1.1) consist of five lobes, the left lung has one oblique fissure 
dividing into superior and inferior lobes whilst the right lung has two fissures (oblique 
and horizontal) dividing into superior, middle and inferior lobes. The trachea, a 
cartilage supported tube connects the bronchi within the lungs to the nasal and buccal 
cavity, each bronchus divides repeatedly to form a tree of airways, the bronchioles, 
which terminate with alveoli, the respiratory surface of the lungs.
1.2 The Alveoli
1.2.1 The architecture of the alveoli
The role of the alveolus is the exchange of respiratory gases. The alveolus therefore 
contains a thin cellular barrier called the epithelium physiologically adapted for 
optimal gas exchange (Figure 1.2). There are five main cell types within the alveoli: 
alveolar macrophages, endothelial cells of the pulmonary capillaries, epithelial type I 
and II cells and fibroblasts of the interstitium.
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Figure 1.1: A diagram illustrating the human respiratory system. Source: Encarta 2000.
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Figure 1.2: Representation of the alveoli illustrating the five main cell types within the lung: 
macrophages, epithelial type II and type I cells, fibroblasts and aidothelial cells. (Hoet and Nemery., 
1993). Pictures inset are EM images of alveolar macrophages and epithelial type II cells (courtesy of 
Mr. D Dinsdalc. 2000).
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1.2.2 The Alveolar Epithelium- Epithelial Type I and II
The alveolar epithelium is a differentiated surface of two main cell types: epithelial 
type I and II cells (Figure 1.2). Type I cells are large flattened cells, covering up to 
90% of the alveolar surface area, constituting 8% of the total cell population. They 
are both metabolically and anatomically specialised for gaseous exchange, providing 
a slender barrier to gaseous exchange with low metabolic activity, reducing their own 
oxygen consumption although rendering the cells susceptible to injury upon inhalation 
of foreign materials. Type I cells have an important role in maintaining the blood air 
barrier at the alveolar level. When challenged, surface alterations including blebbing 
may result in cell damage and facilitate the stripping of the cells from the basement 
membrane.
Upon injury and damage to the type I cell, epithelial type II cells (or stem cells within 
this population) will replicate and differentiate in order to restore normal alveolar 
architecture. The type II cells are cuboidal in shape, covered at its apex with 
microvilli, characteristically containing inclusions (lamellar bodies) (Castranova, 
2000). Type II cells have three main functional roles within the alveoli, firstly as a 
progenitor population for type I cells, replenishing cells and differentiating to restore 
normal alveolar architecture upon minor to moderate cellular damage. Type II cells 
orchestrate the biotransformation of inhaled species: these cells contain significant 
levels of enzymes especially the P450 dependant mono-oxygenases, important for the 
metabolism and detoxification of a wide range of xenobiotics within the lung and 
finally in the secretion, maintenance and metabolism of surfactant. Pulmonary 
surfactant is a component of the epithelial lining fluid, a specialised material secreted 
and metabolised by epithelial type II cells serving to reduce the surface tension at the 
air water interface within the alveolus, providing stability of the airways and 
preventing collapse of the alveoli. Surfactant comprises of dipalmitoyl 
phosphatidylcholine (50%), unsaturated phosphatidylcholines (25%), 
phosphatidylglycerol (5-10%), cholesterol (5%) and protein (8-10%). The surfactant 
phospholipids are transported and processed within the lamellar bodies of the type II 
cells and by exocytosis, a process that has been found to be stimulated upon 
inhalation exposure to many toxicants (Dobbs et al, 1978). Type II cell dysfunction or
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failure of the immature type II cells to produce sufficient surfactant culminates as 
respiratory distress syndrome, common in premature babies.
Type II cells contain well-developed Golgi apparatus, indicative of their high 
metabolic activity. Their role as the progenitor population is forefront in the repair 
and restructuring of the alveolus. The epithelial cell is the first cell to replicate and 
differentiate following epithelial damage, a consequence of exposures and local 
inflammation. It has also been postulated that the replaced cell population becomes 
less susceptible to subsequent exposure (Mason et al., 1977). Hyperplasia of the type 
II cell population has been traced in both lung injury and the developing lung 
(Quinlan et al., 1995). Upon injury or damage to the type I cell population competent 
type II cells will replicate and differentiate becoming flattened and gaining the type I 
cell phenotype. However, upon sustained or severe damage to the epithelium may 
result in uncontrolled cell division (hyperplasia) of the type II cells, resulting in 
thickening of the epithelium.
1.2.3 The Alveolar Macrophage (AM)
Alveolar macrophages are derived from bone marrow and form part of the 
mononuclear phagocytic system of the body. AM’s represent a heterogeneous 
population of scavenger cells with the primary function to phagocytosis and clearance 
of cellular debris (from normal cell turnover), foreign particles and micro-organisms 
within the lung (Sibille and Reynolds, 1990). Metchnikofif (1881) was amongst the 
first to recognise the importance of these phagocytic cells “[They] engulf the 
tubercule bacilli readily but perish shortly after or become engulfed themselves by 
other mononuclear phagocytes”. Alveolar macrophages are distinct from their 
pulmonary interstitial counterparts in that they have no ability to replicate and have 
poor antigen processing and presentation capabilities. Free alveolar macrophage cells 
can be easily isolated from the lung, from the bronchial-alveolar lavage and are 
morphologically distinct from neutrophils and other alveolar cells, with large rounded 
nuclei. Upon challenge in vivo, these cells are responsible for the phagocytosis of 
particles, inciting the further recruitment of other phagocytic cells and initiation of 
inflammation within the alveolus.
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1.2.4 Endothelial Cells and Interstitial cells
The endothelial cells are squamous flattened cells bound to the basement membrane 
and make up the capillary walls surrounding the alveolus. Interstitial cells encompass 
a multitude of cell types including smooth muscle and fibroblast cells, producing 
connective tissue proteins including elastin and collagen. Inappropriate activation of 
these cells by inhaled xenobiotics can result in excess deposition of these products 
attributing to the lung pathogenesis. Cell to cell communication, directly via cell 
contacts or indirectly via soluble mediators, is an important mechanism to control and 
regulate the cell activities and cell cycle in the alveolus. Overlying Type II epithelial 
cells repress fibroblast cell cycle and division (Shannon et al., 1987), loss of this 
repression may result in the proliferation and activation of the underlying fibroblasts, 
or the improper deposition of cell products such as collagen within the alveoli to the 
detriment of lung flexibility and reducing the efficiency of gaseous exchange within 
effected tissue.
1.2.5 Clara Cells of the Upper Airways
Clara cells are non-ciliated secretory cells within the bronchioles. These cells contain 
a variety of enzymes including P450 mono-oxygenases, central to the detoxification 
of xenobiotics, in addition, they serve as progenitor cells for new Clara cells and 
ciliated cells of the airway (Oreffo et al., 1990).
1.3 Particulate Air Pollution
1.3.1 PMio and Health Effects: An Overview
The earliest documented links of adverse health effects with air pollution were made 
in medieval England. In 1733, a prominent scientist of the day, John Arbuthnof, 
stated, “c/Yy air was not as friendly as that o f the country- fo r its replete with 
sulphorous streams o f  fuel. " Episodes of severe air pollution have arisen since the 
industrial revolution, the London smog’s of the 1950’s with PMio levels exceeding
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6000 fig/rn (24 hr average) recorded resulted in the implementation of the Clean Acts 
from 1956. These acts have successfully improved air quality, but the increase in 
traffic has resulted in the re-emergence of air pollution episodes within many of our 
towns and cities exceeding the government and European implemented quality 
standards (50 /*g/m3 24 hr averages) (POST Technical Report, 82, 1996).
Air pollution monitoring has reported a decline in the levels of pollution, measurable 
by ambient levels of PMio, since the notable pollution episode in London (1952) but 
health effects are still being reported. These adverse effects may not arise as a result 
of the general level of pollution, but may be attributed to a more specific aspect of air 
pollution (Frampton et al., 1999). Whilst levels of larger particles and exhaust gases 
have decreased, there has been an increase in the prevalence of smaller sized particles 
that make up very little, by mass, of collected samples, but contribute a highly 
significant proportion, by number and surface area, of samples (Pooley, personal 
communication 2000).
Several countrywide networks funded by Department of the Environment/Local 
Authority currently monitor UK PMio levels. The Automated Urban Network 
measures the hourly concentrations of a range of pollutants including particles, 
established in 1992, it now comprises of more than 29 urban sites. Respirable 
particles (PMio) are measured by mass (jig per m3). Annual levels are usually in the 
range 20-30/xg/m , with the highest UK levels recorded (62 \kg) m ) during a pollution 
episode in October 1994 (POST Technical Report, 82, 1996). The national 24 hour 
standard for air pollution (50 /tg/m3) set by E.P.A.Q.S. (Expert Panel on Air Quality 
Standards) has been exceeded at most of these sites since monitoring was initiated. A 
number of new UK EPAQS policies have been designed to reduce vehicle exhaust 
emissions by up to 39% by 2010.
1.3.2 PMio
Particulate matter is a generic term used to describe airborne particles with a wide 
range of chemical and physical characteristics (POST Report 82, 1996). Particulate air 
pollution is a suspended mixture of solid and liquid particles varying in size,
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composition, origin and effects (Dockery and Pope, 1994). The size and composition 
of particles are influenced by source. Coarse particles (~7 microns in aerodynamic 
diameter) are predominately from mechanical processes, erosion, re-suspended soils 
and sand whilst finer particles, contributing 80-95% of the total number of particles, 
result from controlled combustion processes including traffic and some industrial 
processes.
Major elements of particulate matter in the U.K. include sulphates, nitrates, chloride, 
sodium, ammonium, acids, elemental carbon particles, organic carbon compounds, 
metals, crustal and biogenic material (Harrison, 2000). Metals may contribute up to 
5% of a typical PM sample (Harrison, 1995) and are postulated to be highly 
influential towards the overall toxicity of a PM sample (Adamson et al., 1999 and 
2000. Gavett et al., 1997). The metals present in ambient particulate pollution may 
derive from both natural and anthropogenic sources and levels of several transition 
and heavy metals including copper, lead, vanadium and zinc are commonly measured 
in PM samples. Secondary pollution arises as a result of interactions and chemical 
reactions between pollutant moieties within the atmosphere and includes gases and 
organics that may associate or accentuate particle toxicity.
In vivo studies investigating the toxicity of urban PMio in animal models have used 
diesel exhaust particles (DEP) as a surrogate for urban PMio (Figure 1.3). DEP 
contributes up to 90% of urban particulate matter and was considered to well 
represent the highly heterogeneous, physicochemical mixture (Berube et al., 1999).
Characterisation of DEP reveals that it consists of distinct types, aggregates of carbon 
spherules, contained within an organic coating and as liquid drops: a hydrated 
sulphate nucleus encompassed by a mainly organic coating (Harrison, 1995). 
Characterisation studies of the DEP particles conclude that the particles consist of 
three morphological types: (1) individual particles or spherulites, with a mean 
diameter of 30nm; (2) small aggregates of spherulites in the form of chains or clusters 
and (3) large agglomerated spherules 1-2/mi in diameter (Berube et al., 1999).
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A typical South Wales PMio sample (Figure 1.3) is a heterogenous mixture of carbon 
soot, diesel exhaust particles, salts and minerals, smelter particles consisting of chiefly 
iron particles and anthropogenic particles.
Sea salt
Gypsum 
Pollen
Mineral
Figure 1.3: SEM image of a typical Cardiff (South Wales, urban) PM10 sample on a polycarbonate 
filter. The sample may contain up to 80% (by number of DEP) and smelter particles blown in from 
nearby steel works at Port Talbot (up to 6%).
1.3.3 South Wales PMio
A high volume cascade impact collector (Harvard) has been used to collect samples of 
PMio from around the country (Moreno, 2003)(Figure 1.4). This sampling technique 
enables sufficient sample to be collected to allow full chemical, morphological 
characterisation and assessment of the reactivity of the PM both in vivo and in vitro. 
This analysis of the bio-reactivity of both in cell free toxicology (Greenwell et al., 
2003), cellular toxicity in vitro and in vivo with a well characterised sample provides 
the potential to attribute the toxicity with chemical or morphological characteristics of 
the ambient sample. The collector samples air at 1100 litres/min'1 through three 
polyurethane foam (PUF) filters within the collecting head. Particles bigger than 10 
/xm (insects, fragments of plant or hairs) impact onto the first PUF substrate, the air 
then moving to the next step by passing through a 10 /xm inlet with the 10-2.5 /xm 
particles, the air then progresses through to the 2.5 /xm inlet, depositing 2-5-0.1 /xm in 
a third PUF (Moreno et al., 2003).
•melter
particle
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Airflow 
(1100 L/min)
PM>10
PM,m.5
To pump
PUF Filter: PM;
Figure 1.4: A diagram illustrating the mechanisms of the Harvard high volume cascade elutriator PM 
collector used for the larger scale collection o f PMkmm for all PM samples described in this thesis. 
(Moreno et al., 2003)
The studies described in this thesis concentrate on the bio-reactivity of two main 
collection sites, Cardiff and Port Talbot. The Cardiff collection site is located within 
the civic centre; approximately 500 metres form the city centre. It is positioned in 
close proximity to several major routes including Park Place (100 m, NE), the main 
A470 (250 m, SW) and the main route through Cardiff (A48, 1600 m). The main 
Cardiff sample (CF 2) used for the studies described in this thesis concerns a 
collection period of 43 days (January 2001- March 2001) when a daily average of 38 
mg was recorded. The Cardiff location represented an urban location close to the
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South Wales coast (approximately 3.5 km), with high volume levels of local human 
activity, including high traffic volumes and local construction. The in vitro studies 
also compared a sample collected from Port Talbot (PT 1), an industrial site located 
approximately 50 km west of Cardiff, in close proximity to the South Wales coast, a 
steel factory and power station and bordered by the M4 motorway. This sample was 
collected over a 25-day period and up to 30 mg per day was recorded, with a peak of 
38 mg. Comprehensive elemental, morphological and size distribution 
characterisation has been completed on the PMio samples studied in this thesis using 
inductively coupled plasma mass spectrometry (ICP-MS), field emission scanning 
microscopy, scanning electron microscopy and image analysis (Moreno et al., 2003). 
The two sample sites showed several common attributes but analysis revealed that the 
samples were distinct in both chemical and morphological compositions. The Cardiff 
samples had far higher ratio of finer fraction (PM <2 .5)  to coarser (PM 10-2.5)  (ratio 2.8-
4.2 compared to Port Talbot ratio 1-2) over the sampling period. The Port Talbot 
sample was dominated by dense iron spherules (PM<2.5 microns) (>30% by particle 
number). These spherules were present, in lesser amounts, in the Cardiff samples 
(<6% % by particle number), blown from the steel works at Port Talbot.
The Cardiff PM samples were heterogeneous, particularly the finer fraction, analysis 
showed clear particles and finer particles nucleating to form larger particles, the urban 
sample was dominated by soot particles from combustion and vehicles exhaust 
emissions. Elemental analysis showed that the finer fraction and coarser fraction had 
a slightly different composition. The coarser fraction comprised chlorides (26%, 
chiefly coastal origin), sulphates (23%), elemental and organic carbon compounds 
(20%) and other compounds (1%- nitrates, silicates, iron containing moieties, 
carbonates). The finer fraction contained fewer chlorides (20%), more sulphates 
(35%) and more nitrates (21%) by particle number. Compounds common to samples 
from both locations included elemental and organic compounds, including biological 
compounds such as pollen, bacterial and fungal spores. The chlorides are chiefly 
sodium chlorides or ammonium chlorides, wind blown from the sea or from salt 
treatment of nearby roads. Iron (II) spherules dominate the Port Talbot samples 
(>30% by mass of samples collected); much of the in vitro bio-reactivity of the 
samples is attributed to this transition metal (Greenwell et al., 2003). The spherules
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are condensates of iron released during the high temperature smelting procedures at 
the nearby steel works. Nitrogen containing compounds chiefly comprised of 
irregularly shaped nitrate and sodium nitrates. Silicates include minerals such as 
quartz, kaolinite and feldspars, from erosion of local geological features and local 
activities such as quarrying and construction.
1.3.4 PMio Health Effects
Particulate matter of less than ten microns in aerodynamic diameter (PMio) is 
considered as respirable and will penetrate into the trachea and larger airways of the 
lung; finer particles (PM<2.s) will enter the smaller airways and alveoli
Increases of ambient levels of particulate matter are correlated with increased 
incidences of cardiovascular and pulmonary related deaths, increased hospital 
admissions and exacerbation of lung conditions (Anderson et al., 1991). Many 
epidemiology studies conclude that 1% of the population are at a higher risk of 
mortality as a result of a 10 /zg/m3 increase in ambient PMio levels (Seaton et al., 
1995), an expected 1.4% increase in cardiovascular deaths.
Personal exposure to ambient PMio is reflected in both indoor and outdoor PMio 
levels. Individuals spend op to 90% of their day within an indoor environment. 
Indoor pollution levels are heavily dictated by the conditions outside in addition to 
indoor activities (Janssen et al., 1998). Thus PMio exposure comprises a significant 
risk to health.
In the UK there appears a straight-line relationship between exposure and response 
(health effects), up to levels of approximately 200 /zg/m3 (POST Report 82, 1996). 
Hospital admissions for asthma related conditions increase by 2 % and by 1 % for all 
respiratory conditions for every 10 /zg/m increase (Dockery and Pope, 1994).
Summaries of UK based studies are illustrated in Table 1.1. In 1991, small increases 
in mortality (10%), hospital admission rates (4 %)- especially amongst young children 
and elderly or those with pre-existing cardiovascular conditions- were observed in
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central London and correlated with increases up to 3.4 times the monthly average 
levels of total suspended particles (referred to as black smoke) (Anderson et al., 
1995).
Table 1.1: Summary o f health effects attributed to rise in PMio levels in the UK. Adapted from POST 
Report 82 (1996). Based on data from both time series studies and panel studies. Conclusions drawn 
from such analyses show a significant link between particulate levels and short-term adverse health 
effects.
Health Effect % Change (10/ig/m increase)
Mortality
Total 0 .7 -1 .6 %
Respiratory 1 .5 -3 .7 %
Cardio-vascular 0 .8 - 1.8%
Hosoital Admissions
Asthma 1.9-2.1 %
Respiratory conditions 0 .8 -3 .4 %
Exacerbation of Asthma
Attacks 1.1 - 11.5%
Epidemiological studies on school children during air pollution episodes reported a 
repression in lung function during and directly after episodes, normal lung function 
was restored up to two weeks following the improvement in air conditions. Although 
such effects are transient, increases in air particulates have been associated with other 
complications, a multitude of independent studies have shown a coherence of effects 
across a range of related health outcomes (Dockery and Pope, 1994). Particles 
promote the premature death, hastening the onset of death in compromised and 
susceptible individuals and increases susceptibility to infectious conditions (Seaton, 
1995).
A number of studies have also correlated the changes in ambient PMio levels with 
alterations in lung function. Scarlett (1995) reported a decrease in lung function in 
symptomatic and asymptomatic school children with increases in ambient pollution 
levels, this change has also been noted in adults. It has been postulated that small 
shifts in lung function could be detrimental to those in a borderline state of health to
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elicit a clinically important response (Scarlett et al., 1995). The impact on short-term 
health and respiratory effects have been well described, longer-term health impacts 
may include increased mortality. Data from a wide range of studies indicate that 
increased incidences of non-neoplastic cardio-pulmonary disease and asthma may be 
associated with long-term exposure to particles (IEH (2000) Airborne Particles: 
Exposure in the home and health effects).
Frampton (1999) studied the effect of a short term closure of a local steel mill in the 
Utah Valley (1986-1989) and the subsequent changes in air pollution to evaluate the 
contribution of the metals to observed health effects in the nearby population. Pope
(1999) reported that during the 12-month shut down, local levels of PMio were 
reduced and this decline was accompanied by a decrease in reported health effects. 
These findings were supported by both instillation studies in the rat (Dye et al., 2001) 
and in vitro studies using primary rodent epithelial cells (Pagan et al., 2003). These 
studies correlated increases in pulmonary inflammation, cellular stress and toxicity 
with the increased metal content of the ambient PM samples, specifically copper, 
vanadium and zinc (Dye et al., 2001).
Frampton (1999) concluded that respiratory health effects were influenced by changes 
in particle source and composition as well as exposure composition. The toxicity of 
the suspended particles is influenced by many factors including bulk chemical and 
trace element composition, acid content and particle size distribution (Harrison, 
1995). Particulate matter is an anthropogenic mixture of chemicals and the 
composition varies according to source, locality (local activities etc), climatic factors 
and seasonal influences. Particles typically contain high levels of elemental carbon, 
sulphates, nitrates (oxidation products of sulphur- and nitrogen- oxides), ammonium 
and associated organic material. The trace element composition of PM samples is 
often influential on its overall toxicity. Increased levels of bioavailable transition 
metals such as zinc, lead and iron, increase toxicity of samples in animal models 
(Richards et al., 1989. Adamson et al., 2000). In vivo studies (Rice et al., 2001) 
instilled equi-molar doses of a variety of metal sulphates into the rat and concluded 
that inflammation and lung responses were distinct for different metals. Therefore, 
chemical and metal composition must be taken into consideration, in addition to
13
particle size, when ascertaining the overall toxicity of pollutant or toxicant samples. 
Particulate size influences the behaviour of the aerosol, smaller particles are more 
likely to be deposited within the respiratory tract and remain airborne for longer, more 
likely to be transported further from their source than larger particles. In animal 
studies, fine and ultrafine particles have been found to provoke different magnitude of 
response in the lung, than larger particles. Oberdorster (1992) compared the 
biological effects of ultrafine (0.001-0.1/xm), fine (0.1-2/xm) and coarse (2-10/xm) 
titanum dioxide particles in vivo. It was concluded that the more severe response 
elicited by the smaller particles arose as a result of increased surface area and an 
increased particle number per unit mass of the ultrafine particles.
1.4 The Lung Response to Inhaled Particles
1.4.1 Particle Deposition within the Respiratory Tract
Particle deposition patterns within the lung have been modelled using radiolabelled 
particles to estimate the physical behaviour of particles in a simple anatomical model 
of the lung. Age, sex, health and personal activity levels are all instrumental in 
dictating the deposition of particles within the lung in addition to changes in 
deposition efficiency with different particle sizes. Higher deposition efficiencies of 
fine particles (<0.5 /xm diameter) were found in the smaller airways to terminal 
bronchioles and alveolar regions compared to coarser components (>1 /xm), these 
efficiencies increased in younger children for the same environmental exposure (MRC
(2000).
The lung has three main means of defence: mechanical, phagocytic and immune 
response. Nasal hair and impaction filters coarser particles (PM>10 microns in 
diameter) and foreign objects from the inhaled air. The nasopharynx serves to 
humidify passing air. The trachea and bronchi are lined with ciliated epithelium 
containing mucosal cells, responsible for secretion of a mucoid material lining the 
airways. Large particles enter the mouth and nose becoming deposited within these 
larger airways and are engulfed within the mucus secretion. Underlying ciliated cells 
beat in unison, pushing the overlying material into the upper regions, until it can be 
removed, either by coughing or swallowing (the mucociliary escalator). A key to the
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success of this method of clearance is the efficient production of peri-ciliary fluid, the 
maintenance of appropriate physiochemical properties of the mucus and integrity of 
the ciliated epithelium (MRC 2000). Lung or disease conditions that compromise the 
functioning of respiratory cilia such as cystic fibrosis will impede the clearance of 
particles in this manner. Particles within the smaller airways may also be removed 
from the lung via a macrophage-mediated clearance. Scavenging alveolar 
macrophages ingest the particulates or cellular debris and either digest the material or 
become particle laden and more rounded and removed from the airspaces via the 
mucociliary escalator. Failure to remove the particles or their associated chemicals 
may result in interaction with the respiratory epithelium. The chief targets for the 
particles would appear to be the epithelial cells, pulmonary alveolar macrophages and 
inflammatory cells. Particles are also removed from the lung tissue over a longer 
period of time involves the lymphatic drainage. Particles have been traced to the 
lymph nodes following exposure to inhaled particles. Lee (2003) reported cytoxicity 
within the lymph nodes themselves following lung instillation of crystalline silica, 
resulting in significant cellular changes both within the lung and pulmonary lymph 
nodes.
1.4.2 Particle Interactions within the Respiratory Airways
The fate of a particle deposited into the respiratory system is dependant on its 
solubility and ability of the lung to clear the particles from the airways. The 
bronchio-alveolar lavage fluid (BALF) is the first physical interface encountered by 
inspired particulate matter (Zielinski et al., 1999) and contains the antioxidant 
defences of the lung. The mucous and lining fluids sequester up to 35% of a 
delivered dose of PM into the lung. The BALF contains a plethora of antioxidants, 
such as ascorbic acid (AA), glutathione (GSH), super oxide dismutase and uric acid 
(UA), which sequester particles and associated compounds within the lung (Kelly and 
Richards, 1999). The BALF also contains surfactant, a lipid and protein rich solution 
that has an important role in the smaller airways of the lung, reducing surface tension 
of the airways and pulmonary alveoli. However, persistent particles may not be 
impeded by the BALF, the fluid may even serve to facilitate the release of potent
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chemical entities, such as bioavailable metals and free radicals, to invoke further 
challenge to the lung.
Particle deposition results in an immediate increase in surfactant and mucoidal 
production. Bioreactive particles may be able to penetrate the protective BALF and 
interact with the underlying epithelial cells. Alveolar macrophage (AM) cells will 
phagocytose the particles, and remove them from the respiratory tract. Particle laden 
macrophages become rounded and less mobile and may be degraded or removed from 
the lung via the mucociliary escalator or via the lymphatic system. Morrow (1988) 
showed that particles themselves might exert toxicity independent of any chemical 
interaction- the “particle effect” (Oberdorster, 1991). Pulmonary toxicity was 
achieved by decreasing the lung clearance of the particles with doses that resulted in 
as little as 6% of the alveolar macrophages becoming laden with engulfed material 
served to compromise of AM mediated pulmonary clearance. Macrophage mediated 
pulmonary clearance was significantly halted when 60% AM were loaded with 
particles. Exposure and alveolar macrophage mediated phagocytosis of extremely 
toxic particles, such as quartz, may result in toxicity to these cells by the internalised 
particles, further impairing pulmonary clearance. The decrease in particle clearance 
results in increased lung retention, increased exposure of the particles to the alveolar 
cells, increased epithelial cell mediated uptake of particles, increased interstitialisation 
and subsequent interaction with fibroblasts, culminating in lung inflammation, 
neutrophil influx and pulmonary oedema, measurable by biochemical and histological 
methods.
Alveolar macrophages are the primary source of pro-inflammatory mediators, and 
cytokines (including IL-8, TNF-a and IL-1) (Becker, 1996. Donaldson et al., 2003). 
The simultaneous release of chemotactic factors and signal molecules from activated 
(phagocytosing) macrophages attract more phagocytes to the alveolar surface, 
influencing epithelial permeability hence allowing cells from the blood to enter the 
lung tissue, protecting the lung from inhaled particles and simultaneously promoting 
further particle ingestion. With increased lung burden and overload at higher or 
longer exposures to suspended particles, large scale activation of AM’s results in 
excess release of these factors (reactive oxygen species, free radicals, proteases and
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growth mediators) and may result in AM cell lysis, spewing the cell contents and re 
releasing particles into the alveolar region. All of these have the potential to 
contribute to chronic lung injury, influencing neighbouring cells and if transported 
into the blood stream to initiate systemic effects (Khandoga et al., 2003). These 
effects are summarised in Figure 1.5.
Alveolar macrophage
Toxicity
(High exposure to 
reactive particles)
Activation
(Low exposure to 
reactive particles)
Overload
(High exposure to low  
reactive particles)
Inflammation
Imnaired clearance
Figure 1.5: Summary o f the interactions o f particles with alveolar macrophages. Low reactive particles 
include titanium oxide and reactive particles e.g. quartz. Adapted from IEH (2000) Airborne Particles: 
Exposure in the home and health effects.
Fine particles enter the interstitium more readily than larger sized particles (Richards, 
personal communication, 2003), eliciting a greater magnitude of inflammatory 
responses, a consequence of the larger surface areas of the particles. The smaller 
particles appear to remain undetected by AM’s longer and induce local chemotactic 
factors (to induce migration of AM’s) poorer than larger equivalent particles and so 
remain as free particles able to migrate into the lung cells and across the epithelium 
(Oberdorster, 1992). The longevity of the particles at the respiratory epithelium, the 
greater the possibility of damage to the underlying cells. Alveolar cells such as
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pulmonary macrophages, epithelial cells, fibroblasts and endothelial cells have the 
potential to release chemical signals into the airways such as tumour necrosis factors 
(TNF) and interleukin’s (IL), propagating the inflammatory response with the area. 
Macrophage phagocytosis is accompanied by the release of chemotactic mediators 
that may affect neighbouring cells or increase the permeability of the endothelial cells 
lining the blood capillaries, assisting neutrophil migration from the circulation and 
interstitium into the local area. Increases in the epithelial permeability facilitates the 
interstitisation of particles into the lung tissue and compromises epithelial integrity. 
Loss of the epithelial barrier integrity results in an influx of plasma protein into the 
alveolar space, pulmonary oedema. Reactive oxygen species (ROS) either in 
association with the particles themselves, produced from reactions with components 
in the inhaled PM (e.g. transition metal) or released from the lung cells may be 
released into the alveolar space. Mammalian cells contain an elaborate repertoire of 
enzymatic and non-enzymic antioxidants to scavenge ROS, under conditions of 
oxidant stress, the normal balance of ROS and antioxidant defences may be lost, 
leading to increased risk of oxidant mediated lung injury to the cells within the alveoli 
and their cellular components (cellular membrane and DNA).
A significant percentage of the any instilled dusts will be retained within the lung 
tissues. Oberdorster (1992) reported that 15% of ultrafine titanium oxide was 
retained, indicating the fraction that had left the alveolar surface and been taken up by 
the macrophages and into the interstitium. Ultrafine particles enter the interstitium 
more readily than the equivalent larger particles therefore exert greater pulmonary 
toxicity
It is possible that interstitialisation and subsequent uptake by and activation of 
interstitial macrophages creates a chemotactic gradient in the lungs shifting the influx 
of inflammatory cells into the interstitium rather than the alveolar space, decreasing 
the respective signs of inflammation in the alveolar space. Thus, reduced numbers of 
neutrophils are counted in the alveolar space in response to instillation of ultrafine 
particles compared to an equivalent dose of larger particles (Donaldson et al., 1998). 
Damage to interstitial cells including the fibroblasts and disruption to the cell 
communication between epithelial: interstitial communications. Disruption to cellular
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communications may result in loss of control of cell cycles, inappropriate cell 
replication and activation, deposition of cell products within the alveolar space and 
culminating, in extreme cases, remodelling of the alveolar regions and pulmonary 
fibrosis. The epithelial and pulmonary responses to lung injury is summarised in 
Figure 1.6.
'ibrogenesis
Fibrosis
Normal I -ung
Primary damage
Inflam m ation
Figure 1.6: Diagram summarising alveolar cell damage and repair. BM (Basement Membrane), F 
(fibroblasts), Co (collagen), PS (surfactant), AS (alveolar space), E (endothelial cell), M (macrophage), T1 
(Type 1 cell), T2 (type II cell) and PMN (polymorphonuclear leuocyte). Source: Richards (1991).
1.4.3 Local and Systemic Effects of Air Pollution Particles
Particles deposited within the respiratory tract provoke local inflammation, trigger 
allergic reactions in sensitised individuals and may exhibit cytotoxic effect to the lung 
epithelium resulting in cellular damage and pulmonary changes. Adverse effects may 
be either immediate (respiratory) or longer term (systemic effects).
Significant exposure to particulates or inhaled toxicants has been shown to elicit lung 
injury and inflammation, characterised by the compromisation of gaseous exchange 
and epithelial destruction leading to cell influx, surfactant dysfunction and pulmonary
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oedema. Inflammation is considered to be a response to the myriad of mediators, 
oxidants, growth factors and reactive oxygen species (ROS) generated at the lung 
surface in response to exposure to particles, toxicants or micro-organisms (Leikauf
2002).
Several studies have linked the increase in asthma symptoms and induction of asthma 
with ambient particles, some particles such as acidic particles of diesel exhaust have 
an adjuvant effect on IgE production in mice (COMEAP (1995)) and may interact 
directly with mast cells and airway cells influencing the release of mediators of 
bronchio-restriction.
Speculations of how lung inflammation can exert effects outside the lung include 
cytokines and chemokines released in the lung as a consequence of lung 
inflammation, entering the blood stream and altering cellular activity in other major 
organs including the liver and heart. Human volunteer (Magari et al., 2002) and 
animal studies (Watkinson et al., 2001) have shown a correlation between ambient 
PMio levels and irregularities in heart rate, heart rate variations and core body 
temperatures suggesting a putative effect on neuronal stimulation by PM i0. Cytokines 
may influence the sympathetic autonomic nervous system (ANS), increased vasal 
tone, increased heart rate and decreased heart rate variability (HRV) has been 
observed in the elderly during pollution episodes (Dockety, personal communication) 
potentially leading to increased incidences of cardiovascular attacks and mortality. 
Cytokines from sites of lung inflammation, may pass into the blood resulting in 
systemic oxidative state and/or enter the liver resulting in protein changes influencing 
fibrinogen levels, other cytokines and cell mediators. Increased blood coaguability 
induced by IL-6 expression, increased haemostasis, increased platelet and neutrophil 
levels and increased fibrinogen levels could contribute to an increased risk of 
cardiovascular complications (Seaton et al., 1999. Khandoga et al., 2003). Studies 
following the occupational exposure and heart rate variability in boilermakers (Magari 
et al., 2002) suggest an association between exposure to PM (sub 2 microns), 
particularly airborne metals and significant irregularities in cardiac autonomic 
function. Seaton (1995) hypothesised that particle deposition within the lungs of the 
elderly, very young or those with cardio pulmonary disease was increased compared
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to those healthy general population. This increased exposure would therefore carry an 
increased and potentially exacerbated risk in changes in inflammation, changes in 
blood coagulation and plasma viscosity that would pre-dispose to acute cardiovascular 
events. An alternative mechanism by which inhalation of PM may result in greater 
systemic effects relate to the normal balance in antioxidant defences, Rahman (1996) 
recorded severe imbalances in oxidant-antioxidant in the favour of oxidant stress in 
the plasma of smokers, chronic asthmatics and acute COPD patients, with evidence of 
lipid peroxidation. A model of effects induced by diesel exhaust/PMio in rats is 
illustrated in figure 1.7.
Longer-term exposure of particles, particularly diesel exhaust particles has been 
linked to increased incidences of cancer, attributed to surface associated PAHs and 
nitro-PAH’s. Bronchioalveolar tumours (adenomatous and carcinomatous lesions- 
type II cell hyperplasia and metaplasia) and squamous cell tumours have been 
reported in rats following high exposure to some particles (Morrow, 1996). Driscoll 
(1996) proposed that such neoplasia might be a secondary consequence of the chronic 
inflammation process, requiring prolonged inflammation and arising as a consequence 
of oxidant mediated genotoxicity.
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Figure 1.7: Possible mechanisms for the propagation of local and systemic effects of particle 
inhalation: Source: IEH (2000) Airborne Particles: Exposure in the home and health effects.
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1.5 Studying the Effects of Air Pollution
Local and systemic effects of particulates are usually studied in animal models. 
Common models are rodents, cats, dogs, rabbits, primates, pigs and horses.
Common methods of administration of particulates include instillation and inhalation. 
Instillation composes of a large dose in a one off distribution that can result in a large 
exposure for each animal. Inhalation involves exposure of the subject to an aerosol of 
the toxicant at a given concentration within a chamber.
Exposure route of cell cultures can also be varied. Dilution of dust suspensions in 
culture media provides a means of direct exposure, as adopted by this study. 
However, obviously it does not reflect the situation in vivo, whereby the toxicant will 
be altered by components within the epithelial lining fluid. A large variety of cell 
types exist in the lung, which interact to produce co-ordinated cell and organ 
responses. The use of isolated cell cultures may not completely reflect their 
behaviour in situ, resulting in destruction of spatial relationships critical to normal cell 
function and maintenance of differentiated state. Primary cell isolates have increased 
longevity over perfused organs and tissue extracts, it has also been shown that they 
retain characteristics and function over a greater period, that may otherwise be lost in 
cell lines (Dobbs et al., 1997. Reynolds et al., 1999. Oreffo et al., 1988). Good 
toxicological research with isolated cells will lead to a better understanding of the 
whole lung, and thus will contribute to a better understanding of the pathogenesis of 
other lung diseases (Nemery and Hoet, 1993).
The plethora of cell types within the lung renders the in vitro study of an individual 
primary lung cell type more difficult than would be the case for other organs, such as 
the liver. Standardised, efficient isolation methods are required to produce 
functionally viable homogenous type II cell cultures, in order to produce reproducible, 
reliable results from any subsequent study. Epithelial type II cells have been isolated 
from the lung by several different methods (Table 1.2). Great emphasis has been 
placed on isolating and culturing of the cells to maximise the sustained expression of 
type II cell characteristics and phenotypes in vitro (Oreffo, 1987, Reynolds, 2001).
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Any study of isolated type II cell cultures requires the consistent isolation of high 
purity populations. Type II cell isolation has been developed over the last 20 years 
and in a variety of methods adopted The isolation methods adopted and subsequent 
culturing can introduce great variability within studies.
Table 1.2: Historical development o f Epithelial type II isolation
Research group Date Method adopted
Kikkawa & Yoneda 1974 Crude trypsin/Ficoll 
gradient
Greenleaf et al. 1979 T rypsin/ centrifugal 
elutriation
Dobbs et al. 1980 & 1986 Elastase/Trypsin
Centrifugal
Elutriation/Panning with 
IgG
Leary et al. 1982 Phosphine-3R Probe on 
rabbit type II cells/Laser 
flow cytometry
Finkelstein & Shapiro 1982 Low elastase/Trypsin
Skillrud and Martin 1984 Elastase/Percoll gradient
Richards et al. 1987 Trypsin/Percoll gradient
Primary epithelial type II cells can be maintained in culture but will readily lose their 
characteristics of differentiated function in vitro. The meaningfulness of any in vitro 
study on type II cell cultures is highly dependant on the similarities in morphology 
and function of the cell culture compared to in vivo. Culturing of the cells is of great 
importance and requires mimicking the cell environment in vivo, this has been 
achieved through culturing on biological substrata such as ECM at high plating 
densities (Reynolds, 2000) or using cell feeder layers to mimic cell to cell contacts 
between type II cells and fibroblasts (Shannon 1987).
24
1.6 Toxicogenomics and Gene Expression Studies
1.6.1 Introduction to Toxicogenomics
Toxicology investigates the harm that chemicals may cause to humans. 
Toxicogenomics is an extension of this science, reflecting recent advances in our 
knowledge of the genome and technology evolved around this. Described by the 
National centre for Toxicogenomics as “an important complementary investigation, 
not replacement for existing strategies, aimed to significantly increase and improve 
our understanding o f basic biological responses to environmental stressors and 
toxicants” (NCT statement, 2000). Specifically, toxicogenomics may be defined as 
the study of the relationship between structure and activity of the genome and adverse 
biological effects of exogenous agents (Aardema et al., 2002), concerned with the 
characterisation of the genetic responses of cells and tissues to variety of toxicant and 
chemical insults.
Toxicogenomics is one of the families of emerging global disciplines, termed “-omic” 
technologies. Other strategies encompass the study of alternate intracellular bio 
molecules as an insight into cellular events: DNA (genomics), RNA
(transcriptiomics), proteins (proteomics) and cellular metabolites (metabonomics).
1.6.2 The Basis of Toxicogenomics
Toxicity is often preceded by, and results in, an alteration of gene expression and 
therefore toxicogenomics may serve as a more sensitive, characteristic and 
measurable endpoint than more conventional techniques. The challenge for the 
toxicologist is to define, under given experimental conditions, the specific expression 
profile elicited by a given toxicant (Nuwaysir, 1999). It is hoped that toxicogenomics 
may provide an opportunity for scientific advance into the categorization of toxicants 
according to their mode of action. Toxicogenomics has been employed to assess and 
characterise changes in transcriptional and signal responses as a consequence of a 
variety of stresses, providing an insight into mechanisms of toxicity. Fingerprints of
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specific gene changes will provide the necessary information to design predictive 
toxicity, defining mechanisms with the potential to predict toxic responses. 
Identification of biomarkers that may serve as early sensitive indicators of potential 
toxicity following personal exposure before any clinical manifestations.
The gene array system is used to produce expression profiles or expression 
"signatures” from samples promoting the identification of key genes involved in the 
response, recovery and toxicity. The system has great potential, a powerful tool 
yielding large amounts of information on the snap shot of a sample’s expression 
profile, providing a differential gene display with information on genes identically, 
similarly or distinctly expressed in the lung (Leikauf et al., 2000). This could 
potentially assist in hazard assessment of chemicals without the reliance on larger 
scale animal studies and lead to a greater insight into putative mechanisms of toxicity. 
The generation of a comprehensive data bank of gene profiles for a range of 
chemicals and toxicants could facilitate their classification based on similarities in key 
obligatory genetic processes leading to the toxic effect.
The gene array technology could produce toxicant profiles that may serve to further 
our understanding of the mechanism of toxicity or the signalling pathways leading up 
to the onset of toxicity. They have the potential to be more sensitive, assessing 
relative changes at lower dose levels than those required to exert effects in animal 
studies, importantly, reduction in doses used may reflect more of the real life 
exposure to toxicant. Currently animal studies may use higher doses of exposure to 
ascertain the nature of the toxic effect and extrapolate any conclusions back to real 
life exposure. Alternatively, the use of human cell systems and arrays may further 
reduce the need to extrapolate between species. Two main types of gene array are 
oligonucleotide arrays (containing short oligo sequences bound to the solid surface) 
and cDNA gene arrays. Arrays may be either macroarrays, cDNA sequences fixed to 
a flexible membrane such as nitro-cellulose or nylon, or microarrays (biochips), using 
a solid surface such as glass. Micro arrays have a greater capacity than macroarrays.
However, the generation of large amounts of data lends to be easily misinterpreted. 
Investigators must decipher between sensitive changes in gene expression that may
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not be correlated to the toxicant at all, merely an adaptive or inconsequential change 
not related to the experimental conditions, alternatively, the changes may reflect part 
of a defence mechanism that may or may not contribute to cell toxicity.
Macro or microarrays have been successfully incorporated in studies examining key 
gene changes and early responses to specific toxicants and to generate more global 
impression of changes in genes within cell pathways. The gene array has been 
employed as a means to generate hypotheses: fishing for clues which may be 
consequently supported by alternative methods, or as mechanistic assessments of 
toxicity, using designed arrays of relevant genes to examine perturbations on known 
gene pathways.
There are technical difficulties that must be overcome prior to successful analysis of 
any data. The array reflects changes only at the RNA level; changes at the protein 
level are not taken into consideration. The generation of large volumes of data can be 
overwhelming and it is important to consider the physiological relevance of any 
results. However, arrays have been successfully used to profile genes e.g. for down 
stream of tumour suppresser genes in lung cancer invasion (Kaminiski et al., 2000) 
and have proven to be a simple and accurate technique, comparable with the 
conventional southern blot.
1.6.3 Limitations and Requirements in Array Data Handling
Nadon (2002) outlines features of array experiments that may influence the validity of 
such experimental conclusions if not correctly addressed within the experimental 
design and data analysis, a goal shared by the MIAME guidelines (Brazma et al., 
2000). A common aim of all array experiments is the identification of differentially 
expressed genes between two or more different scenarios, which may be attributed to 
true biological basis rather than random error. Suitable experimental design, 
including the use of standardised array protocols and adequate number of replicates of 
array experiments (a minimum of 3-4 replicates per treatment group has been 
recommended- Nadon, 2002) will minimise the systemic errors and reduce random 
variations in gene expression.
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Data transformation to stabilise the variance within the array data and to correct the 
data to a more normal distribution is required. Speed (2000) recommended the use of 
log transformation, although log transformation of raw expression data background 
adjusted) serves to eliminate significant numbers of extremely low expressed/non 
expressed genes (adjusted expression is close to zero). Rocke and Durbin (2001) 
examined the effect of such a transformation on the variance amongst replicates and 
concluded that using log transformation (background adjusted expression +c)~ 
whereby c is any constant positive integer, serves to provide greater data stabilisation 
for all highly expressed or lower expressed genes. Other approaches have 
incorporated more detailed and advanced mathematic algorithms to establish 
transformation calculations (Hawkins, 2001). Kroll (2002) describes and evaluates a 
variety of scaling factors for normalisation within array experiments. The paper, 
primarily assessing a methodology to determine the quality of array data sets, 
establishes the use of an array mean expression, array trimmed mean and median 
expression values as potential scaling factors. The study concludes that using their 
data sets; a trimmed mean normalisation-scaling factor provided “reasonable 
normalisation result”, the use of a mean expression value was highly biased toward 
extremely expressed genes (sensitive to saturation and high background noise). All 
values were explored in the development of the procedures to analyse array data 
(chapter 3).
Laboratory based validation is a necessity, providing an independent experimental 
verification of gene expression levels preferably within the same samples/tissue 
source used in the initial array experiments (Chuaqui et al., 2002). Da Silva (2003) 
adopted the Atlas nylon arrays (Chapter 3 and 6) to assess the pulmonary responses 
following exposure to the pulmonary toxin, ricin. The paper outlines the array 
procedure and subsequent validation of results using RT-PCR. Normalisation of the 
array data using trimmed mean scaling factors, as explored in chapter 3, in 
conjunction with transformation and statistical evaluation provided promising results 
and led to the identification of candidate genes in the pulmonary toxicity observed 
following inhalation exposure to ricin in mice. The study links genomic, histological
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and physiological effects arising as a consequence of the ricin exposure and 
contributes to the understanding of the ricin intoxication process (Da Silva, 2003).
1.7 Aims and Objectives
The overall aim of the study is to evaluate the toxicity of well-characterised PMio 
collected from the South Wales conurbation with a variety of model test systems.
Firstly, changes induced in lung permeability and inflammation were examined 
following the instillation of PMio into healthy rats (Chapter 2). Assessment of the 
changes were made utilising quantitative biochemical and cellular techniques of lung 
lavage samples coupled with more subjective histopathological assessment. Gene 
profiling was then carried out on selected lung tissue samples to identify important 
molecular changes brought about by PMio following the pollutant-induced increased 
permeability and inflammation (Chapter 3). This work was carried out using 
commercially available macroarrays and required development of the best methods to 
interpret the mass of bioinformatic data.
Following this, attention was given to two important target cells for PMio in the lung, 
namely the alveolar macrophage and epithelial type II cell. The cells were isolated, 
exposed in vitro to PMio and the toxicity assessed utilising a semi-quantitative 
detachment assay and nuclear changes associated with cell apoptosis (Chapter 4). In 
the latter regard, such studies were carried out utilising a new experimental tool, the 
IN Cell Analyser™ 1000 in conjunction with Amersham Biosciences, UK. Once the 
in vitro assays provided a dose that caused stress to the cells, but not overt cell death, 
a final gene expression study to identify candidate genes for PMio was undertaken 
(Chapter 5).
It was anticipated that this series of investigations could better identify the importance 
of durable particles and the role of soluble metals in producing mild pulmonary 
changes or stress in important lung target cells.
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Chapter 2.0
In vivo characterisation of the pulmonary 
toxicity induced by the instillation of Cardiff
PMio *nto the rat
2.0 In vivo characterisation of the pulmonary toxicity 
induced by instillation of Cardiff PM10 into the rat
2.1 Introduction
The respiratory surface comprises approximately 75 m2, over 40 times greater than 
the exterior body surface area. The respiratory surface constitutes the primary defence 
against inhaled foreign bodies and xenobiotics, harbouring an extensive myriad of 
defence mechanisms and strategies to facilitate the detection and detoxification of 
these moieties. A healthy adult inhales approximately 20 m3 of air per day (Baeza- 
Squiban et al., 1999), national guidelines for air quality have enforced a 24 hr 
standard of 50 ptg/m3 for PMio at this level there is a potential exposure of up to 1 mg 
per day, a significant and possible threat to human health.
Epidemiological studies have reported strong associations between ambient PMio 
(particulate air pollution with a mean aerodynamic diameter less than or equal to 10 
microns) and several adverse health outcomes, including death and increased hospital 
admissions for cardiopulmonary and respiratory conditions (Anderson et al., 1995, 
Pope et al., 1995, Schwartz et al., 2001).
There have been few studies whereby animals have been exposed to ambient PMio for 
toxicological investigation. Studies by Watkinson (2001) investigated the extra- 
pulmonary responses of rodents to ambient pollutants. The studies provided support 
for human epidemiological evidence by showing decreases in important indices of 
cardiac and thermo-regulatory functions. The same study also reported increases in 
blood pressure, decreases in heart rate and core body temperature, increased 
incidences of arrhythmia and lethality following both instillation and inhalation 
exposure of particulate matter and co-exposure of PM and ozone in rats, mice and 
guinea pigs.
The instillation of PM surrogates such as diesel exhaust particles into male rats has 
indicated that these particles induce transient but early changes in pulmonary oedema 
and inflammation (Murphy et al., 1998). Studies by Adamson et al (1999) examined 
the toxicity of doses (inhalation exposure to 54 fig/m3 over a four-hour period) of an
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atmospheric dust sample collected from Ottawa (EHC-93). The studies involved the 
instillation of a fractionated sample (mean diameter <lfim) into mice, and reported 
that inflammatory responses, epithelial necrosis and damage were evident within a 
week post-instillation. Investigations (Adamson et al, 1997, 1999 and 2000) showed 
that this bioreactivity could be attributed, in part, to the soluble fraction (15% by 
mass) of the EHC-93 sample and specifically the bioavailable (water soluble) metal 
content including zinc and copper salts that were found at high levels in this fraction.
The investigations described above were possible in that large amounts of a respirable 
fraction of PM could be obtained from processing ambient matter collected by huge 
roof filter traps. Recent improvement in sampling ambient particulate matter has 
facilitated the collection of increased yields of PMio by means of high volume air 
collectors. The particles are collected as PM 10-2.5 or PM2.5-0.1 fractions and are directly 
trapped by inert (polyurethane foam) filters that do not contribute to the bioreactivity 
of the PM. Such collections better represent the mixture of ambient particulate 
pollution than many of the surrogate dusts previously used. By means of such high 
volume samplers the collection and moiphological and chemical analysis has recently 
been completed on PMio samples from the South Wales conurbation (Moreno et al., 
2003). These workers have shown that the levels of detectable transition metals and 
zinc were present in both soluble and insoluble fractions and were highly dependent 
on source and weather conditions during sampling. In contrast to the Canadian 
sample, the south Wales, UK soluble fraction contributed up to 70% by mass of the 
PM 10-0.1. Further in vitro toxicological studies showed that most of the oxidative 
potential of the UK PM samples was found in the water soluble fraction of PMio 
(Greenwell et al., 2002). The contribution of individual and mixtures of these soluble 
metals, including zinc and selected transition metals, to the oxidative capabilities of 
this PM fraction is still under investigation. Ascertaining the contribution of the 
various components ofPMiois an important step towards deciphering the mechanisms 
involved leading up to observed lung inflammation and systemic health effects.
Use of the superior, high volume collectors enables sufficient PM samples for in vivo 
studies and the aim of the present investigation was to examine the short-term 
pulmonary responses to fully chemically and morphologically characterised urban PM 
samples. Cardiff PMio has been fully characterised within our laboratory, using Field
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Emission Scanning Electron Microscopy and Image Analysis (morphological 
analysis) in addition to EPXMA and Inductively coupled plasma mass spectrometry 
(ICP-MS) for chemical composition (Moreno et al, 2003). Conventional toxicological 
methods were used to assess pulmonary oedema and inflammatory cellular influx at 
the alveolar surfaces following instillation of three different fractions of the PMio, the 
whole PMio, the water soluble component and the insoluble “durable” particles that 
remain after washing the whole PMio. The water soluble fraction comprises of metals 
and organic compounds, and has been found to contribute up to 70% by mass of the 
particles (Moreno et al., 2003). Durable particles have greater longevity at the 
epithelial surface and the carbonaceous material, devoid of adsorbed compounds and 
reactive species have been found to induce inflammation (Oberdorster et al., 1990). 
In the present study, a dose of PM or a derived fraction (0-10 mg/animal, n=5) was 
introduced by a single intracheal instillation into healthy male Sprague Dawley rats. 
Animals were sacrificed at 3 days post-instillation, to ascertain the extent of 
pulmonary oedema and existence of inflammation, and at 6 weeks, to examine if any 
inflammation persisted or was just an early transient event. Pulmonary oedema and 
inflammatory events were measured at each time point using changes in lung to body 
weight ratio, changes in total acellular lavage protein and total and differential large 
free cell counts. Lung parenchyma to body weight ratio and total lavage protein are 
indicators of pulmonary oedema, a consequence of a loss of integrity to the 
pulmonary epithelium accompanied by an influx of cellular and plasma protein into 
the alveolar space. Free cell counts and differential staining were incorporated to 
establish the magnitude of inflammatory and phagocytic cellular influx into the 
alveolar regions. This semi quantitative assessment of lung damage was correlated 
with lung histology to assess changes of lung and lymph node architecture arising 
from PMio instillation.
This part of the work programme was completed in conjunction with Dr Lucy 
Reynolds and was funded under the NERC urgent programme.
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2.2 Materials
Male (200-250g) Sprague Dawley Rats (pathogen free, CD-I) were purchased from 
Charles River Ltd, Margate, Kent Euthatal and Halothane was purchased from Rhone 
Merieux, Harlow, Essex. Streptomycin/penicillin (P 0906 was purchased from 
Sigma, Poole, Dorset The sterile Luer cannulae (200/300/050) were obtained from 
Portex, Hythe, Kent Bradford Reagent (B6916.), Evans Blue (E2129) and Tween-20 
(P7949) were purchased from Sigma, Poole, Dorset. HRP Conjugate Sheep anti 
mouse Secondary Antibody (NA 931) was purchased from Amersham UK. rT 140 was 
kindly donated by Dr Mary McElroy (Rayne Laboratories, University of Edinburgh). 
Immobilon-P membrane (PI5552) was supplied by Millipore. Lambs Quick stain was 
purchased from Raymond A Lamb (Lamb/034-K)
2.3 Methods
2.3.1 Preparation of Instillate
PM 10-2.5 and PM2.5-0.1 were collected on polyurethane foam (PUF) filters using the 
High Volume Cascade Impact Illutriator (Moreno et al, 2003). In brief, air is sucked 
through the collection head at a rate of 1100 L/min. This system provides a larger 
collection of dusts than other methods (TEOM, Partisol, Negretti) providing sufficient 
sample for in vitro and in vivo studies. The PM samples were removed from the filter 
using a standardised protocol (Moreno et al, 2003), enabling the consistent 
preparation of fractions between other studies (Greenwell et al., 2003. Moreno et al.,
2003). The PM used in this study (see section 2.3.1) was collected near Cardiff city 
centre over a 43-day period in January-March 2001, termed CF 2, the same sample 
was also used for tissue and cell toxicogenomic assessment and in vitro cellular 
toxicity studies in this thesis (Chapter 3-5).
Pre-weighed PUF filters containing both the 10-2.5 micron and 2.5-0.1 micron 
fractions of PMio were halved and each portion placed in 5 ml double distilled and 
autoclaved water. The samples were loaded onto a Vortex (Vortex Genie 2, Scientific 
Industries) for one hour at medium speed and then sonicated gently (1 minute) to
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remove the dust particles. The PUF filters were removed from the solution 
(designated wash 1) and transferred to a fresh volume of water (5 ml, double distilled) 
and underwent a second period of vortexing (30 minutes) and sonication (1 minute). 
The solution was stored overnight (4°C) and then was vortexed (3 hours, medium 
speed) once again and sonicated (1 minute) ensuring that the filters were well 
submerged in the water.
The PUF was removed and water squeezed from it. The solution was transferred to a 
fresh (weighed) tube (designated wash two) and both the first and second wash were 
freeze dried to leave the collected PM. This was weighed and the percentage 
recovery calculated.
The PM 10-2.5 and PM<2.5 fractions were pooled and re-suspended in sterile water to a 
stock concentration of 20 mg/ml. A volume of this stock was removed and 
centrifuged (1,000 x g, 2 hours). The supernatant containing the water soluble 
fraction at a concentration equivalent to 20 mg/ml of PMio was stored. The durable 
washed particles were re-suspended to the equivalent concentration. Freshly collected 
and processed samples were used for the experiments to reduce the possible effect of 
ageing on the toxicity observed (Murphy et al., 1999. Johnston et al., 2000). Whole 
PM io and the equivalent doses of washed particles and water soluble component 
fractions were prepared for 5 mg, 10 mg and 20 mg and saline sham-treated control 
(n=5) (0.15 M NaCl). Each animal was instilled with 0.5 ml of solution.
2.3.2 Instillation and Sacrifice
Male Sprague Dawley rats were acclimatised within the animal holding facility for 
one week prior to instillation. The animals were kept on wire-bottom cages with 
pelleted food and tap water ad libitum. The animals were lightly anaesthetised with 
Halothane before receiving a single intratracheal instillation of PM suspended in 0.5 
ml of saline (0.15 M). Sham-treated controls received saline only. Animals (n=5) 
were instilled with doses of 10 mg, 5 mg, 2.5 mg of each whole PM sample and the 
equivalent doses of washed “durable” particles and water soluble fraction of Cardiff 
PM (CF 2). Animals (n=5) from each exposure group were sacrificed at 3 days post
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instillation and 6 week post instillation. A farther set of animals (n=3) exposed to 10 
mg whole PMio and water soluble components (3 days) and 10 mg whole PM (6 
weeks) in addition to respective sham-treated saline controls, were instilled for 
histological examination. All animals were carefully monitored post instillation and 
throughout the recovery time. Body weights and general health of each animal was 
carefully recorded in accordance with Home Office guidelines. With all treatments, 
there was no significant alteration in body weights or any adverse effects on the well 
being activity of any animal.
All animals were sacrificed by anaesthesia with Halothane and then administered a 
lethal intraperitoneal injection (1-2 ml) of Euthatal. Each animal was subsequently 
weighed and cardio-respiratory death confirmed prior to dissection.
The far was washed with ethanol (70 % v/v) and the ventral surface skin removed. 
The peritoneal cavity was opened by midline incision and the major dorsal blood 
vessels cut. A tracheotomy was performed and a Luer Cannula, attached to a 20 ml 
syringe, securely tied into place in the trachea. The diaphragm was subsequently 
opened and the ventral portion of the rib cage and thymus removed.
A Luer cannula attached to a gravity feed of sterile saline was then fed into the 
pulmonary artery and the right atrium was cut upon expansion to allow fluid to exit. 
The lungs were perfused via artificial ventilation with 8-10 ml of air by means of the 
syringe attached to the luer cannula of the trachea, until the pulmonary circulation was 
clear of all blood to produce white parenchyma lung tissue (usually 8-10 ventilations).
The heart was removed and the lungs and trachea dissected free from the carcass. The 
oesophagus and any fatty tissue were dissected from the lungs and trachea. Any 
mucoidal material or blood clots on the exterior of the tissue were removed by means 
of absorbent tissue and the lung and trachea weighed. Digital photographs of the 
gross anatomy of the lung were taken at this stage to detect any overt damage and 
deposition of particulate material.
The lungs were lavaged (five to eight times) with 6-8 mis of saline (0.15 M). The 
resultant lavage fluid was pooled in a centrifuge tube and maintained on ice. Lavage
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was centrifuged (300 X g, 15 minutes) and the cell pellet re-suspended in saline (0.15 
M, usually 3 mis) to enable the large free cell count (LFC) to be estimated using a 
haemocytometer. Aliquots of the supernatant lavage fluid were frozen in liquid 
nitrogen and stored for protein analysis.
The remaining lung parenchyma was cut from the trachea, dried and snap frozen in 
liquid nitrogen in preparation for genetic studies (see chapter 3) and stored below 
minus 70 °C until use. The trachea weight was subtracted from the initial lung and 
tracheal weight to give an approximation of lung parenchyma weight for each animal. 
This was used to calculate the lung parenchyma to rat body weight ratio, used as an 
estimation of pulmonary oedema within the animals.
Lavage free cells were diluted to 200,000 cells/ml in saline (0.15 M). Cytospin 
preparations were prepared from these samples. Slides and filters were sealed into 
cytospin chambers and the diluted LFC suspension (0.5 ml) added prior to 
centrifuging (8,000 X g , 5 minutes). Slides were removed and left to air dry and 
stored at room temperature. Slides were fixed and subsequently stained with a 
general-purpose nuclei stain and finally mounted. In brief, a three step fixing and 
staining procedure as carried out in accordance to manufacturers protocol (Raymond 
A Lamb Ltd). The Lamb Quick stain kit uses three solutions, fixative to stop 
metabolic processes, an acid dye with affinity for basic cell components and a basic 
dye, with affinity for acidic cell components, staining cells on the cytospin - a 
Romanowsky type effect. Each slide was dipped in fix solution (4 seconds), followed 
by both dyes in turn (4 seconds), with a final rinse in water before being left to air-dry 
at room temperature. The slides were then mounted using DPX mount and analysed. 
This stain facilitates the differentiation of cell types by highlighting characteristic 
features of cells within the section.
Neutrophils were identified based on differences in size and nuclei structure from 
macrophage cells. Neutrophils are smaller and their nuclei more lobular in 
appearance, in contrast to the larger and rounder nuclei of the macrophage. Increases 
in total cell numbers (macrophages and neutrophils) are indicative of an inflammatory 
response. An increase in the proportion of neutrophils is usually considered as a more 
acute or progressive inflammation (Richards et al., 1999).
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23.3 Preparation of Lung tissue for Histological Assessment
Animals exposed to 10 mg whole, 5 mg whole and 10 mg water soluble fractions of 
Cardiff PM (3 days) and 10 mg whole PM (6 weeks) alongside sham-treated controls 
at each time point (n=3) were sacrificed as outlined previously. Non-perfused lungs 
were dissected free from the lung tissue and lymph tissue removed. The lung tissue 
was immediately fixed in 10 % v/v formal saline introduced via a tracheal cannula. 
The whole lung preparation was then stored in 10 % v/v formal saline for at least 2-3 
days to ensure complete fixation. The equivalent lobe from each lung was dissected 
free and paraffin embedded in preparation for slide preparation. The sections were 
fixed onto glass slides and stained using Hematoxylin and Eosin (H and E), a general- 
purpose stain universally used for routine histological examination of tissue sections. 
Hematoxylin acts as a basic stain and binds nucleic acids, which appear blue in the 
nucleus and cytoplasm. Eosin is an acid aniline dye that stains the more basic proteins 
of the cytoplasm pink, nuclei stain blue-black, red blood cells appear orange to red 
shades and fibrin deposits appear deep pink to red. Slides from each animal were also 
stained with Trichrome Massons. This stain is commonly used to assess the 
deposition of collagen in tissue sections. Cell nuclei appear blue to black, muscle, red 
blood cells and fibrin appear red and connective tissue stain blue-green using this 
stain.
Lung sections were subsequently analysed for morphological changes arising as a 
result of the instillation.
23.4 Conventional Toxicological Assessment
Total protein was measured in the lavage fluid using a standard Bradford™ assay, 
using a series of diluted bovine serum albumin (BSA) standards. Briefly, a sample of 
lavage fluid (100 /xl, n=3) was mixed with Bradford™ reagent (Sigma, 50 /xl), 
alongside BSA standards diluted (0-20 /xg/ml) total protein used on a 96 well plate. 
The plate was incubated (5 minutes, room temperature (RT)) and absorbance recorded 
(595 nm).
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1T I 40 analysis was completed on lung lavage fluid supernatant. rTUo is a monoclonal 
antibody marker for an apical surface protein of rat type I cells, a potential target for 
PM io- Thus increases in fT l4o ui the lavage fluid would be expected if the type I cells 
were compromised or damaged following PM administration (Dobbs et al., 1988). 
Lung lavage was diluted in pH 8.2 tris buffered saline (TBS - 15.5 mM Tris and 0.15 
M NaCl) to a final concentration of 2 pg protein/100 pL TBS, lung tissue to 1 pg 
protein/100 pL TBS. The lavage samples (100 pi) were applied to Immobilon - P 
membrane (Millipore) using a dot-blot apparatus (Biorad). The membranes were then 
blocked (2hrs, RT) with 5 % w/v non-fat milk in TBS. They were subsequently 
incubated with monoclonal antibody against rT l4o (1:100 diluted in blocking buffer) 
(30 minutes), washed with TBS containing 0.05 % v/v Tween-20 (TBS-Tween) (30 
minutes) and incubated with sheep anti-mouse secondary antibody conjugated to 
horseradish peroxidase (1:5000 dilution, Amersham, 30 minutes, Dobbs et al., 1988). 
Blots were washed again with TBS - Tween and then developed utilising enhanced 
chemiluminescence reagents (ECL, Amersham). Blots were exposed to film 
(Amersham Hyperfilm ECL) for 30 minutes. In all cases a control blot was 
performed in which primary antibody was not added. Semi-quantitative analysis of 
results was achieved by reading the membrane on a plate reader at 540 nm (McElroy 
et al., 1995).
Adult rat lung homogenate of known protein concentrations was used to standardise 
the rTUo assay. For data analysis 1 pg of rT l4o was equivalent to the rT l4o 
concentration of 1 pg (wet weight) of adult rat lung homogenate.
23.5 Expression of results and Statistical Analysis
Data for each group (n=5) was tested for normality using the Anderson Darling 
statistical test for normality. Non-parametric data was analysed using a Mann- 
Whitney statistical test. Parametric data was analysed using a two-sample t-test. A 
significant difference between the group data was taken when p<0.05.
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2.4 Results
2.4.1 Collection and Preparation of the PM samples
The Cardiff PM lo-o.i sample was collected as part of a comparative study described by 
Moreno (2003). A total of 697.05 mg was collected in the Cardiff location, over a 43- 
day period between January 2001 and March 2001, a daily average of 38 mg per day. 
Weather conditions and wind direction were recorded during the collection period and 
were described as variable, with wet conditions dominating the first 15 days of 
sampling, followed by a period of colder, drier and less humid conditions. The PM2.5- 
0.1/PM10-2.5 ratio during these collections was high (2.8-4.2) as expected with a PM 
sample containing a high contribution of traffic related pollution. PUF filters were 
changed every 4-11 days depending on collection rates. PM10-2.5 and PM 2.5-0.1 
fractions were recombined after removal from the filters with respect to the average 
recorded PM2.5-0.1/PM 10-2.5 ratio to provide the PM 10-0.1 sample for instillation.
2.4.2 In vivo Toxicity of PM
2.4.2.1 Summary of in vivo Responses to Cardiff PM Instillation
A summary of the mean data recorded for each group is shown in Table 2.1. Changes 
in lung to body weight ratio, total non-specific lavage protein and large free cell 
counts have been calculated as group averages and SEM calculated (n=5). A high 
degree of animal-to-animal variation was observed in the response to the different PM 
fractions by each parameter with the exception of lung to body weight ratio.
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Table 2.1: Summary o f group mean (n=5) and Standard Error of mean (SEM) for changes in lung to body weight ratio, total non specific protein in the lavage and rTi40 
reactivity of the lavage at 3 days and 6 week post instillation.
Time point Fraction Dose (mg) Lung/body weight ratio Total Lavage Protein (UtL per animal) rT140 reactivity
Mean SEM Mean SEM Mean SEM
3 days Control 0 0.0044 0.0001 2041 307 1511 272
Whole PM 2.5 0.0045 0.0001 2030 266 663 68
Whole PM 5 0.0048 0.0001 3358 328 608 68
Whole PM 10 0.0053 0.0002 5044 785 1360 375
Washed 2.5 0.0045 0.0001 1934 149 350 45
Washed 5 0.0047 0.0000 3927 316 809 171
Washed 10 0.0047 0.0002 3682 231 431 36
Soluble 2.5 0.0041 0.0000 1639 52 488 42
Soluble 5 0.0044 0.0003 2076 286 527 50
Soluble 10 0.0046 0.0003 4304 662 745 139
6 weeks Control 0 0.0034 0.0001 2445 43 320 50
Whole PM 2.5 0.0036 0.0001 2869 281 1006 200
Whole PM 5 0.0033 0.0001 3059 403 365 54
Whole PM 10 0.0031 0.0001 2982 135 557 123
Washed 2.5 0.0028 0.0001 2481 193 770 145
Washed 5 0.0031 0.0001 3199 403 763 167
Washed 10 0.003 0.0002 3307 277 554 73
Soluble 2.5 0.0031 0.0002 1974 0.1581 542 63
Soluble 5 0.0033 0.0001 2.250 0.2259 1010 184
Soluble 10 0.0031 0.0001 2721 0.2119 351 50
2.4.2.2 Changes in Lung to Body Weight Ratio
The lung to body weight ratio is a parameter examining the extent of pulmonary 
oedema within the lung. Increases in lung parenchyma weight are accompanied by 
loss of integrity of the barrier function of the epithelium, permitting the influx of 
plasma protein and water accumulation into the airways. A dose dependant increase 
in lung to body weight ratio was observed at 3 days post instillation (Figure 2.1a). 
Statistical significance was only observed at the highest dose of the whole Cardiff 
PM io fraction (10 mg, p=0.02), a 25% increase from sham-treated control and 
indicative of pulmonary oedema. At six weeks, this effect was diminished and no 
significant (p<0.05) differences from sham-treated controls were observed with any of 
the samples (Figure 2.1b).
2.4.23 Changes in Total Non-specific Lavage Protein
Total non-specific protein from the cell free lung lavage is a more sensitive measure 
of alveolar oedema than lung to body weight ratio. Instillation of the PM and other 
toxicants result in cellular damage and compromises the barrier function, resulting an 
increase in plasma protein and cellular debris within the alveolar space.
Dose dependant increases in total protein levels were observed for both water soluble 
and whole PM preparations at 3 days, this trend was also apparent in all whole, 
washed and water soluble fraction at six weeks. Approximately a two-fold increase in 
total protein was observed following treatment with as little as 5 mg whole PM or the 
equivalent dose of 10 mg water soluble fraction. Less pronounced increases were 
observed at six weeks. These results suggest the presence of pulmonary damage at 
both time points in all fractions of PM examined. The 10 mg dose or equivalent water 
soluble dose induced significant oedema at 3 days, as did 5 mg doses of whole and 
washed particles (durable fraction). However, instillation of the 2.5 mg and 5 mg of 
water soluble fraction failed to result in any increase in protein levels from the sham- 
treated controls. At six weeks, only 5 mg and 10 mg doses of the particle containing 
fractions resulted in significant increases in lavage total protein. In contrast the 
highest dose of the water soluble fraction had no effect at 6 weeks whereas the lowest
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dose (2.5 mg equivalent dose) produced a significant drop in lavage acellular protein 
compared with sham-treated rats. These results are illustrated in figure 2.2a-b.
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Figure 2.1: Changes in the lung to body weight ratio following instillation o f the increasing Cardiff (CF 
2) PM fractions at (a) 3 days and (b) 6 weeks post instillation. Values shown are group mean (n=5) and 
vertical bars representing SEM o f each group * denotes statistical significance (p<0.05).
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Figure 2.2: Changes in total non-specific protein at (a) 3 days and (b) 6 weeks post instillation o f 
Cardiff (CF 2) PMi0. Values shown are mean ±SEM (n=5) * denotes statistical significance (P<0.05)
2.4.23 Large Free Cell Numbers and Differential Counts
The large free cell (LFC) counts for whole, washed and water soluble instilled 
animals have been summarised previously (Table 1). There was a dose dependant 
trend at 3 days post instillation, with cell numbers of each treated group exceeding 
that of the sham-treated group with exception to animals exposed to the water soluble 
fraction (figure 2.3). At the earlier time point of 3 days, an increase of almost two 
fold was observed in free cells numbers at the highest dose, 10 mg (washed “durable” 
particles and whole PM). The increases were less apparent for all doses of water
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soluble treated group. Only the group exposed to 10 mg whole PM (3 days post 
instillation) was calculated to be significantly different from the control (p<0.05). 
This is a consequence of a high degree of animal variation related to small numbers in 
each group (n=5).
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Figure 2.3: Large free cell counts changes in response to whole PM, washed durable particles and water 
soluble fraction at (a) 3 days and (b) six weeks post instillation. Data shows group mean values (n=5) 
± SEM (vertical bars). * denotes statistical significance from control at the appropriate time (P<0.05).
Cytospin preparations of the lavage cells and cellular staining to differentiate alveolar 
macrophages and neutrophils showed that there was no significant presence of any 
neutrophils in any of the doses or fractions at either time point, indicating only a 
macrophage response at the lung surface.
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2.4.2.5 Changes in an Epithelial Type I Cell Marker in the Pulmonary Lavage
The apical epithelial type I cell marker, rT l40, was quantified in the lavage fluid from 
all animals (Figure 2.4). Levels of rT l40 are high (1400) in sham-treated animals and 
significantly lowered following most PM sample treatments at 3 days with the 
exception of 1 mg dose (whole and water soluble fractions, Figure 2.4a)
Six weeks post instillation rTl40 levels are much lower in sham-treated rats (300) 
compared to 3 days (Figure 2.4a/b). At 6 weeks most PM samples induce higher 
levels of rTl^. However, significant changes are not linked to dose or different 
specific fractions of the PM.
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Figure 2.4: A graph showing the decrease in rT l40 reactivity in lavage fluid collected from (a) 3 day 
and (b) 6 week post instillation. Reactivity o f r H 40 relative to reactivity in 1/zg lung tissue. Values 
shown are group mean (n=5)±SEM. •  denotes a statistical significance o f p<0.01.
45
2.4.3.2.6 G ross A natom y o f  th e  L ungs
Digital images of the whole lungs following dissection are shown in figure 2.5 and 
2.6. Lungs from sham-treated rats deflate very readily and consist of perfectly white 
parenchyma lobes (Figure 2.5a). In contrast, animals treated with whole PM (Figure 
2.5b-d) are mostly swollen and at 3 days there are clear regions of black particle 
(probably mostly from diesel exhaust) deposition throughout the parenchyma. The 
heaviest deposits of these particles are chiefly in the main bronchial/bronchiole 
branches (Figure 2.5d and g). Lungs treated with water soluble fraction of PMio 
remain white (like sham-treated) but are also swollen with light or clear translucent 
areas that do not deflate well (Figure 2.5h-j).
At six weeks, heavy carbonaceous particle deposition in whole and washed 
component exposed animals is still apparent compared to saline treated animals 
(Figure 2.6b-c). Translucent regions within the lung parenchyma of water soluble 
exposed lungs are still apparent (Figure 2.6d), but once again, to a lesser extent than at 
3 days.
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Figure 2.5: Gross anatomy of the lungs at 3 days post exposure of (a) sham-treated rats (b-d) whole treated PM10 2.5 mg, 5 mg and lOmg respectively (e-g) equivalent doses 
of washed durable particles and (h-j) equivalent doses of water soluble component of PMi0 Black arrows indicate regions of particle deposition in whole and washed PM 
exposed lungs. Blue arrows indicate swollen regions of lung tissue.
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Figure 2.6: Gross anatomy of the lung at 6 weeks following exposure to a) sham-treated saline animals (b) 10 mg whole PM (c) 10 mg equivalent dose of washed durable 
particles and (d) the equivalent dose of water soluble component.
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2.4.2.7 H isto logical E xam ination  o f  the  L ung
Sections of lung tissue from sham-treated rats and animals exposed to the 10 mg 
equivalent of PMio soluble fraction stained with H and E (Figure 2.7) or Masson’s 
trichrome (Figure 2.8) were compared. Sham-treated rats (Figure 2.7 and 2.8a-d) 
show normal lung architecture and clear alveolar spaces and thin epithelial lined 
walls. Clara cells, with protruding heads are normal in the bronchiolar epithelium and 
apparently unaffected by the saline instillate (Figure 2.7b). Alveolar septa remain as 
thin structures with no evidence of swelling as observed during some forms of 
particulate damage (Richards et al., 1999) (Figure 2.7b). Macrophages, devoid of 
particles lie free in the alveolar spaces (Figure 2.7d). At low magnification, lungs 
exposed to the water soluble fraction of PMio have similar architecture to sham- 
treated rats with normal bronchioles and clear alveolar spaces. The absence of any 
particulate matter confirms that the durable particles have been successfully removed 
from the water soluble fraction (Figure 2.7e-h). However, at higher magnification the 
lungs treated with water soluble fraction of PMio have noticeably greater areas of 
general thickening of the tissue which represent swollen micro-capillaries or the 
interstitial regions around these capillary areas (Figure 2.7 and 2.8 f-h).
The instillation of 5 mg whole PMio resulted in significant deposition of particles in 
focal regions of the lung tissue. Low magnification examination of the tissue (Figure 
2.9 and 2.1 Oh) shows that large regions of tissue are unaffected by the instillation of 
material but some regions, particularly close to the major airways have regions with 
heavy particle deposition. Increasing magnification of such areas highlights the 
presence of accumulations of carbonaceous particle associated alveolar macrophages 
that are found in greater numbers in alveolar spaces (Figure 2.9g, h and 2.1 Oh). 
Alveolar septae appear normal with little evidence of cellular thickening following 
instillation of 5 mg of PMio (Figure 2.9 f and h, figure 2.10h). However, in focal 
areas, tissue thickening is prominent with some evidence of cellular influx/increases 
around particle accumulations (Figure 2.9 and2.10 h). When rats are exposed to 10 
mg of PMio the prominence of focal dust deposition, alveolar accumulation of dust 
laden phagocytes and tissue thickening process is much more marked (Figure 2.9 i-1, 
Figure 2.10 j, 1).
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At six weeks post instillation of 10 mg of PMio, some residual particles are apparent 
in the alveolar regions particularly in individual macrophages (Figure 2.11 and 2.12). 
However, fewer macrophage accumulations are apparent than at the earlier time point 
and those that are evident are often within the larger airways (Figure 2.1 lb). It is also 
noticeable that the extensive tissue thickening in most interstitial areas are far less 
than that noted for 3 days exposure, suggesting partial resolution of the early acute 
effects. This may be related to clearance mechanisms for macrophages that join the 
mucociliary escalator or are transported via the interstitium to the thoracic lymph 
nodes.
Histological sections of lymph nodes from rats instilled with 10 mg of whole PM do 
show the presence of carbonaceous particles by 6 weeks (not shown). However, the 
cellular architecture and form of the lymph nodes are unchanged from that observed 
in sham-treated rats.
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Figure 2.7: H and E staining of sham treated (a-d) and rats instilled with 10 mg equivalent of PMio water soluble fraction (e-h) at 3 days post instillation. 
Increasing lens magnification is provided. Black arrow-protruding heads of Clara cells in the bronchiolar epithelium. Black arrow heads- alveolar 
septum. White block arrow- alveolar macrophage. Blue arrow- areas of tissue thickening involving micro-capillaries or interstitium.
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Figure 2.8:Massons trichrome stained lung sections of sham treated (a-d) and rats treated with 10 mg equivalent of PMio water soluble fractions (e-h) at 3 
days post instillation. Increasing magnification of the tissue is provided. Blue arrows highlight areas of alveolar or capillary or interstitial thickening 
with prominent collection of red blood cells (stained orange/pink with masons stain).
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Figure 2.9: H and E stained lung sections of sham treated (a-d) and rats treated with 5 mg (e-h) or 10 mg (1-1) whole PMio at three days post instillation (magnification of images 
provided). Blue arrow highlights macrophage accumulations containing black carbonaceous material within the alveolar spaces. Black arrowhead indicates alveolar septae. White 
arrows show regions of thickened tissue around particle aggregations.
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Figure 2.10: Masson’s trichrome stained lung sections of sham treated (a-d) and rats treated with 5 mg (e-h) or 10 mg (1-1) whole PM10 at three days post instillation (magnification 
o f images provided). Blue arrow highlights macrophage accumulations containing black carbonaceous material within the alveolar spaces. Black arrowhead indicates alveolar 
septae. White arrows show regions of thickened tissue around particle aggregations.
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Figure 2.11: Hand E staining of lung sections at 6 weeks post exposure to (a) saline treated control (b) 10 mg whole PM
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Figure 2.12: Massons Trichrome staining of lung sections at 6 weeks post exposure to a) saline treated control and (b) 10 mg whole PM.
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Discussion
A conventional toxicological and histopathological approach has been used to 
examine the effects of whole PMio, durable particles derived from this sample (30% 
of the total mass) and the water soluble components of the ambient particulate matter 
(70% of the mass). PMio and its component parts were instilled into rat lungs, a 
procedure regarded as aggressive compared to inhalation exposure. One advantage of 
the procedure however, is that an exact dose of material can be delivered to each 
animal. The instillation is rapid, animal handling is minimal and rats recover rapidly 
from the process.
Semi quantitative toxicological assays to measure pulmonary oedema (lung to body 
weight ratio, a cellular lavage protein), inflammation (number of and differential cell 
counts of free cells in lavage) and alveolar epithelial response (rTUo- type I cell 
marker) were carried out to determine the acute reaction (3 days) and to see if any 
effects persisted following clearance (6 weeks). No previous studies of this type have 
been reported for UK PMio but Murphy et al. (1999) have found that a transient lung 
oedema resulted from instilling 1.0 mg of diesel exhaust particles, one of the 
components of PMio. These workers consider that this effect was mild in that 
bioreactive dusts such as crystalline silica produce much greater inflammatory effects, 
at doses of 0.6 mg- 1.0 mg upon instillation into rats. Recently, Lee and Richards 
(2003) have reported cristobalite, a form of crystalline silica as a 5.0 mg instillate 
causes rapid inflammation, which progresses into more severe damage including 
lipoproteinosis and fibrosis.
Even at the highest doses of PMio (10  mg) used in the present study, no such damage 
was found. Indeed, the acute effects of 10 mg whole PMio, 7 mg of water soluble 
components (70% total mass of PMio) and 3 mg of durable washed particles (30% of 
total PMio) were all relatively mild.
The early effects (3 days) with whole PMio (10 mg) were dose dependant. A 10 mg 
instillation of whole PMio produced a significant increase in lung body weight 
suggesting oedema. A more sensitive assay measuring acellular lavage protein 
confirmed this oedematous response and was also observed at 5 mg instillation but not
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at a lower dose of 2.5 mg. The oedematous effect (lavage protein) was also noted 
with the durable particles alone at both 5 and 10 mg equivalent instillations. These 
durable particle preparations only contain 1.5 and 3.0 mg respectively in mass 
suggesting that the oedematous response may be more closely linked to particles than 
the soluble components of PMi0. Two further aspects of the data emphasise this 
deduction. Firstly, only the 10 mg soluble (actually 7 mg in mass) of the water 
soluble component instillate produced a significant increase in acellular lavage protein 
at 3 days which is only transient (not observed at 6 weeks). Secondly, significant 
increases in acellular lavage protein were found with both whole PMio and the durable 
fraction of PMio at the 2 highest doses used after 6 weeks suggesting significant 
oedema.
Oedema results from damage to the endothelial cells lining the capillaries or the type 
1 alveolar epithelial cells lining the alveolar surface. Thus, changes in a marker 
protein, rT l4o, for type 1 cells might be detected following alveolar damage or 
permeability changes. Indeed, following instillation of all PMio fractions, levels of 
rTUo in lavage were substantially reduced compared to sham-treated rats. There 
seems to be no simple explanation for this unless some mass destruction of type 1 
cells have occurred followed by rapid turnover of this cell membrane marker. 
Histological examination of the tissue offers no evidence for such an event. Ironically 
at 6 weeks post instillation when other measurements and histopathological 
examination suggested that the lung had repaired and was returning to normal 
architecture, a number of significant increases in lavage rTUo were detected. Again, 
there is no simple explanation for this observation.
Increases in the free cell counts, specifically of macrophage but not neutrophils, 
suggest a mild inflammatory response. This effect was only present at day 3 for the 
highest dose (10 mg) of PMio and resolved by 6 weeks. This correlated veiy well 
with the observations of the lung tissue sections. No macrophage response was 
detected with the water soluble fraction but focal aggregation of dust laden 
macrophages filled alveolar spaces in animals instilled with whole PMio after 3 days. 
This latter effect was not detected after 6 weeks with whole PMio when only 
individual particle laden macrophages were seen. Thus, the effect of a relatively large 
instilled dose of whole PMio is transient with very little likelihood of disease
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progression as noted with other particulates such as crystalline silica (Murphy et al., 
1999. Lee and Richards, 2003). Perhaps one reason for this is that much of the mass 
of the PMio was present as a soluble component, which readily translocates the lung 
and enters the bloodstream. The durable particles of PMio that remain are mostly 
diesel exhaust particles previously shown to be of low bioreactivity and thus readily 
cleared from the lung. One major route of clearance for diesel exhaust particles is via 
the lymphatic system and in the present study, black carbonaceous materials were 
found in the otherwise undamaged lymph node 6 weeks after instillation of the PMi0. 
Similar findings for diesel exhaust particles have been reported (Richards et al., 
1999).
In summary, instillation of whole PMio at high concentrations in rats produces mild 
but transient permeability and inflammatory changes. Much of the effects noted may 
be caused by the durable particle component(s) of the PMio although major mass 
soluble components are not without effects. The data obtained in this study provides 
an excellent basis to conduct a toxicogenomic investigation examining changes in 
specific parenchymal genes associated with mild and transient lung damage, details of 
which are reported in the following chapter.
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Chapter 3.0
Toxicogenomic profiling of Cardiff PMi0
induced lung injury
3.0 Toxicogenomic profiling of Cardiff PM10 induced lung 
injury
3.1 Introduction
Toxicology is the science of predicting and understanding the adverse effects 
resulting from the exposure of organisms to chemical/physical or biological agents 
(Kaminski et al., 2000). In this regard, the use of animal model to provide different 
endpoints of lung toxicity has proved invaluable. The relevance of animal models to 
risk assessment for man is under constant debate. This is because no animal model 
can mimic exactly the cell types, their xenobiotic metabolism or protective systems 
found in humans. Nevertheless, once the lung is treated with a toxicant the cellular 
responses and disease development process (see Figure 1.6) is very similar in humans 
and animals. This makes the continued the use of animal models vital for a better 
understanding of the mechanism of protection provided by lung cells and how these 
systems can go wrong resulting in damage endpoints such as oedema, inflammation 
and fibrosis.
In the previous chapter a quantitative conventional approach showed that 
inflammatory and oedematous reactions were produced in rodent lungs following the 
instillation of PMio collected in South Wales conurbation. However, these studies 
provided no information on the molecular basis of these changes. To understand 
more of such changes a variety of approaches may be adapted. Firstly, the expression 
of candidate genes, thought to be important in inflammation or oedema could be 
examined in the lung tissue by quantitative PCR. Such an approach suffers from 
selection problems and may miss important links between different gene activities. A 
second approach is to examine global gene expression using the newly developed 
commercial macro- or microarray systems. This approach involves generating 
fluorescent or radiolabelled cDNA transcripts from RNA samples, hybridisation to the 
target array bound probes and semi-quantification and a bioinformatic comparison of 
relative gene expression between untreated and toxin treated samples.
To date, there have been no reports in the literature whereby array technology has 
been employed to examine the effects of PMio on the lung. However, Reynolds and
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Richards (2000), using a commercially available macroarray, reported that consistent 
changes in gene expression concerned with DNA metabolism, cellular repair and 
detoxification could be detected following instillation of diesel exhaust particles into 
rat lungs. In the present study it was decided to use a similar macroarray to examine 
the effects of PMio (with diesel exhaust particles a major numerical component) on 
the rat lung. The advantages perceived with this array system was the manageable 
number of genes (1176 genes) and in that the system was commercially available, 
important findings could potentially be reproducible intra and inter laboratories. The 
chosen macroarray is relatively inexpensive compared to other microarray systems 
and if proven useful, could be readily available to a wide spectrum of laboratories.
Thus, the primary objective was to examine changes in lung gene expression 
following the instillation of whole PMio (two doses: 5 mg and 10 mg) and the 10 mg 
equivalent dose of the water soluble fraction of ambient Cardiff sample. Lung tissues 
from animals already treated with these samples (Chapter 2) were selected on the 
basis that conventional toxicology had shown oedematous and inflammatory changes 
compared with sham-treated animals. At the commencement of this toxicogenomic 
study there was no general agreement how to handle and draw reliable conclusions 
from the huge amount of data generated from macroarrays. In 2000, the MIAME 
guidelines (minimum information for a microarray experiment) (Speed et al., 2000) 
had devised and subsequently adopted by many journals. The chief aims of these 
guidelines were to standardise the recording and presentation of experimental data to 
facilitate the critical assessment by third parties and the determination of 
reproducibility of the study. For this purpose, a more simplistic analysis approach 
using basic computer packages were favoured, allowing array data to be evaluated in 
an easy step by step manner over large complex array analysis packages.
Thus, during the course of the study, methods had to be developed (alongside 
colleagues) to distinguish consistent small changes in gene expression with 
appropriate stringency for the production of meaningful gene lists for further 
investigation. Once gene lists reflecting gene changes induced by PMio were 
established it was necessary to check the quality of the array data. Therefore the 
expression of selected lung genes were further examined by qPCR for comparison 
with the findings from the array data.
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3.2 Materials
3.2.1 Materials and Suppliers
RNeasy™ Mini kit (74104) containing all appropriate buffers, solutions and vials and 
Deoxyribonuclease I, QIA™ shredder (79654) purchased from Qiagen. p- 
Mercaptoethanol (436022 A) was obtained from BDH Biochemical Laboratory 
Supplies, Poole . Ultra-pure (HPLC) Grade Ethanol (95% v/v) (CAS 64-17-5) was 
bought from Fisher Life Sciences.
Tri-reagent ™ solution (T-9424), Isopropanol (>99% v/v) (I 9516), Chloroform 
(>99% v/v, containing no iso-amyl alcohol or additives) (C 2432), Agarose (Type 
1A)(A 0169), 20X TBE* (T 4415), Ethidium Bromide (lOmg/ml) (E 1510) and 
Loading Dye (G 2526) were all purchased from Sigma -  Aldrich.
The nylon Atlas™ Rat 1.2 array system (7854-1) was purchased from BD Biosciences 
in kit form. Each kit containing: Cot-1 DNA (1 mg/ml), 10 X Termination mix (0.1 
M EDTA, 1 mg/ml MgCb, pH8.0), Reaction buffer (250 mM Tris-HCl), 375 mM 
KC1, 15 mM MgCb, pH 8.3), 10 X dNTP mix (5 mM of each dNTP except dATP), 
DTT (100 mM), 10X CDS Primer mix, Powerscript MMLV Reverse Transcriptase 
and nucleospin™ extraction/purification columns and wash solutions.
[a-32P]-d.ATP (10 n Ci/mmol, Cat No. PB 10204) was purchased from Amersham, 
UK. Sheared Salmon Testes DNA (D7656, 10 mg/ml) was bought from Sigma. 
Atlas™ Image 2.0 and Atlas™ Navigator (Clontech) were used to interpret the array 
data. 20% w/v SDS solution (ultra pure) (EC 874) and 20% w/v SSC Solution (ultra 
pure) (EC-873) were purchased from National Diagnostics. The Kodak Phospho- 
imager screen (Kodak 118 8077) was purchased from Biorad.
Oligo DT Random hexamers were purchased from Gibco (100 pmoles//xl). dNTPs 
(each at 100 mM, U13300), Moloney Murine leukaemia virus Reverse Transcriptase 
(MMLV-RT) and appropriate buffer, RNase inhibitor, lOObp DNA ladder (G2102), 
pGEM-T vector system (A3600), DNA Wizard SV Mini prep kits (A 1340), 
Ampicillin (1 mg/ml), IPTG (1.2 g diluted to 0.1 M in water, V3955), X-Gal (50 
mg/ml, V3941) were all purchased from Promega. Relevant gene primer sequences,
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Gene Elute Agarose spin columns (56500) were purchased from Sigma. BD 
Advantage™ 2 PCR kit (639207) was purchased from BD Biosciences and contained 
50x Polymerase Mix (Taq DNA Polymerase and Taqstart antibody (1.1 fig/fi\) in lOx 
Storage buffer (50% v/v Glycerol, 15 mM Tris-HCl, 75 mM KC1, 0.05% v/v EDTA, 
pH 8.0). lOx Advantage™ 2 PCR buffer (400 mM Tricine KOH, 150 mM KOAc, 35 
mM Mg(OAc)2 , 37.5 /xg/ml BSA, 0.05% v/v Tween-20 and 0.05% v/v Noridet P40). 
PCR Sybr green Quantitect kit (204243) was purchased from Qiagen.
Thermofast®96 well detection pates (AB1100) and cap strips (AB0866) were
purchased from Abgene, UK.
3.2.2 Stock Solutions for the Macroarray procedure
♦ Master Mix:
Single Reaction (per reaction): 2 /d Reaction buffer (250 mM Tris- 
HCl), 375 mM KC1, 15 mM MgCl2, pH 8.3), 1 /d 10 X dNTP mix (5 
mM of each dNTP except dATP), 0.5 /d DTT (100 mM) and 3 .5 /d [a- 
P32].dATP (10 /*Ci/mmol).
Double reaction* (per reaction, used instead of single rxn if sample 
RNA (2 fig) volume exceeds 2 /d): 4 fi\ Reaction buffer (250 mM Tris- 
HCl), 375 mM KC1, 15 mM MgCl2, pH 8.3), 2/d 10 X dNTP mix (5
mM of each dNTP except dATP), 1 /d DTT (100 mM) and 5 /d [a- 
32P]-d.ATP (10 /iCi/mmol).
♦ Luria-Bertani (LB)- agar plates and LB liquid media containing antibiotic were 
made up fresh as required.
3.3 Methods
3.3.1 Safety Implications
Radio-isotope (32P): All radioactive work was carried out in a designated radiation 
area and all radioactive samples stored and waste disposed of in compliance with 
local guidelines.
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Competent E. Coli (JM109): Low risk genetic modification with the disabled vector 
and cells was carried out. All equipment, waste and surfaces were sterilised and 
disposed of in accordance with GM guidelines.
3.3.2 Selection of PM Exposed and Sham-treated control animals for 
Toxicogenomic Analysis
The toxicogenomic analysis was completed on selected rat lung tissue from the 
instillation study (Chapter 2). Rats were selected from sham-treated, water soluble 
(10 mg) and whole PM exposed groups (5 mg and 10 mg) at three days post 
instillation.
Conventional parameters used to assess the pulmonary responses of individual rats 
showed animal-to-animal variations. Animals were therefore selected based on their 
individual responses differing from sham-treated controls. Changes in lung to body 
weight ratio, lung lavage acellular protein and increases in large free cell counts were 
used to ascertain three animals from each treatment group most severely affected from 
the treatment.
3.3.3 RNA Extraction
Two methods of RNA extraction from lung tissue were explored, RNeasy™ (Qiagen) 
and Tri-reagent ™ (Sigma).
Total RNA was isolated from lung tissue using RNeasy Mini kit, Qiagen. The 
technique provides a fast and simple procedure to isolate RNA from a small amount 
of starting material. The system combines the selective binding properties of a silica 
gel based membrane which under high salt conditions, binds long RNA molecules and 
serves to wash and then elute a purified product suitable for a range of subsequent 
techniques (supplier’s manual).
In summary, lavaged whole lung tissue isolated from the rat was snap frozen in liquid 
nitrogen and ground to a fine powder using a pestle and mortar. The tissue cells were 
lysed and homogenated in the appropriate volume of denaturing guanidine 
isothiocynate (GITC) containing buffers, which acts to immediately denature any
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RNases, thus preventing any initial denaturation of the RNA. Samples were either 
stored at -80°C in the GITC-buffer or used immediately. Samples were disrupted by 
either centrifuging (>8,000 x g, 2 minutes) in a QLA shredder column or passing the 
lysate (at least five times) through a 20 G needle fitted to a syringe. This serves to 
reduce viscosity of the lysates, shearing genomic DNA and high molecular weight 
cellular components. All insoluble material and high molecular weight DNA were 
removed by centrifugation (12,000 x g, 3 minutes) and the supernatant retained in a 
fresh tube. An equal volume of ethanol (70 % v/v) was added, to provide appropriate 
conditions for the binding of the RNA. The entire sample was loaded, in successive 
aliquots, to the RNeasy mini column and centrifuged in a bench top centrifuge 
(>8,000 x g, 15 seconds). The elutant was discarded and deoxyribonuclease 
suspended in provided buffer (Qiagen) was incubated (RT, 20 minutes) in the column 
then eluted by centrifugation (>8,000 x g, 30 s). The column was rinsed with wash 
buffers provided with the kit, RW-1 (700 /x1, spin >8,000 x g, 15 seconds). An 
optional on-column DNase treatment was completed at this stage. An aliquot of 
DNase (Qiagen) suspended in ultra pure water (70 /xl) was applied to each sample 
column and incubated (RT, 15 minutes). The enzyme was denatured and eluted from 
the column by centrifugation (spin >8,000 x g, 15 seconds) and washed twice with 
RW1 wash buffer (350 /xl, spin >8,000 x g, 15 seconds) and twice with the ethanol- 
containing buffer, RPE, (500 /xl, spin >8,000 x g, 15 seconds) in order to remove all 
contaminants. The column was centrifuged (>8,000 x g 1 minute) to eliminate any 
residual traces of ethanol from the RPE buffer that would interfere and contaminate 
the RNA. The RNeasy column was transferred to a new, sterile Eppendorf and RNase 
/ DNase free water was applied to the column (20-30 /x1). The column was left to 
equilibrate on ice for a few minutes before being spun in a bench centrifuge (1 
minute, >8,000 x g) to elute the RNA.
Total RNA from lung tissue was isolated using Tri-reagent™ as outlined in the Sigma 
Technical Bulletin (MB 205). This technique provides a quick and convenient one 
step procedure based on an extraction outlined by Chominski and Saachi (1987), 
allowing the simultaneous extraction of RNA, DNA and protein.
Tri-reagent™ (1 ml), a mono-phase solution of guanidine thiocyanate (to denature 
RNA degrading enzymes) and phenol was added to the ground lung tissue (~1 mg). 
The tissue was lysed by thoroughly mixing the suspension with a pipette to form a
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homogenous lysate. All insoluble material and high molecular weight DNA were 
removed by centrifugation (12,000 x g, 10 minutes at 4°C) and the supernatant 
retained in a fresh tube. Chloroform (0.2 ml per ml of Tri-regent™) was added and 
mixed vigorously before centrifugation (12,000 x g, 15 minutes, 4°C). This resulted 
in a three-layered solution containing a red organic phase (protein), an interphase 
(DNA) and colourless upper aqueous phase (RNA). The latter was carefully removed 
and isopropanol (0.5 ml per ml o f Tri-regent™ used) was added, the mixed sample 
was left to stand (-20°C, 30 minutes) and subsequently centrifuged (12,000 x g, 10 
minutes, 4°C) to precipitate the RNA. The pellet was washed in 75 % v/v ethanol (1 
ml) and a pellet reformed by centrifugation. The pellet was air dried to remove all 
residual ethanol before being resuspended in RNase/DNase free water (20-30 /xl).
3.3.4 Quantifying the RNA and Checking its Integrity
The purity and yield of all RNA samples were assessed regardless of extraction 
procedure using the GeneQuant™ (Pharmacia). Purity was established by measuring 
the 260:280 nm ratio. The ratio for RNA suitable for subsequent gene analysis should 
be between 1.8-2.1. A ratio outside this range indicates contamination in the sample. 
The yield of the sample was deduced from the absorbency of the sample at 260 nm.
A 1-2 /xl specimen of the RNA sample was size fractionated on a 1 % w/v agarose gel 
(0.5 g/50ml 0.5 % v/v TBE with 1 /xl o f  10 mg/ml Ethidium bromide) in 0.5 % v/v 
TBE (with <1% v/v 10 mg/ml Ethidium Bromide). Each well was loaded with 1-2 /xl 
RNA in water, 2 /xl loading dye, to a total of 10 /xl in high purity RNase/DNase free 
water. The gelS were subjected to electrophoresis (30 minutes, 80 volts) and viewed 
under UV using the Syngene™ Gel documentation System.
3.3.5 RT-PCR
Reverse Transcription-PCR was completed on early preparations of DNase treated 
RNA samples isolated using the Qiagen RNeasy™, with the aim to confirm complete 
removal o f all functional DNase enzyme that would be detrimental to subsequent 
array procedures.
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Reverse Transcription (RT) was completed on total RNA. Random hexamers (200 
pmoles) and target RNA was mixed up to a final volume of 11.5 /xl in HPLC water 
and incubated at 70°C (10 minutes) then quick chilled on ice (5 minutes). The 
preparation was made up to a final volume of 20 /xl with dNTPs (500 /xM of each), 1X 
reaction buffer (10 mM Tris-HCl, 15 mM KC1, 0.6 mM MgCh, 10 mM dithioreitol, 
pH 8.3), RNasin Ribonuclease inhibitor (20 units, Promega) and Moloney Murine 
Leukaemia Virus (MMLV) RNase H- Reverse Transcriptase (200 units, Promega). 
The solution was incubated 42°C (1 hour) followed by 90°C (30 s), made up to 100 /xl 
with tissue culture grade water and used immediately. A sample of total RNA was 
made up with the same RT mixture but the volume of MMLV-RT was replaced with 
water (no RT).
PCR was completed on 10 /xl of cDNA (with RT and no RT cDNA samples) using 
GAPDH forward and reverse primers. The primers and optimised PCR conditions are 
shown below (S.Irvine, personal communication, 2001).
GAPDH Forward Primer 5’CCCTTCATTGACCTCAACTAC ATGG-3 *
GAPDH Reverse Primer 5 * AGTCTTCTGGGTGGCAGTGTGATGG-3 *
The PCR mixture consisted of the following: 10 /xl cDNA, 0.5 /xl forward and reverse 
primers (100 /xM each), 1.5 mM MgCb, 5/xl 10 X PCR buffer (16 mM (NFL^SCU, 67 
mM Tris-HCl, pH 8.8 at 25°C, 0.1% v/v Tween-20), 0.5 /xl of each dNTP (10 mM) 
and 1.25 units of Taq Polymerase and made up to a final volume of 50 /xl in HPLC 
grade water.
The PCR cycle employed a denaturing step at 95°C (5 minutes) to denature the 
cDNA, annealing (55°C, 1 minute), extension (72°C, 2 minute) and melting (94°C, 30 
seconds) with a final long extension on the final cycle (72°C, 10 minutes). PCR was 
continued for 32 cycles and the cDNA cooled and stored at 4°C.
The resultant products were electrophoresed on a 1.5 % w/v agarose gel (80 volts, 30 
minutes).
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3.3.6 Macroarray Preparation
3.3.6.1 Preparation of the Membranes
The macroarray membranes were washed with deionised water and were each placed 
in a hybaid tube. Salmon Sperm (0.5 mg/membrane) was denatured (95°C, 5 
minutes) and placed on ice. The salmon sperm was added to hybridisation solution (5 
ml per membrane) and added to each membrane and left to prehybridise (68°C, 30 
minutes, with constant agitation).
3.3.6.2 Preparation of 32P-labelled first strand cDNA Probe
Isolated, genomic free RNA (2 /xg) was mixed with 10X CDS Primer mix (1-2 /xl), 
and placed on ice. The master mix stock (Materials) and the RNA/Primers were 
preheated (70°C, 2 minutes and then 48°C, 2 minutes). MMLV Reverse Transcriptase 
(I fi\ per reaction) was added to the cooled (48°C) master mix and heated (48°C) for a 
further 2 minutes alongside the RNA. Master mix (8 /xl single reaction or 14 /xl 
double reaction) was added to the RNA immediately incubated at 48°C (25 minutes). 
The reaction was terminated using 10 X termination mix (1 /xl) and placed on ice. 
The labelled cDNA probe was purified from unincorporated 32P-labelled nuclides and 
small cDNA fragments through a nucleospin column supplied with the array 
membranes The reaction mixture was diluted to a final volume of 200 /xl in binding 
(NT-2) solution and applied to the column. The solution was centrifuged (>10,000 x 
g, 1 minute) and elutant, containing unincorporated radionucleotides, discarded. The 
column was washed in an ethanol buffer (NT 3, 400 /xl) and centrifuged at each step. 
The radioactivity of each elutant was assessed to ensure that all unbound dNTPS were 
removed. The purified probe was subsequently eluted in Eluting buffer (NT-E, 100 
/xl) incubated (1 minute, room temperature) in the column before centrifugation (2 
minutes, 10 000 x g). 10X Denaturing solution (11 /xl, 1 M NaOH,10 mM EDTA) 
was added and the solution placed at 68°C (20 minutes) to allow full denaturation of 
the cDNA probe. CGt-l DNA (5 /xl) and 2X Neutralisation solution (111 /xl, 27.6 g 
NaH2P0 4 *H20 in 200 ml H2O (pH 7.0, adjusted with 10 M NaOH) were added and 
placed at 68°C for a further 10 minutes.
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3.3.6.3 H y b rid isa tio n  o f  th e  P ro b e  to  th e  A rra y
The denatured radiolabelled probe was added to the hybaid bottle containing the 
membrane and hybridised overnight (68°C) with continuous turning.
The membranes were washed in wash solution 1 (0.1% v/v SSC, 0.5% v/v SDS) and 
the more stringent wash solution 2 (0.01% v/v SSC, 0.25% v/v SDS ) as appropriate 
until the radioactive counts dropped to 10-20 c.p.m. (usually 2 washes of 10-20 
minutes each in wash solution 1 was sufficient). The membranes were removed, 
wrapped well and placed under a phosphor-imager screen (Kodak) within a cassette 
and left (room temperature) for 5-7 days depending on the final radioactivity on the 
membrane.
The exposed phosphorimager screen was scanned (50 fim sensitivity) and the 
resultant image analysed using the Atlas Image 2.01a (BD Biosciences). The 
software facilitated the identification of differentially expressed genes in compared 
arrays.
3.3.6.4 Stripping the Membranes
The array membrane was stripped of the cDNA probe prior to storage at -20°C. The 
membranes were boiled vigorously in 0.5 % v/v SDS solution (5-10 minutes) and 
rinsed (wash solution 1). The membranes were checked for radioactivity prior to 
storage in a sealed bag at -20°C. The phosphor imager screen was cleaned by 
exposure to bright light (15 minutes) and stored at room temperature until required
3.3.6.5 Visualisation of the Array
Scanned images of the gene arrays were visualised using Atlas™ image 2.01a (BD 
Biosciences, UK). This programme assists in alignment of the membrane image with 
the outline plan of the array. Nylon arrays are versatile and economical way to 
produce macroarray data. However, with repeated use they can become increasingly 
distorted, requiring careful alignment and positioning before meaningful conclusions 
can be made. Image 2.01a is a useful programme, calculating background intensity 
levels and adjusting spot intensity accordingly. Estimated background intensities were
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calculated from each array based on assigning regions of membrane devoid of any 
target cDNA to adjacent regions of the array containing target sequences and attached 
probe. It was deemed to be a more accurate approach than assigning a selected region 
to describe the extent of background noise across a potentially variable array 
membrane. Finally, the programme was used to complete comparative analyses 
between individual test/control arrays or used to generate average controls and 
exposed profiles. To ensure that all array analyses were comprehensive and similar, it 
was judged that all variables were set as equal. Therefore, the ratio signal threshold 
was reduced on all aligned arrays to 50% and all genes were reported to an excel 
worksheet. All analyses were therefore conducted on similar analysis outputs within 
the excel package.
3.3.7 Data Handling and Bioinformatics
3.3.7.1 Transformation and Normalisation of the Raw Array Data
Data exported from the Atlas programme consisted of several data components 
including an estimation of local background intensity for each gene, the intensity of 
each spot corresponding to each gene and a background adjusted intensity for each 
gene. The lists of background adjusted signal spot intensity for each gene were 
compared across each exposure and sham-treated lungs.
The data derived directly from the Atlas 2.01a programme has not been normalised or 
transformed in any way. The distributions of replicated raw expression values (and 
consequently ratio data) tends to be skewed, thus violating the assumptions of many 
statistical tests and distorting many p -values associated with parametric tests such as 
ANOVA and t-tests. Log transformation reduces the random error of raw expression 
data. The first important step was to correct for this using a standard data 
transformation, to ensure the data is approximately normally distributed to allow 
normal statistical assumptions to be made. Statistical evaluation of the distribution of 
the data using an Anderson Darling test (p>0.05) confirmed that the raw array data 
was not normally distributed.
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For this purpose, the logio (adjusted intensity +c) was calculated for each gene 
intensity spot on each array prior to normalisation. Log-transformed data are 
generally preferred to ratios of raw signal intensity (Nadon et al., 2002).
All arrays were globally normalised, a normalisation technique involving calculation 
of all gene intensities to produce a scaling factor and adjusting accordingly rather than 
to a single or a few housekeeping genes. Alternative approaches with more recent 
arrays involve spiking the RNA sample with known amounts of foreign transcripts to 
calculate a scaling factor to correct the relative expression of all other genes. Early 
analysis had confirmed that variation within the housekeeping genes did occur.
Logio transformation served to correct the data to an approximately normal 
distribution, thus allowing normal statistical assumptions to be inferred. 
Normalisation adopted for this study was a two step procedure, reducing 
heteroscedasticity of the data resulting from random errors and alteration in 
background noise and allowing more meaningful comparisons between the arrays.
The first step of normalisation involved calculating the median spot intensity within 
the array as a scaling factor, an estimate of error. The intensity for each spot on the 
array was then divisible by this value to correct for variations across the array. The 
second step involved calculating the median spot intensity value of each gene across 
each of the arrays (control and exposed profiles). The intensity of each spot was then 
divisible by this new scaling factor for each gene on the array to produce the final 
normalised data. A variety of different scaling factors were examined, including the 
mean, median and ranked/trimmed mean. Mean expression values were highly 
influenced by the extreme behaviour of relatively few genes (i.e. highly 
expressed/over expressed genes and nominally expressed genes), trimmed means 
(adjusted expression values from each array or genes across the arrays were ranked 
and trimmed accordingly) and median values produced only minimal differences to 
the final data and so the median values were adopted as the scaling factor in all 
subsequent analyses. This global method uses an estimate of error (the median 
expression for each array) to control for proportional differences across membranes 
and assumes that most probes are unaffected by treatment. This was proven to be the 
case in previous studies by Reynolds (2000), whose experiments using diesel exhaust 
particles reported that overall 5% of the genes examined were altered by the exposure. 
If a large proportion of the genes are altered by exposure, the global approach could
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serve to mask the effect of differentially expressed genes or, create differential effects 
where none exist (Nadon et al., 2002).
Normalised data was subsequently tested for normality once again using the Anderson 
darling Test for normality on random selection of genes using the statistical package, 
Minitab (P>0.05).
3.3.7.2 Selection of Gene Lists
Several methods of analysis were explored and the following section describes four 
approaches.
3.3.7.2.1 Pair wise Comparison
The simplest way to identify candidate genes across related experiments is a simple 
analysis to establish lists of consistently up- or down regulated genes, incorporating a 
very basic approach. Data from the array profiles were transformed (as outlined 
previously). Single sham-treated control/PM exposed profiles were normalised 
together, as previously described and compared in a pair wise manner. Fold changes 
in gene expressions were compared between different pairs. A two fold ratio change is 
detectable by the most sensitive alternative methods in greater than 50% of cases, 
whilst a 5 fold alteration may be detected in more than 90 % of cases (Dr. L 
Reynolds, BD Biosciences, personal communication).
It was considered that retaining the pair-wise comparisons might have been a more 
sensitive method to detect changes in the animals that may have differing extent of 
pulmonary responses to the toxicant exposure. It was anticipated that examining only 
the fold change did not take into consideration any extent of change. Gene A may 
have an adjusted intensity of 10 under control conditions increasing to 20 under 
experimental conditions and still undergo a two-fold change. Whereas Gene Y may 
increase from 1000 to 2000 for the equivalent fold induction. The second gene would 
therefore be more likely to be detected using conventional techniques. An estimation 
of extent of fold change could be enforced by applying an arbituary minimum relative 
difference/change in relative expression of 1000 or 2000 for each gene.
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A mean sham-treated profile was calculated from the expression of the replicated 
profiles (n=3) and then used in comparisons to individual PM exposed arrays. Lists 
of genes expressed in a minimum of two out of the three comparisons were analysed. 
The effect of using mean or median control array values was also evaluated (data not 
shown).
3.3.7.2.2 Expression Range Analysis
This method was developed in collaboration with fellow colleague, Miss Dominique 
Balharry.
The method uses transformed and normalised data to estimate ranges of gene 
expression of both sham (saline) treated (n=3) and PM exposed (n=3) lung samples. 
Genes that have non-overlapping gene expression in both sham-treated and PM 
exposed profiles were considered (Figure 3.1). A further condition was enforced to 
further reduce the candidate gene lists. Although a notable difference in relative 
expression levels of the genes were apparent, this method had no semi quantitative 
measure of the change. Therefore a minimum fold change in gene expression was 
used to further select altered genes between control and test arrays.
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Figure 3.1: A representation of the expression range analysis. A range of expression based on the 
replicate samples produces an accepted variation in expression. Comparing these ranges of sham- 
treated and PM exposed profiles to ascertain significantly altered genes. Both gene 1 and 2 would be 
deemed significantly changed whilst gene 3 would not.
3.3.7.2.3. Statistical Comparison
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Sham-treated control (n=3) and PM exposed (n=3) profiles were normalised together 
as previously described prior to analysis. Lists of candidate genes from this analytical 
approach were selected on the basis of a combination of two statistical features. 
Firstly, a student’s /-test was completed. This tested the unpaired, unequal variance 
control and exposed profiles and genes were deemed significantly differentially 
expressed when p<0.05. Array profiles o f three individual animals were completed 
for each experimental and control condition, this is a low replicate number for strong 
statistical inferences and combine with the large degree of animal variation and 
variability within the array procedure itself, it was considered that for the purpose of 
such a pilot study it would be justified to extend the statistical significance to p<0.01. 
The /-test alone reduced the gene list considerably, however, it made no allowance for 
the extent of variation of expression of genes amongst individual animals. It was 
deemed important that a normal range of variation of gene expression was acceptable 
between control arrays. Therefore, a 2 standard deviation range of expression was 
calculated and genes with a mean exposed expression outside this area were deemed 
significant by this parameter. The gene analyses were combined to produce a suitably 
shortened gene list, proving that this method was stringent enough to obtain candidate 
gene lists for further analysis.
3.3.7.2.4. Logio fold Change Method
A fourth method was examined to assess candidate gene lists. This method used 
transformed and normalised data outlined previously for the standard deviation and 
statistical approach. A median sham-treated (n=3) and PM exposed (n=3) profile and 
the logarithmic (logio) of each gene fold changes were calculated. The mean logio 
(fold change) and standard deviation (SD) was calculated for the entire array and 2 
SD range determined, all logio (fold change) changes in genes lying outside this range 
were noted. Examining the equivalent of a minimum 2- and 4-fold change in gene 
expression further reduced these lists.
3.3.7.3 Analysis Overview
The previous sections contain detailed information regarding data handling and 
computation of the array data. These steps are simplified in the following flowchart 
(Figure 3.2)
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Background adjustment to address “noise1
Logio Fold change
-Genes changed outside a 
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mean Log 10 fold change
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Statistical Analysis
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consistent gene changes
Group Normalisation:
(Sham-treated controls (n=3) and exposed 
group (n=3) normalised together)
Global Normalisation of arrays:
Two step within individual arrays and 
between the different arrays being compared.
Array Images
Expression range analysis
-Identifies genes with non- 
overlapping expression 
between untreated controls 
(n=3) and exposed (n=3)
Figure 3.2: A flow chart to summarise each step involved in the analysis of the macroarray and the 
different analytical approaches used to generate candidate genes in the lung injury resulting from PM^ 
exposure.
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3.3.8 Quantitative PCR Confirmation
Several array analysis approaches were explored in this chapter. However, no method 
can be completely ruled out or firm conclusions drawn until the results have been 
confirmed using an alternative method. Genes were selected upon their basis of 
change by the different analyses including some genes deemed not to change and a 
housekeeping gene.
3.3.8.1 RT and PCR of Standard Gene Products
Reverse Transcription (RT) was completed on total RNA from a reference RNA 
sample, RNA pooled from control and exposed samples in order to have aliquots of 
standard gene products for quantitative PCR standards. Random hexamers (200 
pmoles) and target RNA (2 /xg) was mixed up to a final volume of 11.5 /xl in HPLC 
water and incubated at 70°C (3 minutes) and then quick chilled on ice (5 minutes). 
The preparation was made up to a final volume of 20 /xl with dNTPs (500 /xM of 
each), IX reaction buffer (10 mM Tris-HCl, 15 mM KC1, 0.6 mM MgCb, 10 mM 
dithioreitol, pH 8.3), RNasin Ribonuclease inhibitor (20 units, Promega) and Moloney 
Murine Leukaemia Virus (MMLV) RNase H- Reverse Transcriptase (200 units, 
Promega). The solution was incubated at 42°C (1 hour) followed by 90°C (30 s).
A sample of total RNA was made up with the same RT mixture but the volume of 
MMLV-RT was replaced with water (no RT). Completing a standard GAPDH PCR 
reaction as outlined previously served to check each RT reaction.
Sequences for forward and reverse primers for each selected gene were supplied by 
BD Biosciences (array suppliers, Table 3.1). Preliminary PCR experiments were 
completed using two methods, firstly using a standard PCR mixes and, for genes that 
failed to PCR successfully, a BD Advantage 2 PCR enzyme kit.
Initial PCR experiments underwent PCR reactions across a stepped gradient (55°C- 
70°C). The PCR mixture consisted of the following: cDNA (1 /xl), forward and 
reverse primers (0.4 /xl, 20 mM each), 2.5 mM MgCk, 2/xl 10 X PCR buffer (16 mM 
(NH^SO*, 67 mM Tris-HCl, pH 8 .8 at 25°C, 0.1% v/v Tween-20) dNTP (0.4 /xl of at 
10 mM each) and 1.25 units of Taq Polymerase and made up to a final volume of 20
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/xl in HPLC grade water. Each PCR reaction was accompanied by suitable water 
blanks, devoid of any cDNA to guard against contamination.
Initial PCR cycles (30) comprised of an initial denaturation (94°C, 2 minutes), cycle 
denaturation (94°C, 30 seconds), annealing (55-70°C, 1 minute), extension period, 
(72°C, 2 minutes) and final extension period (72°C, 5 minutes) and left to cool (10°C).
The Advantage PCR system was adopted for difficult genes that failed to amplify 
under the extensive optimisations using the alternative method. This system involved 
a patented ready-made PCR buffer containing an optimal mixture of Taq Polymerase 
and lOx BD advantage™ 2 PCR Buffer (see materials section). In brief, a PCR 
reaction was made up as follows: 5 X Advantage™2 reaction buffer (5 /xl), 
appropriate forward and reverse primers (1 /xl, 20 mM each), dNTP mixture (1 /xl) 
containing each dNTP at a concentration of 10 /xM, Taq Polymerase mix (1 /xl) and 
made up to 50 /xl in molecular grade water. PCR cycles were completed as outlined 
in the Advantage™ 2 protocol, involving a two step PCR cycle (30-35 cycles) 
incorporating an initial denaturation period (95°C, 1 minute), two cycle steps of 95°C 
(30 seconds) and 688C (1 minute) followed by a final elongation (68°C, 1 minute). 
PCR reactions were size-fractionated on a 1.5% w/v agarose gel (45 minutes, 80-90 
volts) alongside a suitable DNA ladder (Promega) and single bands for each gene 
were excised and then eluted using a gel extraction kit (Sigma) in TE buffer to 
stabilise the DNA product.
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Table 3.1: Selected gene sequences for (1) forward and (2) Reverse primers (BD Biosciences).
Coordinate Genbank Gene Name Fragment length(bp)
PRIMER (bp) Expected 
Change in 
expression
B04m M59980 potassium voltage gated channel, 193 primer 1 TGATCGTGTCTAACTTCAGTCGGATC 26 Down
regulatedprimer 2 CT AACGAAGGCCGGTTC ATCCTCC 24
C02b X52625 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 239 primer 1 GCCACACCAGGATCTGCTCTTGAC 24 Up
regulatedprimer 2 GAGGGACGCCGGGCGTAAGTTC 22
D09n L08490 gamma-aminobutyric acid (GABA-A) receptor 234 primer 1 GGACAACACCACTGTCTTCACGAG 24 Down
regulatedprimer 2 TTCAGCCGGAGCACTGTCATGGG 23
D14i U37101 Colony stimulating factor 3 (granulocyte) 297 primer 1 AGCTGCTGCTGTGGCACAGTGCAC
24 Down
regulated
primer 2 GCAGTTGGCTCAGGCACTTTGTCTG 25
D12m D16817 mRNA for metabotropic glutamate receptor mGluR7 281 primer 1 GGATCATTGCCACCATCTTTGTCATG 26 Downregulatedprimer 2 GGGAGCTGTCACCGATTTCTTGCC 24
G43 V01217 cytoplasmic beta-actin 285 primer 1 CCCTCTGAACCCTAAGGCCAACCG 24 No change
primer 2 GT GGT GGT GAAGCT GT AGCCACGC 24
B02k L31619 Cholinergic receptor, nicotinic, alpha polypeptide 7 228 primer 1 CCCAGATGTCACCTACACAGTAACC 25 Up
regulatedprimer 2 ATCAAGGGCACAGAATCAGATGTTGC 26
B13g Y13380 Amphiphysin II (AMPH2) 300 primer 1 GCGAAC AAGAT AGC AG AGAAC AAT GAC 27 Down
regulatedprimer 2 GTTAGTTTGAGCTACAAGATGAGCCTG 27
C12i U49729 Bcl2 -associated X protein 298 primer 1 TGATTGCTGACGTGGACACGGACTC 25 Up
regulatedprimer 2 GCCACAAAGATGGTCACTGTCTGCC 25
E05a M22 899 Interleukin 2 (IL2) 282 primer 1 TGGACTTACAGGTGCTCCTGAGAGG 25 Up
regulatedprimer 2 CTGGCTCATCATCGAATTGGCACTC 25
ElOm U23443 p21 (CDKNlA)-activated kinase 1 305 primer 1 TGGAGTTCCTGCATTCAAACCAAGTC 26 Downregulatedprimer 2 GGT AGCAATGAGGTAC AAGGCTCTC 25
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3.3.8.2 L ig a tio n  o f  P C R  p ro d u c ts  a n d  T ra n s fo rm a tio n
PCR fragments were ligated into pGEM-T vector (Promega) overnight (4°C) using a 
standard manufacturer’s protocol. In brief, a sample of PCR product (3 /xl), pGEM-T 
vector (50 ng), T4 DNA ligase (3 Weiss Units) and 2 x Ligation Buffer (5 /xl) (60 mM 
Tris-HCl, 20 mM MgCb, 20 mM DTT, 2 mM ATP, 10% v/v Polyethylene glycol, 
pH7.8) was made up to 10 /xl with molecular grade water and incubated overnight 
(4°C, overnight) for optimal transformation. The ligated vector was transformed into 
competent E.Coli (JM109, L2001) and the cells plated onto X-Gal (0.5 mM)/IPTG 
(80/xg/ml) supplemented LB plates containing ampicillin (100 /xg/ml) and cultured 
overnight (16-20 hours, 37°C). Transformed colonies were identified using 
blue/white colour screening. Only cells containing the pGEM-T vector were 
ampicillin resistant, whilst cells containing the vector with an insertion of the ligated 
PCR product were unable to metabolise the IPTG to its blue metabolite. White 
colonies were sub-cultured overnight and in LB-Ampicillin (100 /xg/ml) media.
The plasmids were isolated from the cultured colonies using the DNA Wizard SV 
Mini-prep system (Promega). In brief, cells were pelleted from the culture media and 
suspended in the supplied Wizard Plus SV Cell Resuspension buffer (5 mM Tris-HCl, 
10 mM EDTA, 100 /xg/ml RNase A, pH 7.5). The cells were lysed (Wizard Plus SV 
Cell Lysis Solution- 0.2 M NaOH, 1% w/v SDS). The solution was neutralised upon 
addition of Wizard Plus SV Neutralisation Solution (4.09 M guanidine hydrochloride, 
0.759 M potassium acetate, 2.12 M glacial acetic acid, final pH 4.2) and high 
molecular weight cellular components pelleted by centrifugation (14,000 x g, 10 
minutes, room temperature). The supernatants were applied to vacuum filters and 
successively washed with Column Wash buffer (500 /xl- 162.8 mM potassium acetate,
22.6 mM Tris HC1, 0.109 mM EDTA) and dried under vacuum (10 minutes). 
Residual wash buffer was removed by centrifugation (14000 x g, 2 minutes) prior to 
the DNA being eluted in molecular grade water (20-40 /xl, 14000 x g, 1 minute) and 
stored at -20°C.
A sample of each mini-prep product was digested with DNA endonucleases, chosen 
to specifically release the amplified insertion within the pGEM-T vector. Sal I and 
Nco 1 were selected and used in association with appropriate Promega Buffer. In 
brief, digestion of each mini-prep sample (10 /xl) was completed using the enzymes (2
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Weiss units) in Buffer D. The mixture was incubated (37°C, 1.5 h) to allow full 
digestion of the plasmids. The linearised products were size-fractionated on an 
agarose gel (1.5% w/v, 85 volts, 45 minutes) and were viewed under UV. Samples 
with a band corresponding to the expected insert were sent for sequencing (Molecular 
Biology Sequencing Services, Cardiff University) to identify the correct insert. Mini 
prep samples containing the correct inserts were accurately quantified and diluted 
(100 pg//xl - 10 fg//xl) for quantitative PCR (qPCR) standard curves for each gene.
3.3.8.3 q-PCR
The qPCR was accomplished using the AB1 Sequence Detection System (ABI PRISM 
7700). Initial standard curves of each gene were size-fractionated prior to 
quantification using samples to confirm successful PCR amplification of the inserts 
using the SYBR green quantification. Standard curves of the plasmid DNA and 
inserts (100 pg//xl -  10 fg//xl) diluted in molecular grade water (n=3, total volume 
used 1 /xl) were added to a 2x Quantitect Sybr green PCR buffer (25 /xl) (HotStar Taq 
DNA polymerase in Qiagen Sybr green PCR buffer), forward and reverse primers 
(concentration used) and made up to 50 /xl with water and were appropriately 
dispensed into qPCR 96 well plates and sealed prior to use.
A 40 cycle PCR was used on the ABI 7700: an initial plate warming (50°C, 2 
minutes), DNA polymerase activation (15 minutes, 95°C) followed by 40 cycles of 
95°C (30 seconds) and 68°C (1 minute).
The specificity of the PCR products were checked by agarose gel electrophoresis 
(1.5% w/v agarose gel, 80 volts, 45 minutes) to rule out primer dimer and multi 
product interference. Once successful PCR amplification had been achieved, fresh 
cDNA (1 /xl) from each experimental and control samples were analysed for each 
gene alongside the appropriate standard curve as described previously.
Initial data analysis of the qPCR experiments was carried out using the ABI PRISM 
detection system. The ABI PRISM system records the change in fluorescence of the 
PCR mixture with increasing cycle numbers and produces a sigmoid-shaped 
amplification plot. A calculation of a cycle threshold (Ct, a constant fluorescence 
level) across the series of standard dilutions produces a linear standard curve and
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regression equation to estimate the initial concentration of the gene in each 
experimental sample. An unpaired student t-Test (assuming unequal variance) was 
conducted to determine statistically significant differences in expression levels 
between experimental and sham-treated controls.
3.3 Results
3.4.1 Selection of PM-exposed and Shain-treated rats for Toxicogenomic 
Assessment
Three rats from each group (sham-treated control, 5 mg whole PM, 10 mg whole PM 
and 10 mg equivalent dose of water soluble component of PM) were selected on the 
basis of increases in lung to body weight ratio, increases in lavage protein and 
increases in LFC relative to saline treated (sham) control (Table 3.2).
Table 3.2: Summary table for selected (n=3) animals exposed to whole and water soluble PM and 
saline treated (controls). Data from conventional toxicological assessment (chapter 2) includes lavage 
protein and lung to body weight ratio (pulmonary oedema) and large free cell (LFC) within the lung 
(inflammation)
Experiment
Number
PM
Fraction
Dose Lavage protein 
mg/animal
Ratio
xlO3
LFC
millions
1 Whole 10 mg 4.30 5.1 18.3
4 Whole 10 mg 3.70 5.7 19.6
5 Whole 10 mg 4.10 5.6 13.0
12 Soluble 10 mg 3.46 4.7 9.5
14 Soluble 10 mg 3.03 4.6 8.4
15 Soluble 10 mg 5.16 5.6 5.1
16 Whole 5 mg 3.22 5.0 7.4
17 Whole 5 mg 2.43 5.2 12.3
18 Whole 5 mg 3.27 4.9 10.7
46 Saline 0 1.47 4.2 5.5
48 Saline 0 2.31 4.0 4.8
49 Saline 0 1.91 4.1 7.2
3.4.2 Isolation and Preparation of RNA
RNA isolation from lung tissue in sufficient amount and purity was obtained using the 
RNeasy ™ protocol (Qiagen). This method incorporated a simple and effective DNA 
nuclease (DNase) clean up step to be incorporated within the process, eliminating
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DNA in the RNA sample with a reduced risk of DNase contamination. RT-PCR was 
completed on preliminary samples to ensure that the DNase was efficiently removed 
from the RNA preparations. Contaminating DNA would serve to distort the 
expression profile of the sample whilst failure to remove DNase from the preparation 
would prevent probe synthesis during the array procedure.
The RNA was visually analysed to help ascertain that no significant degradation had 
taken place using the Syngene™ gel doc. System (Figure 3.3a). DNase treatment of 
all samples was completed during RNA isolation and RT-PCR was completed to 
ensure genomic DNA and DNase free preparations (figure 3.3b).
a)
B
wells gDNA
28SRNA
16SRNA 28SRNA
16SRNA
b)
GAPDH (-456 bp)
Unincorporated
dNTPs/primers
Figure 3.3: a) The sample of isolated RNA size-fractionated on a gel was viewed under UV to check 
the integrity and can be indicative of genomic DNA contamination (gDNA). The presence o f a third 
band would be indicative o f genomic contamination. Smeared bands would indicate RNA degradation, 
(b) RT PCR products were subjected to electrophoresis on 1.5 %  w/v agarose gel visualised using 
Syngene. Well 1 (i & ii): No RT (DNase treated RNA). Well 2-4:DNase treated RNA (RT+) (n=3). 
Bands identified on basis of size compared to DNA laddff (not shown)
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3.4.3 G en era tio n  o f  M a c ro a rra y  P ro files
Macroarray profiles from selected animals were completed using the Atlas ™ Rat 1.2 
nylon macroarray (BD Biosciences). This array contains 1176 cDNA spots including 
9 housekeeping genes and negative controls. The genes present on the array may be 
broadly functionally classified into the following groups: Cell surface antigens, 
transcription factors and DNA binding proteins, cell cycle regulators, immune system 
proteins, extra-cellular transporters, oncogenes, tumour suppressor stress response, 
ion channels and transport, ECM proteins, trafficking proteins, metabolic proteins, 
apoptosis related proteins, cellular receptors, DNA metabolism proteins and 
housekeeping genes (GAPDH, tubulin a l ,  ornithine decarboxylase, cytoplasmic P- 
Actin).
Preliminary experiments and previous toxicological investigations (Reynolds et al., 
2001) had used the smaller Atlas™ Rat stress array (207 genes), changing to the 
Atlas™ Rat 1.2 array highlighted several problems.
Sufficient high quality total RNA had to be used for efficient targeted reverse 
transcription (Figure 3.4a). A prevalent problem with the array images is the presence 
of darkened edges along the membranes (figure 3.4b), although first attributed to 
inadvertent drying of the membranes during the whole procedure, it is likely to be the 
result of a blocking problem. Non-specific binding was a significant problem (figure 
3.4c), this was minimised by replacing the hybridisation solution and using fresh 
Salmon sperm. Repeated heating and cooling of the hybridisation solution was 
detrimental to its effectiveness. However, darkened patches are still visible on the 
array membrane, although much of this effect on calculating adjusted gene 
expressions can be eliminated using the Atlas Image 2.01a visualisation package (BD 
Biosciences) by selecting individual areas adjacent to sets of gene to calculate the 
background noise. Successful array images have been achieved using DNase treated 
RNA samples (figure 3.4d)
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BFigure 3.4: Spectrum of images found with the Rat 1.2 macroarray: (A) some spots are 
present, loss of RNA integrity/failure of RT. (B) Darkened edges, drying of membrane or 
inadequate blocking. (C) Uniform spots apparent, non-specific binding. (D) A successful 
array with low background and clear defined gene spots.
The macroarray images from sham-treated, whole PM (5 mg and 10 mg) and water 
soluble (10 mg equivalent dose) lung tissues are shown in figure 3.5a-d. There was 
some variability in gene expression across the replicates, a reflection of the differing 
susceptibility of each animal to the instillate.
3.4.4 Data Transformation and Normalisation
Random genes were selected to test for normality using the Anderson Darling test for 
normality within the statistical package, Minitab™. Resultant plots are shown for one 
gene at each stage of transformation and normalisation. The raw expression data of 
random genes failed to be consistently normally distributed. Logio transformation is 
commonly adopted to ensure that all data is approximately normal, thus allowing 
normal statistical assumptions to be made. Transformation and subsequent 
normalisation resulted in the gene array data to become largely normally distributed 
(Figure 3.6).
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Figure 3.5a: Expression array images of whole lung tissue from animals exposed to saline only (sham 
treated). Array images of (i) Control 46, (ii) control 48 and (iii) control 49.
Figure 3.5b Expression array images of whole lung tissue from animals exposed to 10 mg whole 
Cardiff PM10, sacrificed 3 days post instillation. Array images o f (i) Whole 10 mg (1), (ii) Whole 10 
mg (4) and (iii) Whole 10 mg (5).
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Figure 3.5c: Expression array images of whole lung tissue from animals exposed to 5 mg whole 
Cardiff PM,o, sacrificed 3 days post instillation. Array images o f (i) Whole 5 mg (16), (ii) Whole 5 
mg (17) and (iii) Whole 5 mg (18).
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•  •
Figure 3.5d: Expression array images of whole lung tissue from animals exposed to 10 mg (equivalent 
dose) water soluble Cardiff PMio, sacrificed 3 days post instillation. Array images of (i) Soluble 10 mg 
(12), (ii) Soluble 10 mg (14) and (iii) Soluble 10 mg (15).
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Figure 3.6: Normality plots for a randomly selected gene (AOlh) from 10 mg whole treated (n=3) and 
sham-treated controls (n=3) data. Data was tested for normality as a) Raw expression data (adjusted 
intensities) (p<0.05), b) logio transformed data (p=0.05) and finally c) Two step normalised data (final 
data) (P>0.05).
89
3.4.5 Different Methodologies to assess Candidate Genes of Lung Injury
The different methods of macroarray analysis have been explored using each whole (10 mg, 5 
mg) and water soluble (10 mg) compared to the sham-treated control group (n=3) to enable 
selection of suitable genes for qPCR confirmation. However, for clarity, only those analyses 
concerning sham-treated controls compared to whole (10 mg) PMio-o.i exposed samples are 
described, to ascertain the most appropriate method to normalise and assess the significant 
changes in gene expression.
3.4.5.1. Pair wise Analysis
The list of genes undergoing a minimum of two fold change in expression profiles following 
instillation of 10 mg whole PM was extensive and unmanageable. Application of an arbitrary 
minimum change in relative intensity did serve to reduce the gene lists. Implementation of a 
minimum difference (of background adjusted expression between sham-treated and PM exposed 
samples) of 4000, with a minimum fold change of 2, was applied to reduce the gene lists to 25 
genes, all of which were down-regulated/switched off. These genes were visually examined on 
the array profiles, and several (16) could be seen to alter (Table 3.3a, indicated by bold type). 
Basic function analysis of these genes shows that the majority of the genes have a receptor (15) 
or cell communication (signalling/cell cycle) role (10). HPRT (G15) is considered to be a 
housekeeping gene and its inclusion in the candidate gene list highlights the necessity to 
normalise the array data independently of such genes.
Increasing stringencies (minimum difference and fold change) to filter the gene analyses served 
to suitably reduce the candidate gene lists (Table 3.3b).
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Table 3.3: a) Candidate gene lists and functional analysis o f genes shortlisted using pair wise comparison of 10 mg whole PM exposures compared to an average calculated sham- 
treated profile (n=3).
Whole 10 
expression
mg PM exposed rat lung 
arofile
Gene Classification(s)
Gene code
Difference in gene expression
Test 1 Test 4 Test 5
D02h -6593 -5509 -4421 atrial natriuretic peptide clearance receptor precursor
Hormone Receptors 
G Protein-Coupled Receptors 
Nuclear Receptors
D03n -17076 -13604 -13952 glucagon receptor precursor
D04j -10769 -7509 -6297 calcium-independent alpha-latrotoxin receptor
D06m -6894 -5666 ^6894 galanin receptor 2
D06n -20462 -15534 [-18170 secretin receptor
D071 -6631 -4643 -6631 melanocortin receptor 4
D08h -10143 -8483 -8947 vitamin D3 receptor
D08n -9306 -5610 -9162 glutamate receptor subunit zeta 1 precursor
Neurotransmitter Receptors 
Ligand-Gated Ion Channels
D09i -6996 -6508 -4600 glutamate receptor 4 precursor
D09j -6806 -6134 -6806 gastric inhibitory polypeptide receptor precursor
D101 -7879 -4707 -7879 glutamate receptor, ionotropic
DIOm -6103 -4731 -6103 acetylcholine receptor alpha
D12m -27873 -15313 -21701 metabotropic glutamate receptor 7 precursor Other Receptors (by Ligands) G Protein-Coupled Receptors
D13h -8660 -5620 -5476 low-density lipoprotein receptor precursor Endocytosis Proteins
D13k -12311 -7375 -5619 uociceptin precursor; orphanin FQ Neuropeptides
D131 -7948 -4408 -7112 neuropeptide Y precursor
D14i -8751 -7587 -5703 granulocyte colony stimulating factor Growth Factors, Cytokines and Chemokines
EOli -4236 -4236 -4236 fibroblast growth factor 5
E04n -5191 -4191 -5191 interleukin I, beta Interleukins and Interferons
E05j -6279 -4411 -5207 insulin-like growth factor binding protein 3 precursor Extracellular Transporters and Carrier Proteins
E051 -9514 -7238 -9126 insulin-like growth factor-binding protein Other Extracellular Communication Proteins
E07n -6528 -5268 -5840 c-Jun N-terminal kinase 3 (stress-activated)
Intracellular Kinase Network Members and other Stress Response 
Proteins
F13h -7882 -7030 -6070 Ear-3; V-erbA related protein Oncogenes and Tumor Suppressors and Nuclear Receptors
F131 -9054 -8362 -4754 growth factor Other Cytoskeleton and Motility Proteins
G15 -10480 4120 -4496 hypoxanthine-guanine phosphoribosyltransferase Housekeeping Gene and Xenobiotic Metabolism
Table 3.3 b) Summary o f candidate gene lists undergoing increased stringency o f filtering to achieve 
lists o f manageable length for continued study. Fold change is the extent o f change in relative gene 
expression between sham-treated control and PM exposed expression profiles. “Difference” in gene 
expression between the sham-treated and PM exposed
Stringency and parameters of screening for candidate genes Number of genes undergoing 
changes relative to sham- 
treated control
Fold change Minimum difference
2 fold
None applied
329
3 fold 329
4 fold 329
5 fold 25
2 fold
1000 difference 156
2000 difference 86
3000 difference 44
4000 difference 25
Applying the same pair wise comparisons to water soluble PM exposed profiles, a 
mean calculated control array normalised against each experimental profile in turn, 3 
genes were altered by greater than 2 fold in each comparison. These genes were: a 
ligand-gated ion channel (B02k), a voltage gated ion channel (B04m) and a 
hormone/nuclear receptor (D08j), the direction of the expression change was 
inconsistent across the three exposed samples (data not shown).
A list comprising of 22 genes were identified as being undergoing a greater than two 
fold change in expression (in at least two of the three experimental arrays, minimum 
of 3,000 change in intensity) following exposure to the water soluble fraction of 
Cardiff PM. Only one gene increased (10 fold, B02k), the remaining genes were 
down-regulated or switched off. Basic functional classification of the genes showed 
that large numbers of the genes were associated with ion and water transporters (10), 
intracellular kinases and phosphatases (9) and receptors (6), these genes may be 
strongly correlated with the cellular changes at the lung surface.
92
3.4.5.2 E xpression  R ange  A nalysis
The next approach calculated an acceptable range in expression in both sham-treated 
and PM exposed groups - a result of natural animal variation and differing individual 
susceptibility towards the instillate. Candidate genes were deemed as genes with non­
overlapping range in expression between the sham-treated and PM exposed groups, 
the lists for all exposure groups were extremely large and an additional parameter 
examining the fold change in gene expression between mean sham-treated control and 
mean test (n=3) was incorporated.
A list of 162 genes were identified as potential candidate genes (greater than 2 fold 
change) following instillation of 10 mg whole PMio sample, compared to 44 genes 
following the equivalent dose of the water soluble fraction. These 44 genes from the 
water soluble candidate gene list were all present in the whole PM exposed lists. 
These 44 genes comprise of surface antigens (3), cell cycle controllers including 
oncogenes and tumour suppressors (2), cell (energy, lipid, carbohydrate) metabolism 
(8), ion channels and transporters (5), trafficking and targeting (1), growth factors and 
cytokines (4), hormone and neurotransmitter receptors (12), signalling/communicators 
(7) and proteases (2) (data not shown). The genes all follow the same trends with 
exception of B03k, the ligand gated ion channel/hormone receptor (acetylcholine 
receptor subunit), which undergoes a 2.6 fold decrease in response to water soluble 
and 2.8 fold increase following whole PM exposure.
The numbers of genes generated using a 2 fold change in gene expression to select 
significant genes as the cut off were large, increasing this 2 fold change reduced lists 
to a more manageable lengths. The effect of adding these parameters to the filtering 
of candidate genes on gene list numbers is illustrated in Table 3 .4.
Implementing a minimum of 4 fold changes reduced the lists substantially, 30 genes 
(10 mg whole PM) and 3 genes (10 mg water soluble). The three genes common to 
both lists are B09c- symporter/antiporter (17 fold increase in whole treated, 36 fold 
increase in water soluble), B14b- trafficking and targeting proteins (5.5 fold increase 
following both exposures) and El lk- adaptor protein tyrosine phosphatase (4.2 fold 
and 4.8 fold decreases respectively).
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Table 3.4 Summary o f  candidate gene list numbers with increasing stringency (implementing a higher 
minimum fold change required to select the genes) following the instillation o f whole Cardiff PM (10 
mg). * Number o f genes undergoing changes relative to sham-treated control
Fold change
Number of 
genes*
Up regulated genes Down regulated genes
2 fold 162 97 65
3 fold 54 34 20
4 fold 30 27 13
5 fold 18 12 6
3.4.5.3 Statistical Analysis
Macroarray profiles of tissue from sham-treated (saline instilled), whole PM and 
water soluble PM exposed rats (n=3) showed a high degree of variation in gene 
expression within each treatment group, a reflection of the different animals 
susceptibility to the instillate. Calculating an acceptable range in relative expression 
in sham-treated controls would allow for this natural variance and facilitate the 
identification of genes expressed outside these ranges as a consequence of toxicant 
exposure. A mean (n=4) and 2 standard deviation range of relative expression of each 
gene was calculated from the sham-treated controls and compared to the PM exposed 
expression profiles.
Analysis of the whole PM (10 mg) profiles showed that 94 genes were designated as 
expressed outside a 2 SD range of the mean control array with a fold change of at 
least 2 fold (induced or down-regulated).
Using the students t-test and a minimum of two fold change in gene expression of 
mean control (sham-treated) and test (10 mg whole PM) array profiles, seven genes 
were deemed significantly altered (p<0.05) (9 genes p<0.1). All of these genes were 
expressed outside a 2 standard deviation range (“normal” variation) in control profiles 
(Table 3.5a). The conventional toxicology reported mild pulmonary oedema and 
increase macrophage accumulation within the focal regions of the lung. Interestingly,
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examining the known functions of the candidate genes, they include a range of 
cytokines, growth factors, hormones and interleukins (6) and receptor proteins (3). 
Table 3.5b illustrates the effect of increasing the stringency of filtering the gene lists 
on candidate genes.
Table 3.5: a) Candidate genes proposed to be involved in the pathogenicity o f whole PM,0 (10 mg) 
instilled into healthy rats. Tabulated data showing resultant relative expressions of both sham-treated 
controls (n=3) and whole PM exposed (n=3), fold changes, p- value from student t-test of the data and 
the candidate gene names/gene functions. Purple text indicates genes expressed outside a sham-treated 
control mcan± 2 SD (n=3) in PM exposed (10 mg whole) expression profiles.
b) Summary table of number of genes in candidate lists with increasing stringency of both statistical 
methods applied to expression profiles (sham-treated controls and whole PM exposed (10 mg).
a)
Atlas Gene 
code
Fold
change
P value 
t-test Gene name Functional Classification(s)
D04a Off <0.01 calcitonin receptor precursor Hormone Receptors
D06a -4 0.075 serotonin receptor G Protein-Coupled Receptors
D06k OfT <0.01 cannabinoid receptor 1
D14e -13 0.026
glial cell line-derived neurotrophic 
factor precursor Growth Factors, Cytokines anc
EOlh Off 0.001 fibroblast growth factor 9 Chemokines
EOli Off 0.000 fibroblast growth factor 5
E03b 2.5 0.079 thyroliberin precursor Hormones
E05a 4.8 0.025 interleukin-2 (IL-2) Interleukins and Interferons
ElOm Off <0.01 PAK-alpha serine/threonine kinase
Intracellular Kinase Network 
Members
b)
Gene selection Stringency Number of genes
Sham-treated mean ± 2 SD 2 fold change 94
3 fold change 39
4 fold change 8
Student t-test P<0.1 9
P<0.05 7
Combination 2 fold/p<0.1 4
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3. 4.5.4. Logio(fold change) A nalysis
The Log 10 fold change analysis method failed to produce manageable candidate 
gene lists. There was also less flexibility in the stringency level to assess the 
gene lists and most reported genes were either completely switched on or off. 
The stringency of the analysis could be increased by two parameters: increasing 
the fold change and increasing the acceptable range in fold change (ie. 2SD is 
less stringent than a 3 SD). The effect of altering these parameters is shown in 
Table 3.6. A total of 177 genes had a logio (fold change) outside a 2SD range 
of the mean fold change that would seriously alter the mean value), produced 
significant candidate gene lists and a minimum fold change of 2. Of these, 150 
genes were down regulated/ switched off and 27 were up regulated/switched on 
following treatment.
Table 3.6: Summary o f  candidate gene lists obtained using increasing stringencies o f logio (fold 
change) analysis method in lung tissue exposed to whole Cardiff (CF 2) PM (10 mg). 
* Number o f genes undergoing change relative to sham-treated controls
Fold change SD 
range
Fold change Number o f genes* Expression change
2 Standard Deviation
No limit applied 177 23 switched on 
137 switched off 
4 up regulated 
13 down regulated
2 fold 177
20 fold 173
3 Standard Deviation No limit applied 176 15 up/s witched on 
161 down regulated/off
Examining the median profiles of control (sham-treated) and water soluble 
genes by the same parameters (2 SD, minimum two fold change) resulted in list 
of 100 genes. However these lists showed a reverse trend, 98 genes being up 
regulated or switched on compared to only 2 down regulated or switched off. 
Of these genes, 43 genes were altered by a minimum of four fold (2 down 
regulated or switched off).
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Comparing the whole and water soluble effects judged by this method of 
analysis, 45 genes were common to both candidate gene lists (2 SD range, 
minimum of a 2 fold change). These 45 genes comprised trafficking and 
targeting proteins (9), cell surface antigens (1), metabolism related (10), ion 
channels, transporters and diffusers (16), growth factors/transcription factors 
including chemokines and cytokines (4), extracellular matrix proteins (1) and 
hormones (4) in addition to one housekeeping gene, polyubiquitin, a molecular 
tag to identify damaged molecules and label them for destruction. Eleven of 
these genes do not present the same increase/decrease in soluble treated or 
whole PM exposed profiles.
3.4.6 Quantitative PCR Confirmation
Ten genes were selected from the different candidate gene lists. No genes were 
common to all lists from the different methods of analysis and so it was of 
considerable importance to establish the best way to analyse the data that could 
be confirmed using other methods. Ideally, genes that showed significant up 
regulation and down regulation, in addition to those genes that displayed no 
significant change were selected. Details of each selected gene and the 
analytical method that shortlisted them are summarised in Table 3.7. An 
additional gene, the housekeeping gene, P-actin (G43), was also assessed.
Two genes failed to be successfully analysed using qPCR. One gene (C12i) 
failed to be amplified during PCR and a second gene (B13g) failed to be 
inserted or transformed successfully into competent cells using either pGEM-T 
or PGLA2 basic (blunt ended) vectors into competent E.Coli (JM109) cells. 
The remaining eight genes were successfully analysed.
Each PCR product from the gene primers were ligated into pGEM-T and 
transformed into competent E.Coli (JM109) cells. Incorporated DNA inserts 
corresponding to the expected lengths were sequenced to confirm the correct 
identity. Quantitative PCR standard curves were calculated for each PCR 
product (Figure 3.7a-c).
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Table 3.7: Summary o f the selected genes and predicted behaviour based on the different analysis 
method adopted.
Atlas™  Gene 
Code
Gene Name Fold change Experim ent Analysis method
B04m
Voltage gated
Potassium
channel
Down regulated 
(>-3 fold change)
Water soluble PM 
(10 mg)
Pair wise comparison
C02b
Carbohydrate
metabolism
protein
Up regulated 
(switched on in all 
3 arrays)
D09n
GABA receptor Switched off 
(whole treated)
Down regulated 
(water soluble)
Whole PM 
(10 mg)
Water soluble
Pair wise comparison 
(mean and median control v 
individual exposed
D12m Glutamatereceptor
Down regulated
Whole PM 
exposed analyses
Pair wise comparison
E04n Interleukin 10 Switched off
B13g Amphiphysin II 3 fold decrease
Statistical method 
Expression range analysis
B02k Acetylcholinereceptor
11 fold increase
(P=0.02) Water soluble 
exposedC12i Clusterin 4 fold increase (P=0.07)
E05a Interleukin 2 5 fold increase (P=0.012) Whole PM 
exposed
ElOm Serine/threoninekinase
Switched off 
(P<0.01)
Logio fold change analysis
98
lOOpg
10 pg
500 fg 
10 fg 
100 fg
UL
o «***«
6 21 26 
Cycle Number
36
30 n R = 0.9781
25 
§  20 -
1000 10000 100000 
C oncentration  (fg)
100 500
(c)
Sample Cycle threshold Estimated Concentration
Sham-treated Control 19 1160 fg
Whole PM (10 mg) 25 115 fg
Whole PM (5 mg) 22 380 fg
Water Soluble 20 159 fg
Figure 3.7: An example o f Taqman analysis data. Data shown are expressed as mean value (n=3) for a 
single rat tissue sample. Each tissue sample was analysed using qPCR in triplicate, tissue samples 
from each animal analysed in the macroarray experiment were also analysed using qPCR (n=3). a) 
Sigmoid shaped standard curve of fluorescence o f Taqman PCR analysis for a series of standard 
dilutions for gene E05a. b) Standard curve and regression analysis r2 value for E05a. c) An example of 
the Ct values calculated for experimental samples.
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The mean expression assessed using Taqman analysis for each group and a student t- 
test was completed to deduce any significant differences from sham-treated controls 
and exposed groups for each gene analysed. These results are summarised in Table 
3.8.
Table 3 .8: Summary o f Taqman analysis results for genes tested. Fold change relative to control (3 day 
sham-treated) levels and p  values calculated from unpaired students t-test. Nr- not recorded
Gene Whole PM flO ms) Water soluble Whole PM f5ms)Fold change p  value Fold change p  value Fold change p  value
D09n 1.3 0.1 nr nr nr nr
B02k 2.5 0.05 1.81 0.08 111 0.827
E05a -4 0.19 -2.7 0.25 -8.3 0.16
ElOm -2 0.135 -1.01 0.91 -2 0.15
C02b -10 0.28 -10 0.29 nr nr
B04m -1.05 0.86 -1.6 0.46 nr nr
E04n 2 0.08 2 0.09 nr nr
G43 2.58 0.12 8.95 0.13 nr nr
The next important step was to compare the assessed changes using each method of 
array analysis to the changes calculated from qPCR analysis. These are summarised 
in Table 3.9 (whole) and 3.10 (water soluble). Detailed comparisons were completed 
on the higher dose (10 mg) exposed profiles only.
The more consistently matched method of analysis appears to be the statistical 
approach. This method would be improved with increasing the replicate numbers of 
the arrays, either from using increased animal numbers, or using multiple arrays from 
the same animal tissue sample and calculating mean animal expression levels and then 
comparing mean values as described. Increasing replicate numbers increases the 
strength of statistical assumptions conferred by the calculations.
It can therefore be concluded that a combination of calculating a range (2 SD) of 
normal variation in expression and simple statistical analysis was most appropriate to 
identify changes in gene expression induced by PMio- This analytical approach 
allowed a higher degree of control of stringency to filter insignificant changes in the
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genes. This may be important when examining pulmonary toxicity that is highly 
variable not only between animals but within the tissue. Histological examination of 
the lung tissue (Chapter 2) confirms that only focal regions of issue are affected even 
at the higher doses of whole PM exposure. This poses a significant problem, selection 
of the affected tissue for expression profiling and confirmation with qPCR using the 
same RNA would be the best way to ensure that important candidate genes are 
consistently involved in the lung pathology. However, different preparations of RNA 
from each sample had to be used as degradation of the original samples examined by 
the arrays prevented subsequent qPCR analysis on the same samples.
3.4.7 Generating Final Candidate Gene Lists
Quantitative PCR has identified that the statistical approach was more successful at 
producing candidate genes that may be confirmed using alternative methods. 
Therefore the following section comprises, in full, the candidate genes produced as a 
result of this approach.
3.4.7.1 10 mg Whole PM-exposure
As described previously, using a combination of the students t-test and a minimum of 
two fold change in gene expression produces a candidate gene list of seven genes 
(p<0.05) or 9 genes (p<0.1). All of these genes were expressed outside a 2 standard 
deviation range (“normal” variation) in sham-treated expression profiles (Figure 3.8).
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Table 3.9: A summary comparing the changes o f gene expression judged by the various array analysis method and Taqman confirmation in response to whole PM (10 mg)
exposure. Expected trends and p values (italics) are included where appropriate in addition to stringency o f array analysis.
Gene
Taqman
Analysis
Array Analysis
Pair wise Statistics Expression range Logio fold change Conclusions
B02k +2.5 (0.05) Min +8 in 2/3 +10 fold (p=0.2) Not present Switched on (3SD) Statistical trend
B04m -1.05 (0.88) Down regulate 
(>3,000 difference)
-3 fold (p=0.19) -3.41 fold Switched off (3SD) Trend matched
C02b -10 (0.28) Up regulated +2.4 fold (p=0.1) +21 fold Switched on (3SD) No correlation
D09n +1.3 (0.1) Switched off (all 3) -2.0 fold (p=0.269) Not present Down regulated (-50) 
3SD
No correlation
E04n +2 (0.08) Switched off (>3,000) -Zfo\<i(p=0.16) -2.05 fold Switched off (3SD) No correlation
E05a -4 (0.19) Little change (+1.1 fold) +4.5 (p=0.025) Not present Not present No correlation
ElOm -2 (0.135) Switched off 
(>1000 difference)
Switched off (p<0.01) -5 fold Switched off (3SD Trend matched
G43 +2.28 (0.12) +1.1-1.3 fold changes +1.1 fold #>=0.00 +2 fold Not present Trend matched
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Table 3.10: A summary comparing the changes of gene expression judged by the various array analysis method and Taqman confirmation in response to water soluble PM
(10 mg) exposure. Expected trends and p values (italics) are included where appropriate in addition to stringency of array analysis.
Gene Taqman Analysis
Array analysis
ConclusionPair wise Statistical Expression
range
Logio fold change
B02k + \.8(p=0.08) +10 in 2/3 min 
difference 750
Outside 2SD range 
+17.6 (p<0.01)
Not present Switched on (2SD) Trend matched
B04m +1.6 (p=0.48) Switched off 
In 3/3 arrays
Not outside 2 SD range 
-2.5 (p=0.38)
Not present Not present No correlation
C02b -10.0 (p=0.29) +1.24 change in all 3 
arrays min. diff 400
Not outside 2 SD range 
+2.7 (p<0.1)
Not present Switched on (2 SD) No correlation
D09n nr
Min -2  in 2/3 arrays Outside 2SD range 
-1.5 (p=0.2)
Not present Not present
nr
E04n -2.0 (p=0.09) Switched off 
(2/3 arrays)- 
Min 500 difference
Not outside 2 SD range 
+1.0 (p=0.78)
-2.6 Not present Pair wise 
Expression range
E05a +2.7 (p=0.25) +1.2 to 1.5 in 2/3 
arrays 
min difference 400
Not outside 2 SD range 
+2.6 (p=0.067)
Not present Not present Statistical
ElOm + i.i (P=i) No change-+l-1.3 
fold change
Not outside 2 SD range 
+1.1 (p=0.13)
Not present Not present Statistical
G43 +8.9(p=0.13) +1.00 (no change) +1.0 (no change) (p~l) Not present Not present No correlation
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precursor Hormone Receptors
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G Protein-Coupled 
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(FGF9);
EOli 1.061 0.045 0 O ff 2.23E-05
Fibroblast growth factor 5
(FGF5);
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Figure 3.8: Candidate genes proposed to be involved in the pathogenicity o f whole PMi0 (10 mg) 
instilled into healthy rats, a) Graphical representation of the genes. Values are mean control (n=4) and 
exposed (n=3) and SEM variations, b) Tabulated data showing resultant relative expressions of both 
conditions, fold changes, p- value from student t-test of the data and c) the candidate gene names and 
gene functions.
The nine genes deemed significant following exposure to whole PM (10 mg) 
comprise hormone receptors (3), growth factors and cytokines (3), hormones (1), 
interleukin (1) and kinase network proteins (1).
Calcitonin receptor precursor (D04a) is a G-protein coupled, transmembrane 
glycoprotein and a signalling receptor for calcitonin. It is a GTP binding protein, a 
member of group 2 of G protein coupled receptors, biogenic amine receptors, whose 
activity is mediated by G proteins and upon stimulation, activates adenylate cyclase.
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Serotonin receptor (D06a) is one of a multi gene family of serotonin receptors, also a 
G-protein coupled transmembrane glycoprotein which mediates its activity through 
association with G proteins activating a phospho inositol second messenger system 
within the cell. Serotonin is a biogenic hormone, a potent neurotransmitter and 
mitogen. A member of group 1 G protein receptors, the largest group to date, with a 
diverse role of activities including smell, taste and chemotactic capabilities (Li et al., 
2004).
Cannaboid Receptor (D06k) is also a G protein coupled receptor, which upon 
activation, inhibits of adenylate cyclase (Williams et al., 2003).
Glial cell line derived neurotrophic factor precursor (D14e) is a growth factor, 
capable of acting as a signal molecule stimulating cell growth and proliferation. 
Increased levels of this glycoprotein has been shown to enhance survival and 
differentiation of dopaminergic neurons but is reported to undergo a 7-fold decrease 
following exposure to PMi0. A member of the TGF-(3 family, it serves as an anti- 
apoptotic signal molecule, involved in neurogenesis and signal transduction (Blesch et 
al., 2003).
Fibroblast Growth Factor 9 (EOlh) a potent growth factor with strong mitogen and 
heparin binding capabilities, it has a positive role in cellular growth, development and 
repair, stimulating proliferation in FGF receptor containing cells. It is a member of 
the heparin binding growth factor family and has been implicated in the regeneration 
of (glial) tissue post injury and in the stimulation of glial cell tumours (Miyamoto et 
al., 1993).
Fibroblast Growth factor 5 precursor (EOli) is a proto-oncogene, a member of the 
heparin binding growth factor family, it serves as a mitogen and potent signalling 
molecule (Hattori et al., 1996).
Thyrotrophin releasing hormone (TRH) (E03b) has been implicated as being 
important in causing the stress-induced alterations in the motor function of cells 
within the gastrointestinal tract (Huo et al., 2004). This gene has been reported to 
undergo a 2.5 fold up regulation relative to sham-treated controls (p<0.08) in these 
experiments.
Interleukin-2 (E05a) displays a potent ability to stimulate the proliferation of many 
cell types including epithelial cells in the gut and activated lymphocytes, natural killer 
cells, monocytes and B cells (Cao et al., 2002). This interleukin is strongly associated 
with natural killer cells, although there is no evidence to suggest the presence of such
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cells following the instillation of whole PMio. This cytokine is crucial to the 
regulation of the immune response and the relative expression has been reported to 
increase as a direct consequence of exposure of the lung to whole PM. 
p21 activated kinase (ElOm) is a serine threonine kinase; upon activation it is 
hypothesised to target the GTPase effector, a link to the JNK MAP kinase pathway 
(Ke et al., 2004). It was reported to undergo a significant decrease in expression 
following instillation of whole ambient particulates, a trend confirmed by Taqman 
analysis.
Models of the molecular and cellular events leading up to lung injury following 
exposure to diesel exhaust particles (DEP) and ambient PM conclude that complex 
interactions between the pulmonary cells manifest in the dysfunction of normal lung 
clearance and repair mechanisms at the lung surface (Oberdorster 1990, 1992. 
Donaldson et al., 1998).
Retention studies by Oberdorster (1992) highlighted that the phagocytosis of 
particulates, irrespective of their chemical composition, by AMs, was accompanied by 
the release of a myriad of mediators resulting in epithelial damage (proteases and 
oxidants), growth factors and chemotactic factors. The release of such factors would 
serve to produce bioreactive chemical moieties that may result in further damage to 
the epithelium and cells within the alveolar region, signal molecules to promote the 
replication and repair mechanisms and molecules to produce a chemotactic gradient, 
encouraging the recruitment of activated phagocytic cells into the alveolar space to 
facilitate clearance of the particles. The lung response following the instillation of 10 
mg whole Cardiff (urban) PMio-o.i was a chiefly macrophage mediated response. 
Histology sections showed that particles in close association with alveolar 
macrophages remaining in the alveolar spaces and very little evidence of particles 
crossing the epithelium (interstitialisation), in agreement with other assessments 
revealing a relatively mild and short lived pulmonary oedema and pulmonary damage. 
At 3 days post instillation, slight damage to the epithelium was reported, a possible 
consequence of particle/chemical-cell interaction or the effect of inflammatory 
signalling molecules produced by the activated AMs. Cross talk between the cells 
within the alveoli via signalling molecules may serve to trigger cellular events that 
may protect neighbouring cells from damage and the onset of apoptosis resulting from 
PM interactions and promote the replication of epithelial cells to replace damaged
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cells and restore epithelial integrity. Indeed examples of such genes, including anti 
apoptotic are present in the candidate gene lists. Some of the candidate genes (ElOm) 
have been linked with the MAP Kinase pathways indicates the potential of direct 
effect of signalling molecules derived from activated macrophages and damaged 
epithelial cells on neighbouring cells to promote the transcription and hence 
expression of immediate early genes and transcription factors.
3.4.7.2 5 mg Whole PM-exposure: A Dose Dependant Effect?
Analysis of the macroarray data from tissue exposed to the lower dose (5 mg) of 
whole PMio concluded that no genes were viewed as significant if the 2SD range, t- 
test significance (p<0.05 or 0.1) and minimum 2 fold change were all simultaneously 
applied to the gene profiles. Examination of each parameter alone did produce some 
candidate gene lists and so basic analyses on these lists were undertaken. These 
extremely low stringency examinations were insufficient to produce a final candidate 
gene list as produced for the higher (10 mg) dose, but did serve to assess the profiles 
for any indication of dose dependant changes in gene expression. A total of 8 genes, 
all down regulated, were expressed outside the 2 SD range of normal variation 
(control) and greater than a two-fold change between the mean test and control (Table 
3.10a). A total of 25 genes were significantly altered (p<0.05) but none of these 
genes were expressed outside of the normal control range. No genes were altered 
outside the 2SD range and were significant as judged by the student t test. Genes 
undergoing the most dramatic changes (15 highest up regulation and 15 highest down 
regulation) are shown in Table 3.10b. This list was compiled to assess whether the 
most dramatically altered genes showed any correlation to those genes differentially 
expressed following exposure to either whole (10 mg) PM or equivalent dose of water 
soluble and includes gated ion channels (4), transporter proteins (7), intracellular 
kinases (3) and xenobiotic/lipid metabolism proteins (2) which are all common 
functions to genes altered following the other instillates.
The lists of significantly altered genes following 5 mg and 10 mg whole PMio 
exposure were compared to examine a potential dose dependant effect. None of the 9 
genes (10 mg whole PM gene list) were present in the candidate gene list following 
instillation of 5 mg whole PM. Each gene from the list of nine genes taken following 
10 mg exposure were traced on the 5 mg expression profiles, no gene showed any
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significant difference (p>0.5, fold changes 0.91 -  1.1). It is likely that the 
considerable variation in response to the 5 mg dose has masked any effects at the 
genetic level.
Table 3.10a: Candidate gene lists o f 5 mg whole exposed animals at three days post exposure. Eight 
candidate genes expressed outside a 2 SD range o f normal expression, altered greater than two fold.
a)
Atlas
Gene
List
Mean
Sham-
treated SD
Mean
PM
exposed
Fold
Change Gene Name
Control (5 mg)
B02d
1.0917 0.191 0.3714 -3 glucose transporter protein
B04j
1.0413 0.111 0.4918 -2 sodium channel protein 6 (SCP6)
B lld
1.0147 0.033 0.3788 -3 Aquaporin (pancreas and liver; AQP 8)
B13g
1.0087 0.016 0.3361 -3 amphiphysin II
B13h
1.0718 0.130 0.4342 -2.5 intrinsic factor precursor
B14f
1.0309 0.029 0.3301 -3 fatty acid-binding protein
D08m
1.0709 0.117 0.3482 -3 NOR-1; member o f thyroid/steroid receptor super family
FOln
1.1791 0.256 0.35931 -3 inositol polyphosphate 4-phosphatase type II alpha
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Table 3.10b: Candidate gene lists of 5 mg whole exposed animals at three days post exposure -  the top 15 up regulated and down regulated genes.
Gene
List
2SD
range
P-value 
(T test)
Fold
Change Gene Functional Classification
BOlc N 0.530 -2.0 cytochrome P450 VII (CYP7) Complex Lipid Metabolism Xenobiotic Metabolism
B02d Y 0.185 -2.9 glucose transporter protein Facilitated Diffusion Proteins
B03d Y 0.289 -2.4 acetylcholine receptor gamma Ligand-Gated Ion Channels
B04i Y 0.380 -2.1 sodium channel protein 6 (SCP6) Voltage-Gated Ion Channels
B lld Y 0.235 r2.7 aquaporin (AQP 8) Other Membrane Channels and Transporters
B12h N 0.349 -2.9 myelin proteolipid protein (PLP); Extracellular Matrix Proteins
B13g Y 0.183 p3.0 amphiphysin II (AMPH2) Endocytosis Proteins
B13h Y 0.278 -2.5 Intrinsic factor precursor (INF; IF);
B14f Y 0.167 h31 fatty acid-binding protein Other Trafficking and Targeting Proteins
D08m Y 0.169 -3.1 SOR-l,thyroid/steroid receptor superfamily Hormone Receptors Nuclear Receptors
E07g N 0.482 -2.1 cAMP-dependent protein kinase catalytic subunit Intracellular Kinase Network Members
E07k N 0.522 -2.0 Jak3 tyrosine-protein kinase
E071 N 0.533 -2.0 stress-activated protein kinase gamma (SAPK-gamma) Intracellular Kinase Network Members
Other Stress Response 
Proteins
FOln Y 0.137 -3.3 inositol polyphosphate 4-phosphatase type Ila type IIP Phospholipases and Phosphoinositol Kinases
F02n Y 0.177 -2.2 adenylyl cyclase type VI (ADCY6) Adenylate/Guanylate Cyclases and Diesterases
AOle N 0.280 2.5 kidney band 3 anion exchange protein
Cell Surface AntigensA03e N 0.424 2.4 B7.1
A04e N 0.199 2.0 urokinase receptor
A12a N 0.455 2.3 transforming growth factor alpha (TGFa) Growth Factors, Cytokines and Chemokines
B03e N 0.536 2.0 acetylcholine receptor delta Ligand-Gated Ion Channels
B05e N 0.484 2.1 skeletal muscle sodium channel protein alpha subunit (SCN4A) Voltage-Gated Ion Channels
B07m N 0.225 2.0 Na+/Cl- betaine/GABA transporter
Symporters and AntiportersB07n N 0.525 2.0 excitatory amino acid transporter 3
BlOn N 0.241 2.6 synaptic vesicle amine transporter Other Membrane Channels and Transporters
B13n N 0.227 2.0 secretogranin II precursor Other Trafficking and Targeting Proteins
C02b N 0.347 3.0
cytosolic hydroxymethylglutaryl-CoA synthase (HMG-CoA 
synthase); Simple Carbohydrate Metabolism
C05g N 0.176 3.0 bile-salt-activated lipase precursor (BAL) Metabolism o f Cofactors, Vitamins and Related Substances
C07h N 0.217 2.8 cytochrome P450 2C22 (CYP2C22) Complex Lipid Metabolism Xenobiotic Metabolism
E04d N 0.527 2.0 preprolactin (Prl) Hormones
FOlb N 0.124 2.3 guanine nucleotide release/exchange factor Intracellular Adaptors and Receptor-Associated Proteins
3.4.7.3 10 m g W a te r  Soluble P M -exposu re
Analysis of the water soluble exposed profiles compared to sham-treated controls, 
produces 42 genes whose expression has changed by a minimum of two fold. Of these 
genes, 5 genes were deemed significantly altered (p<0.05) by a students t-test (Figure 
3.10a) whilst a further 13 genes were significant to the 90% level (all up regulate, 
Figure 3 .10b).
One hundred and sixty nine genes were deemed to have a mean exposed relative 
expression outside that of a 2 SD “normaF’ variation range of control expression, 7 of 
which have a greater than two fold change in expression (BO lk, B02k, B03k, B03a, 
B07n, D08j, E03a).
Application of both a 2 SD range and t-test (p<0.05) stringency, reduce the candidate 
gene list to just three genes. Neuronal Acetylcholine receptor protein-a (B02k) forms 
part of a pentameric transmembrane protein ion channel. Upon ligand binding, this 
subunit undergoes extensive conformational changes resulting in opening of the gated 
ion channel (Oshikawa et al., 2003). Array analysis reported a significant fold increase 
(17 fold, p<0.01) and the trend was confirmed by Taqman analysis (1.8 fold increase). 
The second gene, a nicotinic acetylcholine receptor a2 subunit (B03k) was reported to 
undergo a significant increase in expression compared to sham-treated controls. This 
is an interleukin/interferon gated ion channel associated receptor that acts, upon 
stimulation to open the associated potassium channel into the cell and serves to acts as 
an inhibitory factor to adenylate cyclase activity (Khirougss et al., 2004). Finally, the 
up regulated excitatory amino acid transporter 3 (B07n), a solute transporter that may 
act as a gradient driven symporter or antiporter (Foguet et al., 1992). Reducing the 
stringency of the t-test (p<0.1) as summarised in figure 3.10b incorporates an 
additional 15 genes, all up regulated. These genes include a wide range of membrane 
channels (aquaporin) including gated ion channels (calcium and potassium ion 
channels), targeting and transporter proteins (epiphorphin, solute transporters and P- 
glycoprotein) and signalling molecules (interleukin 6 and prolactin). All such genes 
could be hypothesised to be involved in the oedematous response suggested by 
conventional toxicological examination.
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Expression of the 18 candidate genes deemed significant following exposure to the 
water soluble component (70% by mass of Cardiff PM) were assessed in the whole PM 
exposed profiles. Of the 18 genes, 1 gene was found to be expressed outside a mean 
sham ± 2SD range (B02k, p=0.21) whilst three genes were significantly altered (p<0.1) 
from sham-treated controls (B06i, C02b, E05h). This slight correlation indicates that 
there are mild similarities in the lung response to whole and water soluble only 
fractions of the same PM sample, as would be expected from a whole PM sample 
composed of 70% by mass water soluble component. However, the large effect of the 
particle fraction may have masked the changes elicited by the water soluble fraction. 
Each of the four genes identified (Table 3.12) undergoes a similar directional fold 
change compared to sham-treated controls.
Figure 3.11: Candidate genes proposed to be involved in the pathogenicity o f water soluble PMi0 (10 
mg) instillation into healthy rats, a) Graphical representation of the genes deemed significantly altered 
relative to saline treated controls (p<0.05). Values are mean control (n=4) and exposed (n=3) and SEM 
variations, b) Tabulated data showing resultant relative expressions of the 18 genes significantly altered 
(P<0.1, min. 2 fold change), fold changes, p- value from student t-test o f the data and the candidate gene 
names and functions for each gene are given. Red type indicates the 3 genes undergoing a minimum 2 
fold change in expression, relative expression in exposed samples outside a sham-treated mean ± 2 SD 
range and p<0.05.
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Table 3.11: Candidate genes proposed to be involved in the pathogenicity of water soluble PMi0 (10 mg). Tabulated data showing resultant relative expressions of the 18 
genes significantly altered (P<0.1, min. 2 fold change), fold changes, p -value from student t-test of the data and the candidate gene names and functions for each gene are 
given. Red type indicates the 3 genes undergoing a minimum 2 fold change in expression, relative expression in exposed samples outside a sham-treated mean ± 2 SD range 
and p<0.05.
Gene code
Mean
control
Mean
test
Within 
2SD range
Fold
Change
P  value 
T-test Gene iction
BOln 0.4613 1.1928 FALSE 2.59 0.0702 multidrug resistance protein 2 Drug-Resistance Proteins ABC Transporters
B02k 0.2500 4.4063 TRUE 17.63 0.0001 neuronal acetylcholine receptor protein a7
Ligand-Gated Ion ChannelsB02m 0.2875 1.1863 FALSE 4.13 0.0452 cyclic nucleotide-gated channel
B03j 0.6184 1.2770 FALSE 2.07 0.0634 purinergic receptor P2X3, ligand-gated ion channel
B03k 0.0000 2.3333 TRUE on 0.0009 neuronal nicotinic acetylcholine receptor alpha 2 subunit Ligand-Gated Ion Channels
Hormone
Receptors
B06i 0.5635 1.1377 FALSE 2.02 0.0648 potassium channel, voltage gated Voltage-Gated Ion Channels
B06n 0.4001 1.6805 FALSE 4.20 0.0592 calcium channel, beta subunit,
B07n 0.0000 2.3333 TRUE on 0.0013 excitatory amino acid transporter 3 Symporters and Antiporters
B08m 0.3796 1.4658 FALSE 3.86 0.0622 sodium-potassium-chloride cotransporter
B12b 0.4677 1.1000 FALSE 2.35 0.0999 water channel Other Membrane Channels and Transporters
B12n 0.4931 1.3242 FALSE 2.69 0.0588 syntaxin 2 (STX2) Exocytosis Proteins
C02b 0.3952 1.0554 FALSE 2.67 0.0730
cytosolic hydroxymethylglutaryl-CoA synthase (HMG- 
CoA synthase) Simple Carbohydrate Metabolism
E04d 0.2500 1.0875 FALSE 4.35 0.0423 preprolactin (Prl) Hormones
E05b 0.4801 1.1714 FALSE 2.44 0.0871 interleukin 6 (IL-6) Interleukins and Interferons
E05h 0.4650 1.1024 FALSE 2.37 0.0981 leptin precursor; obesity factor
Other Extracellular Communication ProteinsE05n 0.4420 1.1464 FALSE 2.59 0.0674
cocaine/amphetamine- 
induced rat transcript
E06h 0.4674 1.3074 FALSE 2.80 0.0507 secretogranin 3
FOlb 0.5273 1.2341 FALSE 2.34 0.0999 guanine nucleotide release/exchange factor (GNRP) Intracellular Adaptors
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Table 3.12 Assessment of the water soluble candidate genes in 10 mg whole PM exposed samples. 
Either the student t-test or 2 SD range filtering. The data showed that changes in only one of the four 
genes were similarly expressed.
Atlas Gene 
Number
Change reported 
water soluble 
profile
Outside a sham 
mean ± 2SD 
range
P value
(T-test)
Fold change
B02k 17 Yes 0.21 10
B06i 2
No
0.1 1.8
C02b 2.6 0.1 2.4
E05h 2.3 0.1 2.3
3.5 Discussion
The primary aim of this study was to examine changes in lung gene expression 
following the instillation of whole PMio (two doses: 5 mg and 10 mg) and the 10 mg 
equivalent dose of the water soluble fraction of ambient Cardiff sample. A chief 
concern of this experimental strategy was to develop a standardised method of data 
handling, normalisation and transformation within our research group that was 
capable of yielding meaningful candidate gene lists. The instillation of the PM 
toxicant produces a highly variable response in healthy rats. Lung tissue samples 
from experimental animals exposed to Cardiff PMio were selected based on a 
heightened response based on conventional assessments (Chapter 2). Expression 
profiles of each animal were generated and compared to produce candidate gene lists. 
Different animals were used in each analysis; there was no replication of the same 
sample or indeed, the same RNA. This was perhaps was a failing, increasing the 
replicates of array profiles in this manner whilst still retaining low numbers of 
experimental animals would have increased the reliance of statistical approaches used 
and addressed issues relating to the reproducibility of the array. However, conversely 
use of the same RNA or tissue sample fails to take into account the different level of 
effect the exposure has had on individual animals.
The variation between animal responses has provided a challenge for this experiment. 
The wide variation in responses as well as differing severity of a conventional 
toxicological endpoint meant that a uniform effect across the whole was impossible. 
The use of equivalent lobes of tissues from each animal was implemented to
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standardise tissue selection between samples, but it did not ensure that each tissue 
sampled was equally affected by the PM instillate. In this respect, subsequent studies 
with another pulmonary toxin (bleomycin) inducing a more homogenous level of 
effect across the whole lung has been successfully used to assess the data handling 
(Dominique Balharry, personal communication, 2003). In the bleomycin 
investigation the homogenous effect of the toxicant on lung tissue coupled with the 
greater animal numbers (n=9 sham, n=9 exposed) led to very consistent agreement 
between six candidate genes derived from the macroarray and qPCR.
Logio transformations stabilise the variance of the data expressed at high levels, 
however, their performance on data expressed at low or near background levels is less 
effective (Durbin et a l, 2002). Background adjustment of the raw expression data 
could result in adjusted signal intensities of less than 0, in genes with very low 
expression. In this case, all negative values must be treated as 0 or cause such signal 
intensities to be disregarded, which was not advisable and subsequent log calculations 
produced negative values, unsuitable for further analyses of the data. It was 
preferable to incorporate a stabilising transformation that incorporates all signal 
intensities, irrespective whether the intensity is high or near to background levels. 
The introduction of the addition of a constant value (c) to each gene background 
adjusted-intensity reduced the number of spots with intensities close to background 
level, preventing the elimination of these genes from subsequent analyses (Durbin et 
al., 2002). The value for the present study was taken as 1. Therefore for all cases 
when background adjusted expression intensities tended to 0, the logio (0+1) was 
calculated and assigned as 0 rather than logio (0). Durbin and colleagues claim that it 
would also be appropriate to use non-background adjusted spot intensities (i.e. the raw 
spot intensity) instead of the addition of a constant value (c). However, because of the 
extent of variation between background noise between different arrays and even, in 
some cases, between regions of arrays, it was considered better to work from adjusted 
data.
Proper normalisation of array data was of great importance when considering the 
sources and extent of variations in detection and visualisation of expression changes. 
Major sources of fluctuations expected in an array experiment include probe, target 
and array preparation, hybridisation process, background over shining and effects
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resulting from image processing. This list incorporates mRNA preparation and 
transcription efficiency, labelling efficiencies, systematic variations, hybridisation 
parameters and image analysis (Schuchard et al., 2000).
Commercially available arrays were purchased to ensure that all arrays and reagent 
were of the highest possible standards. It was noted however, that background noise, 
radiolabel incorporation and probe hybridisation was variable between batches of 
arrays purchased and that efficiencies generally declined with repeated use. The 
background noise, also noted amongst other Atlas™ array users, was generally higher 
than found with other commercially available arrays and could, mask differentially 
expressed genes with low expression levels. Reduction of background noise is vital to 
the improvement of accuracy of macroarray data experiments (Yang et al., 2001)
Four approaches to analysis of the gene profiles were explored and outlined in this 
chapter. Simple pair wise comparisons using a mean calculated control profile was 
adopted as the first method. This method was initially favoured because it retained 
simple control/test comparisons, however, it failed to take into account of any normal 
range of expression that may be observed between different animals. Indeed, this 
method produced large gene lists that had to be reduced by application of arbitrary 
values attempting to give more weight to a simple fold change in gene expression. 
The methods were then developed in an attempt to address this “normal range” in 
gene expression in sham-treated control and PM exposed profiles. The expression 
range analysis, evaluated the normal range of expression of the genes in both control 
and exposed samples, calculated a minimum and maximum error in each gene for 
both sham-treated and exposed samples (n=3) to identify candidate gene with non 
overlapping range in expression. Candidate gene lists devised from this approach 
showed a large degree of similarity between water soluble and whole PM exposed 
profiles, which was to be expected from a sample that is 70% water soluble (Moreno 
et al, 2003). The third method, the statistical approach was introduced to address 
variation in expression between similarly treated animals. Global normalisation of all 
test and control profiles together was a necessary for the comparison of gene 
expression across the arrays allowing simple statistical evaluation of the data. This 
approach assessed the similarity in range of control and exposed expression (statistical 
tests). A fourth approach was logio fold change analysis method. This calculated an
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alternative range in fold changes across the arrays rather than relative expression 
itself. Calculating the logio ratio of mean control and test profiles and calculating a 2 
SD range in logio ratio from the mean. This method failed to produce short candidate 
gene lists.
The most successful method was the statistical approach. Even with the extremely 
focal regions of PM affected tissue and the low replicate numbers, changes in 
expression of candidate genes, some confirmed by qPCR, were detectable following 
instillation of a low bioreactive PM sample. The comparison of the different fractions 
indicate that some genes are similarly affected between water soluble and whole PM 
exposed samples, but these changes fall below the stringency of the filtering adopted 
for the final candidate gene lists. With increased replicate numbers, increasing the 
number of animals and replicates from the same tissue sample, it may be possible to 
examine the expression profiles using a lower stringency to identify markers 
characteristic to the exposure in animals with differing susceptibility to PM exposure.
Basic functional analysis of the candidate genes following both exposure to water 
soluble fraction and whole PM, include genes with known cellular functions 
consistent with the events at the lung surface confirmed by the conventional 
toxicological study (Chapter 2) and by previous published models of lung injury. 
This is an encouraging result and strengthens the use of macroarray technology to 
examine the effect of such toxicants on a larger cross section of genes and molecular 
pathways rather than several genes in isolation to gain further insights into the 
molecular basis for many of the observed lung and systemic effects post such 
exposures.
The change of patterns and numbers of gene changes observed between the two 
instillates (whole and water soluble PM fraction) could be a reflection of the different 
airway responses towards the different fractions. The durable particles present within 
the full fraction encourage macrophage invasion of the alveolar space to clear the 
foreign materials. This cell response is rarely observed in the absence of the particles 
in the water soluble fraction. The water soluble fraction of PMio has been shown to 
pass through the lung tissue and instigate systemic changes within hours of instillation 
(Whittaker, 2002). The soluble fraction would cause immediate damage and leave the
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airways extremely quickly. Therefore, by 3 days, pulmonary events would be chiefly 
concerned with repair and restoration of airway architecture. In comparison, the 
whole PMio fraction (30% -by number-of durable particles) has greater longevity at 
the epithelial surface and by 3 days, pulmonary damage and clearance are likely to be 
continuing.
The histological analysis of the water soluble fraction of PM exposed tissue displays 
very different airway responses compared to those following the instillation of whole 
dust samples. At high magnification, the lungs treated with water soluble fraction of 
PM io have noticeably greater areas of general thickening of the tissue which represent 
swollen micro-capillaries or the interstitial regions around capillary areas. The 
candidate genes identified using toxicogenomic analysis all display a similar function 
within the cell, many serve as ion channels and transporters that may serve a common 
role to restore the normal fluid balance within these tissues. Calcium has been 
strongly implicated in the stress response of pulmonary cells and the presence of 
calcium channels in candidate genes may be part of the recovery of these cells.
The candidate genes identified from the macroarray profiling do correlate with the 
cellular events observed at the lung surface, characterised by both histology and 
biochemical markers. The down regulation of an anti-apoptosis factor (D14e) and 
induction of proliferative factors (EOlh and E05a) in response to the instillation of 
whole PMio (10 mg) may constitute part of the process of lung repair following the 
injury, promoting the removal of damaged cells and their replacement. The 
dominance of significant changes in the increased expression of ion channels (B02k, 
B03k and D07n) may represent a lung response to the fluid imbalance observed in the 
histology, arising as a consequence of exposure to water soluble component of PMio
In toxicological terms the Atlas™ macroarray system provides a useful preliminary 
screen to identify important candidate genes expressed during lung damage. 
However, accurate quantification and confirmation of these gene changes will always 
require the use of other techniques i.e. qPCR. The Atlas™ array system was 
successful, however the macroarray procedure required large amounts of total RNA 
and the success rate to achieve suitable array images for the study was not always 
reliable.
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Chapter 4.0
Establishing the toxicity of PMi0 to primary lung
cell cultures
4.0 Establishing the toxicity of PMi0 to primary lung cell cultures
4.1 Introduction
The high degree of cell heterogeneity of the lung renders the in vitro study of cellular 
and biochemical features more difficult than other organs (Nemery and Hoet, 1993). 
There are in excess of 40 different cell types within the lung, the alveolar epithelial 
type II cell, alveolar macrophage and the non-ciliated bronchiolar epithelial cell 
(Clara cell) have received the greatest attention in toxicological studies due to then- 
pivotal roles in the transformation, detoxification and clearance of foreign materials 
and toxicants from the lung. The use of primary cells in culture has provided an 
important insight into the mechanisms of toxicity of many pulmonary toxicants. These 
assays incorporate an array of molecular and cellular endpoints including cell death or 
more subtle symptoms of cellular stress and dysfunction including secretion of 
cellular signalling molecules and oxidative capabilities.
The use of isolated cell cultures may not completely reflect their behaviour in situ, 
resulting in destruction of spatial relationships between different cell types critical to 
normal cell function and maintenance of differentiated states. However, primary cell 
isolates have increased longevity over perfused organs and tissue extracts, it has also 
been shown that they retain characteristics and function over a greater period that may 
otherwise be lost in cell lines (Dobbs et al., 1997. Reynolds et al., 1999. Oreffo et 
al, 1988). Good toxicological research with isolated cells will lead to a better 
understanding of the whole lung, and thus will contribute to a better understanding of 
the pathogenesis of other lung diseases (Nemery and Hoet, 1993).
One objective for this thesis was to provide toxicogenomic profiling of primary lung 
cells (epithelial type II and alveolar macrophage cells) following treatment with 
particulate matter (PMio) collected from ambient air in the south Wales conurbation. 
The emphasis of this work was to improve the development of in vitro toxicity assays 
(thus reducing animal experiments) and provide detailed information at the molecular 
level of mechanisms by which PMj0 may damage individual lung cells. In order to 
achieve these objectives, a number of steps were necessary. The first step involved
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the isolation and culture of the primary lung cells and the second required the 
determination of the toxicity of the PM samples under investigation. These steps 
form the basis of this chapter. The purpose of the work outlined in this chapter was to 
establish the doses of PMio that produced low toxicity but could result in measurable 
genetic changes in the target cells in subsequent studies (chapter 6 ). There are a 
number of ways to assess toxicity in cell culture but cell attachment and detachment 
assays for both type II (Reynolds et al., 1999. Murphy et al., 1999) and alveolar 
macrophage cells (Richards, unpublished) have already been used in our laboratory. 
The PM toxicity was assessed by its ability to impair cellular function and viability to 
attach to the culture substrata and has been judged to provide a subtle response by the 
cells. These studies established CD50 values (the total dose, by mass, required to 
damage or detach 50% of the cells in a monolayer cell culture), which allowed the 
comparison of differential toxicity of particles derived from variable sources and sites.
The following chapter outlines the isolation and culture of two lung cells, the alveolar 
macrophage and alveolar epithelial type II cell, from healthy rats and characterisation 
of the cell cultures by phase contrast microscopy, observing cell shape and features, 
such as the presence of lamellar bodies, to identify the cell types in vitro.
Of specific interest in the present study was a comparison of an urban PMio (Cardiff, 
CF 2) and an industrial sample (Port Talbot, PT 1). The former sample, used in the 
previous in vivo toxicity assessment (Chapters 2  and 3), is dominated by traffic 
particulates whereas the industrial sample contains significant numbers (>30%) of 
iron spherules derived from a local steel works. Thus, a toxicity study with primary 
lung cells should identify how such cells respond to these different samples.
Current research on air pollution toxicity has heavily implicated the water soluble 
fraction of PMio in the observed toxic effects (Adamson et al., 1999 and 2001, Dye et 
al., 2 0 0 1 , Greenwell et al., 2003). Therefore in the present study, primary cell 
cultures received a suspension of whole PMio (particles plus soluble fraction), the 
equivalent doses of washed PM (containing solely the washed durable fraction) and 
water soluble fraction of PM (durable particles removed by centrifugation) from both 
Cardiff and Port Talbot samples. In summary, this study investigates the toxicity of 
two characterised PM samples from two distinct sources within the South Wales
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conurbation towards primary alveolar macrophages and epithelial type II cells 
maintained in vitro.
4.2 Materials
4.2.1 Material Suppliers
Male (200-250g) Sprague Dawley Rats (pathogen free) were purchased from Charles 
River Ltd, Margate, Kent. Euthatal and Halothane was purchased from Rhone 
Merieux, Harlow, Essex. Trypsin (Type 1, T - 8003), DNase (DN - 25), 
Streptomycin/Penicillin (P - 0906), Evans Blue (E-2129), Tween 20 (P-7949) and 
Percoll (P 1644) were all purchased from Sigma, Poole, Dorset.
DCCM-1 (050 -  010 - 1) was ordered from Biological Industries, distributed by 
Q.B.S. Ltd, 12 Pembroke Avenue, Denny IND Centre, Waterbeach, Cambridge, 
CBB5 9PB. L-Glutamine (25030 - 024), Gentamycin (15750 - 045), Anti -  PPLO 
(15220 - 049), 10 X PBS (with calcium and Magnesium, 14080-048, without 14200- 
067), Foetal Calf Serum (10109 - 163) and Ultroser G (091 - 25950H) were purchased 
from Gibco BRC, Life Technologies Ltd., High Wycombe, Bucks. The plastic Petri 
dishes (2050200) were ordered from Triple Red and the EHS Sarcoma derived gel 
plates (ECM) (E - TCMT - F) from Biological Industries. The sterile Luer cannulae 
(200/300/050) were obtained from Portex, Hythe, Kent.
4.3 Methods
4.3.1 Type II Cell Isolation
Alveolar macrophages and epithelial type II cells were isolated using a method 
outlined by Oreffo (1987), using a trypsin digestion and Percoll gradient selection. In 
brief, rats (usually 200-300 g) were anaesthetised with Halothane and then 
administered a lethal intraperitoneal injection (1-2 ml) of Euthatal. The rat was 
subsequently weighed and cardio-respiratory death confirmed prior to dissection.
The fur was washed with ethanol (70 % v/v) and the ventral surface skin removed. 
The peritoneal cavity was opened by midline incision and the major dorsal blood 
vessels cut.
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A tracheotomy was performed and a Luer Cannula, attached to a 20 ml syringe, 
securely tied into place in the trachea. The diaphragm was subsequently opened and 
the ventral portion of the rib cage and thymus removed. A Luer cannula attached to a 
gravity feed of sterile saline was then fed into the pulmonary artery and the right 
atrium was cut upon expansion to allow fluid to exit.
The lungs were perfused via artificial ventilation with 8-10 ml of air by means of the 
syringe attached to the Luer Cannula of the trachea. Ventilations (usually 8-10) were 
continued until the pulmonary circulation was clear of all blood to produce white 
parenchymal lung tissue.
The heart was removed and the lungs and trachea dissected free from the carcass. The 
oesophagus and any fatty tissue were dissected from the lungs and trachea. Any 
mucoidal material or blood clots on the exterior of the tissue were removed by means 
of absorbent tissue and the lung and trachea weighed.
The lungs were lavaged (five to eight times) with 6-8 mis of 0.15 M saline. The 
resultant lavage fluid was pooled in a centrifuge tube and maintained on ice. The 
large free cell count (LFC) was obtained by counting a sample of the cells using a 
haemocytometer. The large free cell population comprises of monocytes including 
macrophages, in healthy animals these cells consist of up to 95 % alveolar 
macrophage cells.
The lung was digested as outlined by Oreffo (1987). Briefly, this involved attaching 
the lung and cannula to a 20 ml syringe and filling the intact lung with 0.25% w/v 
Trypsin solution in Solution B (0.133 M NaCl, 5.2 mM KC1, 2.59 mM Na2HPC>4 , 10.3 
mM Hepes and 1.0 mg/ml Glucose, 1.29 mM MgCk and 1.89 mM CaCb) (6-8 ml). 
The solution was subsequently discarded and the lungs refilled with fresh trypsin and 
suspended in saline at 37°C for approximately 30 minutes or until the lungs looked 
mottled and translucent. The digested lung was removed from the saline and the 
trachea, bronchi and any other contaminating tissues were dissected free from the 
lung parenchyma and weighed, allowing calculation of the total lung parenchymal 
weight. Foetal calf serum (FCS) (1 ml) was added to the lung parenchyma, to stop the 
action of the trypsin. The tissue was diced and made up to 25 ml with DNase I
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solution (250 pg/ml (7500 U/100 ml) in Solution A (0.133 M NaCl, 5.2 mM KC1, 
2.59 mM Na2HPC>4 , 10.3 mM Hepes and 1.0 mg/ml Glucose, pH 7.4). The 
suspension was inverted (4 minutes) to encourage the full dissipation of the cell 
aggregates. The cell suspension was filtered through three filters, surgical gauze, 150 
pm mesh and finally a 30 pm mesh, to remove all tissue clumps. This resulted in a 
mixed cell suspension termed the primary digest. The volume and cell content of the 
suspension were recorded. The cell count provides an estimate of the number of type 
II cells isolated (approximately 30% type II, Oreffo et al., 1987).
The primary cell isolate was mixed well using a pasteur pipette and applied to a 
freshly made, cold (4°C) discontinous Percoll gradient to segregate the cells based on 
their density, the type II cells are lipid rich and have lower density than contaminating 
red blood cells and macrophages. Each Percoll gradient comprises of 10 ml of light 
gradient (1 ml Solution C (1.33 M NaCl, 52 mM KC1, 25.9 mM Na2HPC>4 , 103 mM 
Hepes and 10 mg/ml Glucose, pH 7.4), 50 pi FCS, 2.7 ml Percoll made up to 10 mis 
with distilled water) containing a few drops of phenol red to allow the two layers to be 
distinguished, on top of the same volume of heavy gradient (1 ml solution C, 50 pi 
FCS, 6.5 ml Percoll made up to 10 mis with distilled water). The preparation was 
centrifuged in a RC -  3B (swing-out head) centrifuge (20 minutes, 250 x g, 4°C).
After centrifugation, distinct layers were visible in the Percoll gradient. The Type II 
rich layer was recovered in a fresh, sterile 50 ml centrifuge tube and the volume made 
up to 40 mis with DNase II solution (50 pg/ ml or 2000 U/200 ml, 0.01% v/v 
gentamycin, 0.05% v/v anti-PPLO in Solution A) to wash the cells. The cells were 
recovered as a pellet, by centrifugation as before and the resultant supernatant 
discarded. The cell pellet was re-suspended in 5 ml of sterile filtered DCCM-1 media 
containing 1% v/v penicillin and streptomycin and 2% v/v L-glutamine and was 
transferred to a petridish for incubation at 37° C for 1.5 hour. This procedure, referred 
to as differential attachment, separates the cells based on their ability to attach to the 
surface of the petri dish. Contaminating fibroblasts and macrophages will readily 
attach to the plastic surface whilst type II cells will not adhere as readily, resulting in 
an enriched supernatant of type II cell population by the end of the incubation.
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4.3.2 T ype I I  C ell C u ltu re  an d  C h a ra c te risa tio n
The type II cell-enriched supernatant was removed from the petri dish and the final 
cell count of the purified type II cell population was calculated. The cells were plated 
at 250,000-350,000 cells/96 well (ECM coated) plate (equivalent to 6500-9000 
cells/mm2) in DCCM-1 containing 1% v/v penicillin and streptomycin, 2% v/v L- 
glutamine and 2% v/v ultroser G, a serum substitute that facilitates the attachment and 
spreading of the type II epithelial cells. The cells were incubated at 37° C, in 5 % 
carbon dioxide (95% air) and the cultures washed (Solution A containing 1% v/v 
penicillin/streptomycin) and media replaced as required.
Pulmonary epithelial type II cells were typically cultured until a confluent population 
consisting of well spread cells showing the characteristic features of type II cells. 
These were obtained, when plated at 250,000-350,000 cells/96 well, at between 24 
and 48 hours in culture.
A nitroblue tetrazolium/ nicotinamide adenine dinucleotide phosphate 
(NBT/NADPH) stain of type II epithelial cells was completed on preliminary cultures 
to ascertain purity. The stain is specific to NADPH reductase, abundant in the type II 
epithelial cell and Clara cells. Cells attached to the culture substrata or cytospin 
preparations were washed in PBS (no calcium or magnesium) and bathed in 
formalsaline (10 seconds) and washed well. Filter sterile NBT stain solution (10 mg 
NBT, 10 mg NADPH (reduced) in 10 mis PBS) was added to the cells and incubated 
(37°C, 20 minutes) and washed off in PBS (1% v/v penicillin/streptomycin). Type II 
cells were stained dark blue in close association with the lamellae present in the 
cytoplasm, whilst Clara cells, containing greater amounts of the enzyme had a dark 
blue cytoplasm and a white nuclear region. The most likely staining reaction is for 
NADPH-dependent P450 reductase located in the microsomal fraction of Clara and 
Type II cells.
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4.3.3 A tta ch m en t Efficiency an d  P u r ity  D a ta  from  C ell C u ltu re s
The attachment efficiency of the type II cell population was calculated using phase 
contrast photography. Photographs are considered more accurate than counting the 
cells by eye through the microscope. The type II cells were identified as those cells 
containing four or more lamellar bodies. Mature type II cells may contain up to 50 
lamellar bodies but will lose these characteristic features and upon culture in vitro 
become elongated (type I-like morphology). The attachment efficiency was based on 
the total number of cells within a given area of the well relative to control (untreated) 
populations.
4.3.4 PMio Collection and Preparation for Cell Studies
Coarse (PM10-2.5) and fine (PM2.5-0 .1) PM fractions collected on PUF (polyurethane 
foam) filters on the high volume cascade elutriator collector (Moreno et al., 2003) and 
removed from the collection substrate using standardised methods. The two fractions 
were recombined to produce a single whole PM10-0.1 suspension and the washed and 
water soluble fractions were prepared as previously described (Chapter 2). PM 10-0.1 
suspensions were diluted to a stock concentration of 4 mg/ml or equivalent in DCCM- 
1 media containing antibiotic (1% v/v penicillin/streptomycin). Washed particles 
contribute 30% by mass (70% water soluble) to the Cardiff sample (Moreno et al., 
2003), equivalent doses refer to the mass of washed particle or water soluble 
component found in a 4 mg/ml preparation of whole PM. The equivalent dose was 
used in all studies for these two fractions.
4.3.5 In vitro CD5 0 Experiment: Attachment assay
Two approaches to in vitro toxicity assessment were examined, firstly the attachment 
assay, examining the effect of increasing doses of each PM preparation on the 
attachment of cells to the substrata The purpose of the attachment assay is to 
determine the amount of particle/toxicant required to prevent the attachment of 50% 
of the cell population and has been successfully used previously (Jones et al., 1993, 
Richards et al., 1990, Davis et al., 1988). Freshly isolated type II epithelial cells were 
plated at 250,000 cells (6500 cells/mm2) in DCCM media (100 /xl) (1% v/v
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penici 11 in/streptomycin, 4% v/v L-Glutamine, 4% v/v Ultroser-G) into an equal 
volume of media (containing 1% v/v Penicillin/Streptomycin) containing the 
appropriate doses of PMio: 0 fig (control), 12.5 fig, 25 fig, 50/xg, 100 fig and 200 fig 
(equivalent to 0.325 -  5.2 /xg/mm2). Cells were cultured for 24 - 48 hours (until the 
control population was confluent and well spread). This method produced highly 
variable results, particularly following exposure to the fractions containing particles 
(whole and washed). Such variability could arise as a result of physical interference 
of the particles with the cells, hindering their attachment irrespective of their 
biological reactivity. The cell detachment assay, assessing the dose or equivalent 
dose of PM required to cause cells to detach from the culture substrata, was adopted 
for the subsequent study.
4.3.6 In vitro CD50 Experiment: Detachment Assay
The detachment assay is used to determine the amount of particle/toxicant required to 
detach 50% of the cell population from a culture of confluent cells. Dust applied in 
fresh media to a confluent population result in a mild toxicity causing an alteration in 
the cell adherence properties. In effect such a study may better represent the exposure 
of cells to PM as they are attached in situ in the lung to a basement membrane.
Type II epithelial cells were isolated and cultured at a density of 250,000 cells/well in 
a 96 well ECM-coated plate. The cells were cultured until they were well spread (24 
- 48 hours). The DCCM-1 media was then removed and the cells were washed in 
solution A (without calcium or magnesium). Freshly prepared PMio-o.i samples in 
media or the media alone (control) (DCCM-1 media : 1% v/v penicillin/streptomycin, 
2% v/v L-Glutamine and 2% v/v Ultroser G) to a maximal volume of 200 /xl were 
added to the cells ( 0  fig- 2 0 0  /xg/well). The cells were incubated for 24 hours (36°C, 
5% CO2 / 9 5  % air) after which time they were washed in PBS to remove unattached 
and damaged cells. The remaining attached cells were examined using phase contrast 
microscopy and photographed.
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4.3.7 Alveolar Macrophage Detachment assays
Preliminary experiments were set up to investigate the optimum plating density and 
culture times for the primary alveolar macrophages.
Alveolar macrophages were isolated from the lung lavage as previously described. 
Cells (> 90% purity) were plated at densities ranging from 50,000-150,000 cells per 
96 well on plastic wells in DCCM-1 media (1% v/v penicillin/streptomycin and 2 % 
v/v L-Glutamine). The cells were cultured up to 24 hours (36°C, 5 % CO2 / 9 5  % air) 
and washed and harvested to determine the minimum time required for maximal cell 
attachment. The optimal exposure time for PM in subsequent assays was completed 
using Port Talbot (Port Talbot 1) PMio sample.
The CD50 was established using two methods: (i) total non-specific protein, measured 
by the Bradford Assay (Bradford, 1976) and (ii) using cell counts from photographs 
taken whilst under phase contrast microscopy.
4.3.8 Changes in Cell and Nuclear Morphology in Response to PMio Exposure: 
IN Cell Analyser™ 1000
During the past few years, rapid progress has been made in identifying morphological 
and biochemical apoptotic criteria as well as some of the molecules responsible for 
the regulation and execution of apoptosis. Morphological characteristics of apoptosis 
include cellular shrinkage, membrane blebbing, nuclear condensation and 
fragmentation; these are the final stages of the complex highly regulated process. 
Early, biochemical indicators of apoptosis are characterised by plasma membrane 
changes in phospholipid orientation, and mitochondrial changes. The following 
investigation utilised the IN Cell Analyser™ 1000 (Amersham) and was completed in 
conjunction with Dr S. Murphy (Amersham Biosciences, Cardiff) to identify subtle 
changes in cell and nuclear morphology following in vitro exposure to PMio. The IN 
Cell Analyser 1000 (Amersham) is a line scanning confocal imaging system 
performing live and fixed cellular assays. It allows the simultaneous analysis of 
several endpoints using 3-colour imaging combined with x40 Nikon objective lens.
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The IN Cell analyser system has been applied to this study to identity whether the 
plasma membrane alterations at the cell surface typically observed in the initial stages 
of apoptosis such as the translocation of phosphatidylserine (PS) from the inner side 
of the plasma membrane to the outer layer and external surface of the cell. Annexin 
V was used as a sensitive probe for PS and can be used to identify apoptotic cells in 
culture. Another stain used to identify cellular changes was the Hoechst stain, a 
DNA intercalating dye that was been used to characterise the nuclear changes that 
occur during apoptosis. MitoTracker (Deep Red) probes, cell permeant 
mitochondrion-selective dyes accumulate in active mitochondria and were used to 
identify alterations in mitochondrial morphology and organelle functioning associated 
with cellular stress and pathology.
Epithelial type II cells were isolated, cultured until confluent and subsequently 
exposed to Cardiff PMio (CF 2)- whole and water soluble fractions only (0-200 pg -  
whole PM, 0- 400 pg water soluble) as described previously (section 4.3.4). Cells 
were exposed to PM suspended in DCCM-1 media (1% v/v penicillin/streptomycin, 
2% v/v ultroser G, 2% v/v L glutamine) for 24 hours before media and PM were 
removed and cells washed (section 4.3.6). Cells were stained with Annexin V 
(Molecular probes) diluted in Krebs ringer Bicarbonate (Gibco) to a final 
concentration of 16pl Annexin per ml of buffer and applied (100 /xl to each well). 
The cells were incubated (20 minutes, 37°C) before the apoptotic marker solution 
removed and cells washed (lx PBS). The cells were fixed using 4% v/v 
paraformaldehyde solution and stored (4°C). Fixed cells were probed with 
MitoTracker (Deep Red 633 (25 pM) and Hoechst solution (25 pM) in a final volume 
of 100 pL per well (10 min at 37 °C, 5 % CO2) and rinsed in PBS. Cells were imaged 
on the IN Cell Analyser 3000 at 37 °C using the following filter sets: Hoechst Ex: 352 
nm, Em: 455 nm, MitoTracker (Deep Red 633 Ex: 644 nm; Em: 665 nm. The images 
were analysed using the granularity algorithm of the IN Cell Analyser™ 1000 in both 
the nuclear and cytoplasmic compartments. In brief, the granularity algorithm is used 
to analyse both nuclear and cytoplasmic signals. The algorithm works by drawing a 
bounding box around the biology of interest then counting how many granules of the 
specified dimensions are in each box. In each case, the nuclear channel is used to 
identify each cell as an object of interest and the bounding box may be expanded from
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the nuclear size upwards. A granule size is then chosen to best represent the biology 
and the punctuated patterns are quantified within the bounding boxes.
4.4 Results
4.4.1 Cell Isolation and Primary Cell Culture
During the course of this thesis a total of 32 separate isolations of 104 individual rats 
were undertaken (Table 4.1). There are two useful guides to general health of the 
animals indicating that the animal and thus the lungs were free of infection. Healthy 
animals maintain a lung to body weight ratio between 0.0030 and 0.0045. This range 
is dependent on the body weight in that higher ratios are found in younger animals. 
With the standard lavage technique employed the LFC lies between 3-5 million cells 
in animals free of infection or any inflammatory process occurring at the lung surface. 
As can be seen from the data and in Table 4.1, most type II cell isolations were 
carried out on healthy rats and realised approximately 10 million purified type II 
cells/animal.
NBT staining of cell preparations sampled from various stages of the type II cell 
isolation procedure shows an increase in type II cell purity (data not shown). 
Epithelial cells (including type II cells) are enriched with NADPH enzyme and will 
appear as darkened cells whereas alveolar macrophages show only a slight 
background reaction with the NBT stain (Figure 4.1). Comprehensive staining of 
samples following each step of the isolation procedure has been completed (OrefFo et 
al., 1988).
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Table 4.1: Type II cell isolations (n=104 rats) in this study. The mean values are shown ± Standard 
deviation for type II cell isolations. The LP: body weight ratio and final cell counts o f both type II and 
Large Free Cell (macrophage) are included. The average type II cell yield per animal is approximately 
9.4±4.7 million and mean (non-treated) macrophage yield per animal is 3.4 ± 1.6 million. Nr- not 
recorded.
Isolation
No.
No.
Animals
Body
Weight (g)
LP/Body mass 
Ratio (xlO-3)
Type II cells 
(millions)
LFC count 
(millions)
1 2 229±20 2.814 13.511.0 3.810.8
2 2 252±3 2.812 13.4 5.2
3 2 303±10 3.519 8.0±4 2.110.7
4 2 329±38 3.30±0.1 4 2.1
5 2 391±86 3.65±0.94 1413.5 2.910.7
6 2 426±29 3.03±0.77 7.511.9 1.910.1
7 2 424+19 3.28±0.31 16.315.2 3.110.95
8 2 316±64 2.6410.09 1410.5 210.1
9 2 445±288 3.48±1.58 12.714 3.311.5
10 2 464±70 3.28±0.37 14.914.4 4.410.9
11 2 344±4 4.24±0.89 8.515.3 3.110.2
12 6 298±18 3.8010.59 1013.4 4.511.0
13 2 370±10 3.55±0.32 6.613.2 5.710.04
14 5 427±45 3.04±0.06 14.213.2 5.6
15 2 473±16 3.03±0.06 9.413.6 612.8
16 2 495+42 4.3210.03 1615.6 6.911.5
17 3 399±32 2.5±3.23 8.410.3 2.410.4
18 4 408±55 3.7±0.052 nr 2.211.4
19 2 428±11 3.33±0.07 6.311.2 6.512.4
20 2 466+1 3.2210.03 nr 4.0 ±0.1
21 2 534±43 2.6 nr 5.410.8
n 4 129±10 6.2±0.99 1213.4 2.210.5
23 4 315±31 3.9±0.06 12.212.2 3.3810.84
24 4 301 ±32 4.010.012 11.412.9 2.7710.83
25 6 388±30 3.3410.03 12.812.5 1.9610.76
26 4 267±29 4.5810.11 3.711.3 2.2110.63
27 3 313±24 4.0210.04 13.413.0 2.4911.27
28 3 295±15 3.7610.36 13.210.7 2.511.27
29 6 261±45 4.7910.25 4.6 2.2310.41
30 6 295±26 4.4610.75 6.811.7 1.1310.46
31 6 202±7 4.7810.12 7.411.49 3.8510.33
32 6 242±14 4.2410.59 6.711.6 3.0910.8
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Figure 4.1: Images of (a) background NBT staining cells from lavage (magnification x250) and (b) 
cytospin of final preparation of primary type II cell isolates prior to culturing (magnification X400) 
White arrow indicates heavily stained cells.
Type II cells are morphologically distinguishable using phase contrast microscopy, 
they are characteristically rounded in shape and contain multiple (>4) lamellar bodies. 
The photographs (Figure 4.2) record a loss of the characteristic rounded type II cell 
shape to an elongated morphology, accompanied with a gradual loss of the lamellar 
bodies upon culture. This differentiation is a major role of the type II’s cell 
population; to replace damaged type I cells. These cells were removed at various 
times in culture and tested for reactivity to a type I cell marker -  rT l40 (Dobbs et al., 
1988). The cells showed no reactivity up to day five in culture (data not shown). 
Reactivity towards rT l4o, the apical surface protein characteristic to type I cells would 
be gained upon differentiation to a type I morphology, at approximately day 6-7 in 
vitro (Reynolds, 2000).
Epithelial type II cells were cultured in DCCM-1 cell culture media (1 % v/v 
antibiotics, 2 % v/v Ultroser G attachment protein, 2 % v/v L-Glutamine) and plated 
on extracellular matrix (37#C, 5% CO2). Cells were typically confluent at 24-48 h 
under these conditions (Figure 4.2 a and b) and were characteristically well spread 
across the culture substrata and rounded in appearance containing lamellar bodies, 
visible as speckles in the phase contrast photographs. At high plating densities (250- 
350,000 cells/38mm2 equivalent to 6500- 9200 cells/ mm2) these cells retained the 
type II morphology until day 6 in culture (Figure 4.2 c-f). At lower densities or 
beyond this time, the cells progressively lost their rounded appearance, becoming 
elongated as they differentiated to a type I like morphology (Figure 4.2 g-h).
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Figure 4.2 Primary rat epithelial type II cells in culture (a & b) at 48h (xlOO, x200 magnification) (c & 
d) at 72h (xlOO, x200 magnification) (c & f) at 96h (xlO, x20 magnification) and (g & h) at 120h 
(xlOO, x200 magnification). White arrows indicate the distinctive type II cell with defined lamellar 
bodies (black specks) well spread over the culture substrata, progressively losing the characteristic 
morphology to a more elongated shape upon culture (red arrow).
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4.4.2 Type II Cell Toxicity Assays
4.4.2.1 Studies with Cardiff (Cardiff 2) PM10
Cell detachment toxicity studies on epithelial type II cell isolates were completed 
using both an urban (Cardiff 2) and industrial (Port Talbot 1) PMio-o.i samples. The 
cells remaining attached following PM treatment, expressed as percentage of control 
(untreated) cultures (n=3) shows that the toxicity present upon exposure to the whole 
PM sample is retained within the fraction containing the particles (Figure 4.3). A 
maximum detachment of 90% of the cells was recorded at the highest dose of whole 
PM examined (200 fig/96 well) compared to just 40% detachment with exposure to 
the equivalent dose of the water soluble constituent.
Regression analysis was performed on Minitab™ to calculate the dose (or its 
equivalent) required to cause the detachment of 50% of the cells (CD50) compared to 
untreated control populations (Figure 4.3b). The CD50 for Cardiff PMio is 81 fig 
(whole PMio) but much higher (385 fig) for the water soluble fraction.
A second urban (Cardiff) sample (Chapter 2, CF 2), collected during a 43 day period 
(January 2001-March 2001) was also assessed using this method. The cell responses 
to each of the three fractions, whole PMio-o.iand equivalent doses of washed particles 
and water soluble fraction were assessed. Phase contrast photographs (Figure 4.4) 
were used to record the loss of type II cell attachment following exposure to whole 
(Figure 4.4), washed durable particles (Figure 4.5) and water soluble component 
(Figure 4.6).
As noted with CF 1, the effects of CF 2 are similar in that the durable particles need to 
be present to exert the greatest effect on cell detachment. The water soluble 
component is considerably less toxic than either the washed PMio or whole PMio. 
Graphical representation of the data is summarised in Figure 4.7. The whole and 
washed samples (CD50 102 fig and 100 fig respectively) have over twice the relative 
toxicity than that following exposure to the water soluble component alone (CD50 
223fig). A statistical difference between exposed and control (untreated) cultures was 
observed beyond a 50 /xg/well (whole), 100 /zg/well (washed) and 200 fig/well (water 
soluble) exposure.
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Figure 4.3: Toxicity o f PM , 0  (CF 1) in a detachment assay o f primary alveolar type II cells. A) Graph 
showing progressive detachment of cells exposed to increasing doses (or equivalent doses o f PM) of a 
summer urban particulate sample, b) Regression analysis summary showing the calculated equivalent 
doses (and actual dose) required to result in the detachment of 50% of the cell culture compared to 
untreated control (n=3). All masses given in fig per 96 well.
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Figure 4.4: Phase contrast images (xlOO magnification) of epithelial type II cells exposed to whole Cardiff (urban, CF 2) PMi0. The cells were exposed to PM suspensions 
(100/d). Red type indicates the mass of total equivalent delivered dose (/ig/well). The images show a dose dependant decrease in cells remaining attached to the culture 
substrata following 24 hour exposure to the water soluble PM (0 -  200 /ig/well).
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Figure 4.5: Phase contrast images (xlOO magnification) of epithelial type II cells exposed to fractions of washed Cardiff (urban, CF 2) PMi0. The cells were exposed to PM 
suspensions (100/xl). Red type indicates the mass of total delivered dose (/ig/well). The images show a dose dependant decrease in cells remaining attached to the culture 
substrata following 24 hour exposure to the washed PM (0 -  200 /ig/well) suspended in DCCM-1 cell media
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Figure 4.6: Phase contrast images (xlOO magnification) of epithelial type II cells exposed to water soluble fraction of Cardiff (urban, CF 2) PMj0. The cells were exposed to 
PM suspensions (100/d). Red type indicates the mass of total equivalent delivered dose (/ig/well). The images show a dose dependant decrease in cells remaining attached to 
the culture substrata following 24 hour exposure to the water soluble PM (0 400 /ig/well) suspended in DCCM-1 cell media
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Figure 4.7: Toxicity o f PM ] 0  (CF2) in a detachment assay o f primary alveolar type II cells, a+b) 
Graphical representation of dose o f PMio and cells remaining attached and (c) regression analysis 
summary showing the CD5 0  and actual dose, n=3 for each dose/sample, vertical bars are SD from the 
mean * denotes statistical change. All masses given in /ig per 96 well.
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4.4.2.2 S tud ies w ith  P o rt T albo t PM io (P T -1)
Phase contrast photographs (n=3, data not shown) were taken to ascertain the relative 
toxicity of this industrial sample of ambient pollution towards alveolar epithelial type 
II cells in vitro. The effects of the toxicity of each of the three fractions, whole 
ambient PMio, washed “durable” particles and water soluble component is 
summarised in Figure 4.8. Once again most of the toxicity was retained in the 
durable/washed particle fraction. The washed fraction appears to have an increased 
toxicity than the whole PM sample (CD50 (washed) 70 pig compared to CD50 (whole) 
82 pig). However both fractions were twice as potent as the water soluble fraction 
(164 fig).
4.4.3 Alveolar Macrophage cell toxicity assays
4.4.3.1 Studies with Port Talbot PMio (PT-1)
Preliminary experiments were required to establish the optimal plating density and 
culture time prior to exposure (Figure 4.9) for the primary alveolar macrophages. 
Culturing the primary cells at 150,000 cells/96 well (4000 cells/mm2) for a period of 4 
hours prior to exposure resulted in the greatest attachment of the cells to the plastic 
culture substrata (Figure 4.9).
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Figure 4.8: Toxicity of PM10 (CF 2 ) in a detachment assay o f primary alveolar type II cells, (a and b) 
Graphical representation of dose of PMi0  and cells remaining attached following PM exposure, n=3 for 
each dose/sample, vertical bars are SD from the mean of whole (blue) and washed (red) preparations 
and b) water soluble (yellow) fractions o f Port Talbot PM]0, an industrial ambient particulate solution. 
•  denotes statistical change (p<0.05). All masses given in /ig per 96 well, (c) Regression analysis 
summary showing the CD5 0  (equivalent dose o f whole PM) and actual dose (fig).
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Figure 4.9: Graphical representation of preliminary experiments to establish the most appropriate 
plating density and culture time prior to exposure to PM. Attachment efficiency (n=2) for each time 
point and vertical error bars represents range from the mean.
Having established the optimum time for the culture time for maximal alveolar 
macrophage attachment, it was necessary to ascertain the most suitable PMio exposure 
time for this cell type. Cells were cultured and subsequently exposed for 4 and 20 
hours. There were little marked differences between the toxicity observed at the two 
exposure times and so a 4-hour exposure was adopted for all assessments (Figure 
4.10).
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Figure 4.10: Graphical representation of preliminary experiments to establish the most appropriate 
exposure time of primary alveolar macrophages to whole PM (PT 1). Attachment efficiency (n=4) for 
each time point and vertical error bars represents standard deviation from the mean for each dose 
following a 4 hour (yellow) and 20 hour (red) exposure.
Regression analysis (1^=0.8261) estimates the CD50 of PT1 towards alveolar 
macrophages as 275.8 /ig. Statistical analysis (student t-test) showed that a 
significant difference (p<0.05) in toxicity was found following 200 /ig/well (whole) 
and beyond, whilst the highest equivalent dose (600 /ig/well) was required for a 
significant toxicity with the water soluble fraction (data not shown).
4.4.3.2 Studies with Cardiff PMio (CF 2)
Alveolar macrophages were exposed to whole and water soluble fractions of Cardiff 
PMio (CF 2) fractions. Phase contrast photographs (Figure 4.11) were used to 
establish the CD50 dose of the urban sample.
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Figure 4.11: Phase contrast images (A-F at X100 magnification) of Alveolar macrophage cultures exposed to a) 0, b) 25/xg c) 50 /ig d) 100 /ig e) 200 /ig f) 400 /ig of whole fraction 
of Cardiff PMio devoid of particles, (g-j) shows increased magnification of the dosed primary cells: g) well rounded control cells h) AM’s exposed to 25/ig i) 100 /xg exposed AM’s 
and j) 200 /ig exposed alveolar macrophages. The images show a dose dependant decrease in cells remaining attached to the culture substrata following 4 hour exposure to the dust 
suspended in cell media. White arrows show well-rounded, healthy attached cells from untreated cultures. Red arrows indicate cells accumulating around dust particles even at low 
doses (25 /ig) and yellow arrows highlight regions of particles visible around the cell periphery.
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Once again, the toxicity of the whole (particle containing) PMio sample is 
considerably greater than the water soluble fraction alone (Figure 4.12). Less than 
10% cells remained attached at the highest dose of whole PMio (400 /xg) compared to 
approximately 40% equivalent dose of water soluble component. A statistical 
difference (p<0.05), judged by the students t test, was found following exposure to 50 
/xg/well whole PM (p<0.03) and above and only at the highest dose of water soluble 
exposure (400 /xg/well, p<0.03).
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Figure 4.12: Toxicity o f PMi0  (CF 2) in a detachment assay of primary alveolar macrophages, a) 
Graphical representation of dose of PM10 and cells remaining attached following exposure to whole 
blue) and water soluble (yellow) components o f CF 2 PM10, n=3 for each dose/sample, vertical bars are 
SD from the mean •  denotes statistical change (p<0.05). (b) Regression analysis summary showing 
the CD5 0  and actual dose, all masses given in /xg per 96 well.
4.4.4 Comparison of CD50 values
The different fractions of the urban sample (whole, washed and water soluble) display 
differences in relative toxicity towards cultured type II cells (Table 4.2). The 
reactivity of the whole CF 2 sample (CD50=102 /xg) is retained chiefly in the durable
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(washed) particles (CDso=100 /xg), both of these fractions are twice as potent at 
inducing cell detachment as the water soluble fraction (CD5o=223 fig). This strongly 
implicates the particles themselves or a factor in close association with them as 
dominating the observed toxicity in this assay.
Similarly, the epithelial cells exposed to the water soluble fraction of the industrial 
sample, Port Talbot (PT 1), were less effected than those exposed to either the washed 
or whole samples (Table 4.2). However, the washed fraction showed greater toxicity 
than the whole fraction, indicative of the washing procedure serving to unmask bio­
reactive entities that increase the overall potency of the particle fraction.
The sample collected from Port Talbot appears to be slightly more potent than the 
urban sample (CD50 (u*an whoie)= 100 fig, CD50 (industrial, whoie)=82 fig) towards epithelial 
type II cells. The increased metal content in the industrial sample could result in the 
increased toxicity of the water soluble fraction of industrial (CD5o=167 fig) compared 
to that of the urban fraction (CD5o=223 fig).
There is a less clear-cut pattern of toxicity o f the PM samples towards the primary 
alveolar macrophages. The whole urban sample (CD50= 93 fig) is more reactive than 
the water soluble fraction (CD50=271 fig) but only a negligible difference between the 
two fractions in the industrial sample (CD50 (whole)= 275 fig, CD50 (soluble)=271
Mg)
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Table 4.2: Summary table illustrating the relative toxicity o f urban (Cardiff) and industrial (Port 
Talbot) PM10 and their associated fractions towards epithelial type II and alveolar macrophages in 
vitro. CD given in total mass o f PM (equivalent mass and actual mass) applied to cells (/ig/well).
PMio source Cell Type Fraction
CD50
equivalent mass
CD50
actual mass
Cardiff (urban) 
(CF 2)
Type II
Whole 102 /xg 102 /xg
Washed 100.5 /xg 30.15 /xg
Water Soluble 223 .0 /xg 156.1 /xg
AM
Whole 92.9 /xg 92.9 /xg
Water Soluble 271.0/xg 189.7 /xg
Port Talbot 
(Industrial) 
(PT 1)
Type II
Whole 82.0 /xg 82 /xg
Washed 70.0 /xg 21.0 fig
Water Soluble 164.5/xg 115.2 fig
AM
Whole 275.8/xg 275.8 fig
Water Soluble 271.4 /xg 189.7 /xg
Some chemical composition analysis has been completed on the two main samples 
investigated (Table 4.3, Moreno, unpublished). Characterisation of each PM sample 
included elemental analysis, the levels of six metal elements with known toxic effects 
are summarised in Table 4.3.
Table 4.3: Elemental analysis o f  the urban (CF 2) and industrial (PT 1) PM samples o f  six selected 
metals. Characterisation completed by Dr. T Moreno (2003, unpublished). Concentration o f each 
metal given in /xg/g o f PM.
Element
(/xg/gPM)
Urban Cardiff (CF 2) PMm Industrial Port Talbot (PT 1) PMm
Whole Water soluble Whole Water soluble
Vanadium 1227 454 425 111
Manganese 1288 710 5148 1118
Iron 55174 3378 156059 4309
Copper 565 335 38 138
Zinc 25262 4480 17278 4892
Lead 3979 548 1669 409
Total metal 87495/xg/g 9905 /xg/g 180617/tg/g 10977 /xg/g
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Correlating the CD50 and metal content (/xg/g PM) for each sample towards both cell 
types (Figure 4.13) show that there is a relationship between toxicity and metal 
content. Comparing actual doses (Table 4.3) in order of decreasing toxicity:
PT l(whole)>CF 2 (whole)>PT 1 (wash)>PT l(soluble)>CF 2 (soluble)>CF 2 (wash)- 
this is in strong agreement with total metal content of the PM samples. No similar 
trend is apparent for alveolar macrophage (Figure 4.14).
Regression analysis was performed between the total metal content and toxicity of the 
sample ( C D 5 0 )  of epithelial type II cells (Figure 4.13) and the primary alveolar 
macrophages (Figure 4.14). Type II cells toxicity correlated better with total metal 
content (i^=0.76, p=0.128) compared to macrophage toxicity (1^ = 1, p>0.9). In 
particular, increases in type II cell toxicity corresponded with increased iron (^=0 .6 8 , 
p<0.15) and zinc (r2=0.69, p<0.15). In contrast alveolar macrophage toxicity showed 
weak correlation with iron, but was linked best with changes in vanadium (1^ =0 .89, 
p<0.05), copper (^=0.74, p<0.15), and lead (r2=0.87, p<0.06). Although generally 
weak correlations, these patterns do indicate trends that levels of a small number of 
metals or chemicals may be highly influential to the overall toxicity of the PM 
sample, a finding also concluded by Whittaker (2003).
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Figure 4.13:Correlating metal content with CD50 value calculated for whole and water soluble fractions 
from both urban and industrial sources towards epithelial type II cells.
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Figure 4.14:Correlating metal content with CD50 value calculated for whole and water soluble fractions 
from both urban and industrial sources towards alveolar macrophage cells in vitro for total metal 
content (^<0.05), Copper (1^ =0 .74), lead (r2=0.87) and vanadium (^=0.89).
4.4.5 IN cell Analyser 1000 analysis of the Type II cell responses to PM 
exposure
During apoptosis the cell undergoes various morphological and biochemical changes. 
Traditional methods for quantifying apoptosis tend to be either destructive 
biochemical assays, or labour intensive microscopic techniques. The IN Cell 
Analyser™ 1000 combines non-destructive methods of quantitation of morphological 
and biochemical changes using specifically targeted fluorescent dyes in multiplex 
high throughput with real-time analysis. In this manner several different endpoints can 
be monitored on a cell-by-cell basis or by using a population average simultaneously. 
The multiplex nature of the data acquisition increases the accuracy of the information
148
as it is derived from the same population of cells. This has the added benefit of 
making the most use of scarce tissue/cell samples.
In this experiment, nuclear changes are tracked using the DNA intercalating dye 
Hoechst. Nuclear changes that occur during apoptosis are tracked using the DNA 
intercalating dye Hoechst 33342. Non-apoptotic cells give a smooth, even nuclear 
stain (fig 4.15A ), as apoptosis occurs with increasing dose of compound, the staining 
moves toward a textured punctuate pattern (fig 4.15.B.) as the nuclear DNA becomes 
condensed.
Figure 4.15. A: Control nucleus (Murine hepatocyte) showing smooth staining pattern following 
Hoechst 33342 staining. B: Hoechst stained nuclear condensation observed following exposure to an 
apoptosis-inducing agent for 4 hours (Dr S. Murphy, in press 2004)
Hoechst and annexin staining of whole PM exposed type II cells reveal a decrease in 
total cell nuclei fluorescence upon increasing exposure to whole PM (Figure 4.16a) 
corresponding to a reduction in intensity upon condensation of the cellular nuclei 
associated with the onset of apoptosis and a simultaneous dose dependent increase 
(P<0.05) in annexin staining, corresponding to an increased incidence of the onset of 
apoptosis in exposed cultures (Figure 4.16b). The images of control and exposed cell 
cultures (Figure 4.16c) illustrate the increased incidence of positive annexin stain, 
although less apparent is the change in appearance of the nuclei, which change from a 
smooth stained pattern to one similar to that shown previously (Figure 4.15b) 
indicating the onset on nuclei condensation in effected cells. Regression analysis on 
the decrease in cellular fluorescence (Hoechst’s stain) predicts a CD50 value of 99.4 
/xg, approximately equivalent to the C D 5 0  using the cell detachment assay using 
equivalent PM sample (Cardiff 2)(102 /xg). Similar regression analysis on cell data
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following exposure to water soluble component of Cardiff PM (Figure 4.17) to the 
same type II cell cultures estimate a CD50 value of 132.7 /ig (actual dose =189.6 /ig). 
This is below the value predicted by the cell detachment assays (223 /ig equivalent 
dose of whole PM, 318 /ig actual dose, Table 4.2). These assays confirm the cell 
detachment conclusion that PM exposure does result in cellular changes including 
detachment and cell death.
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Figure 4 .16:(a) Dose response decrease in cells remaining fluorescent upon exposure to whole PM (CF 
2) (b) Dose dependent increase in annexin staining upon exposure of type II cell cultures to whole 
PMio. Mean value and SEM range shown (n=6). All data points arc significantly different from 
control (p<0.05). (c) Images of cells (control and culture exposed to 200 /ig whole PM). Cell cultures 
stained with Hoechst’s (blue) and annexin (red) showing increases expression of the apoptotic signal 
(PS on the outer surface o f the cell) following PM exposure accompanied by changes in nuclear 
morphology.
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Figure 4.17 Graph illustrating the dose dependant decrease in cell nuclei fluorescence upon exposure of 
type II cells with water soluble component of Cardiff (CF 2) PM,0. Mean values and SEM (n=6) 
given. All decreases except 25 /xg dose were significant (P<0.05).
4.5 Discussion
The aim of this chapter was to investigate the toxicity of two ambient PM samples 
towards two primary cell types in vitro and to identify the relative contribution of the 
different fractions (whole PM, washed “durable” fractions and water soluble 
component) to the sample toxicity. The ambient PM samples collected from the south 
Wales conurbation included an industrial (Port Talbot) and urban environment 
(Cardiff) and had undergone extensive morphological and chemical characterisation 
(Moreno et al, 2003). Two important cellular targets within the lung: the epithelial 
type II cell and alveolar macrophage cells isolated from the rat were exposed to PM. 
In vitro toxicity studies commonly use PM surrogates including diesel exhaust 
particles to assess the cellular responses to exposure. However, these experiments 
characterise the response of primary cells to ambient samples, full characterisation of 
which has allowed the correlation of toxicity with metal content.
The alveolar macrophage and epithelial cells exhibited distinct susceptibility towards 
the urban and industrial PM samples. Type II epithelial cells showed greater 
sensitivity towards the industrial sample (PT 1) compared to urban sample (CF 2), in 
direct contrast to primary alveolar macrophages. Such differences in susceptibility 
may be attributed to the differences in particle size distribution between the two 
samples. A typical urban sample may contain up to 80 % by number of road related 
pollution (including diesel exhaust particles) and is highly influenced by the finer
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fraction. The Cardiff sample was no exception, with a PM2.5 to PMio ratio ranged 
from 2.84-4.27 over the 43 day collection period compared to 1.08-1.94 for the 
industrial sample. The Cardiff PM sample therefore contained more particles per 
mass than the industrial sample and may have induced the heightened response from 
the macrophages. Hetland (2003) investigated the response of epithelial cells 
(primary cells and cell lines) towards ultra-fine (PM<0 .1 ), fine (PM2.5) and coarse 
(PM2.5-10) particles. The study reported heightened responses in primary cell cultures 
to the coarse particles. This finding is in agreement with the present study, in that the 
coarse particle dominated industrial sample displayed greater toxicity towards the 
epithelial cells than the fine particle dominated urban sample.
The relative contributions of the different fractions of the ambient PMio samples were 
assessed in both PM samples. It was found that most of the bioreactivity of the whole 
PM samples towards both type II and alveolar macrophage cells were retained in the 
durable particles, indicating that chemical or physical characteristics retained by the 
particles themselves confer significant toxicity in this system. This is in agreement 
with studies by Imrich (2000), who reported strong correlations of AM cytokine 
release and concentrated ambient air particles, specifically the insoluble fraction and 
failed to find any correlation with any metal component within the insoluble particles 
including iron, manganese and vanadium.
Correlating metal content and cellular toxicity identified distinct trends between the 
two cell types. Strong correlations with total metal content, iron and zinc and type II 
cells were apparent. Such a finding corroborates the heightened cellular responses 
with the industrial sample that contained over three times the level of iron than that of 
the Cardiff sample. Alveolar macrophage toxicity was particle dominated rather than 
dependent on metal content. Therefore, poor correlation with total metal content and 
macrophage toxicity was observed, but associations could be made between 3 metals 
(copper, vanadium and lead). These findings collectively indicate distinct 
mechanisms of toxicity and cellular targets of different metals within the lung.
Most of the data from the present study strongly implicated the importance of the 
durable (washed particle) component in the toxicity endpoint measured. This 
correlates with the work reported in this thesis (Chapter 2) of the histopathological
153
responses observed with instilled PMio- However, in vitro, cell free assays have 
indicated that the water soluble fraction of P M ,  containing bioavailable metal 
components represent the most damaging fraction probably by oxidative processes 
(Greenwell et al., 2002). In truth, both the durable (which may still contain metal 
components) and the bioavailable metals in the water soluble fraction can provide 
toxicity. In this context it is noteworthy that the alveolar macrophages being 
phagocytic are most sensitive to the P M  sample with an increased proportion of finer 
particles (indicated by an increased P M i o  to P M 2 . 5  ratio). The type II cell, which is not 
noted for engulfing particles, displays sensitivity towards the metal components of the 
P M  and is most sensitive to the P M  with a larger metal component (Port Talbot). 
Also worthy of note is the differences in between cell free assays, cellular in vitro 
studies and animal instillation investigations. In the cell free assays the P M  toxicant 
has direct access to DNA (and causes scission). This may or may not occur in cell 
systems, which require the uptake of the (metal) toxicant, processing in the cytoplasm 
and potential transport to the nucleus in enable interaction with the DNA. The 
situation is far more complex in vivo in that instilled bioavailable metals may react 
with antioxidants in the epithelial lining fluid and then, being water soluble, rapidly 
enter the bloodstream (e.g. vanadium reaches the heart via the lung circulation in less 
than 15 minutes post exposure, Dreher et al., 2002). Such complexity is yet to be 
achieved in vitro where bioavailable metals are not cleared and thus remain in contact 
all the time with target cells.
Some pilot studies using the IN Cell Analyser™ 1000 identified changes in patterns 
observed in the nucleus following the exposure of primary cultures of epithelial type 
II cells exposed to ambient PMio. The results were derived from the same population 
and hence gave statistically robust results especially given the variable nature of 
primary cell cultures. The multiplex nature of this equipment could in future studies 
substantially reduce the quantity of primary cells and compound required for 
toxicological assay.
Nuclear condensation typical of late stage apoptosis was clearly visible and 
quantifiable at all concentrations of PM and equivalent water soluble fractions 
adopted in this assay. These assays illustrate that apoptosis has been induced in 
epithelial type II cell cultures following exposure to whole and water soluble fractions
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of Cardiff PM. Thus, the multiplex assays agreed with the results from the cell 
detachment assay and show that the whole PM sample is more reactive than the water 
soluble component alone.
In summary, the work in this chapter has defined the susceptibility of primary lung 
cells in vitro to whole PM and its constituent durable particles and bioavailable metal 
containing water soluble fraction. The study has established doses at which toxicity 
can be observed and implicated apoptosis as a possible mechanism in this process. It 
would be useful if such cultures could be employed in expression profiling the PM- 
induced changes in target lung cells and such an investigation is reported in the 
following chapter (Chapter 5).
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Chapter 5.0 
Preliminary Genetic analysis of primary cells
5.0 Preliminary Genetic analysis of cells
5.1 Introduction
The use of animals as models for investigation has provided an insight into toxicity. 
However, the extent that such models resemble humans, or the physiological 
relevance of the extensive exposures involved, has often been debated. The use of 
large number of animals over a prolonged time scale has been hampered by both 
ethical and economical concerns. The development of modem techniques that may 
serve to reduce reliance of such studies on animals has been encouraged. It has been 
increasingly apparent that in order to gain insights into biological mechanisms of 
toxicity, it is necessary to ascertain whether the toxin has specific cellular targets in 
vivo and to characterise the responses of these cells to exposure (Nemery et al., 1993). 
Establishing in vitro techniques in toxicology for this purpose using cell lines, 
primary cells from experimental animals and human cells has clarified many cell 
responses and has increased the use of human cells, addressing the extrapolation 
problems of experimental animal data to the human situation.
The nature of the initial interactions between particles and the lung will determine the 
subsequent pulmonary effects. Lung cells at the forefront of these interactions are the 
alveolar macrophages and the pulmonary epithelial cells. Phagocytosis during the 
macrophage mediated lung clearance will result in the release of inflammatory 
mediators, inducing further activation of phagocytes and influx of inflammatory cells. 
Overwhelming this particle clearance mechanism will result in the release of excess 
inflammatory mediators, which may become detrimental to the pulmonary epithelium. 
These inflammatory mediators may further compromise the efficiency of macrophage 
mediated clearance (Oberdorster et al., 1992) resulting in increased particle longevity 
at the respiratory surface and increased interactions with the epithelium (increasing 
the risk of direct toxic effects and uptake by the epithelial cells). Monn (2002) 
reported that exposure of alveolar macrophages to PM extracts results in decreased 
cell viability and compromises phagocytic and immune capabilities to subsequent 
inert particle exposure.
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Previous chapters in this thesis have established that the Cardiff (urban) PMio sample 
provokes a mild response in vivo in healthy rats and exposure to PM in vitro results in 
moderate toxic effects towards homogenous primary lung cells. A large range of 
studies have investigated the in vitro responses of pulmonary cell lines including 
macrophage and epithelial cell lines, towards toxic compounds with well documented 
responses in vivo. These studies have identified changes in gene and protein 
expression of a selected range of inflammatory mediators and cell responses 
following exposure, commonly interleukins and NFkB, antioxidant capabilities in the 
cells and the effect on DNA integrity in cells (Comet Assay- Knaapen et al., 2002. 
Plasmid assay-Greenwell et al., 2002) as a measure of bioreactivity. In vitro studies 
have revealed a complex series of gene expression changes associated with PM or PM 
surrogate exposure, inextricably linked with particle size (surface area) (Stone et al., 
1998) and metal content (Wilson et al., 2002) of the samples. Stone (1998) used the 
macrophage cell line MM6 (Monomac 6) in exposure studies with characterised 
particles (carbon black) and found differential responses of the cells to the fine and 
ultra-fine fractions of this PM surrogate. The release of calcium was found to be a 
consistent cellular event, within minutes of exposure and has been postulated as a 
mechanism to drive the stress and inflammatory response in these cell types.
Consistent changes in early (3 days) gene expression were detectable in whole lung 
tissue samples following instillation of the well-characterised ambient sample 
(Chapter 2) and candidate genes involved in the pulmonary responses to different PM 
fractions have been previously described (Chapter 3). The present chapter describes 
the novel application of expression profiling of homogenous primary cells following 
exposure to low doses of well-characterised ambient PMio-o.i samples. The chief aim 
of this study was to apply the macroarray technology to in vitro toxicological 
assessment using cultured primary cells and to assess the system as a suitable model 
for future screening of pulmonary toxicants. Previous gene profiling of lung tissue 
(Chapter 3) identified key changes in gene expression associated with PM exposure. 
Expression profiling of primary lung cells will establish whether similar expression 
changes can be linked to one or more cell types within the lung.
An earlier chapter (Chapter 4) identified the doses of whole PMio (Cardiff and Port 
Talbot) required to cause the detachment of 50% (CD50) of a primary culture of 
alveolar macrophages and epithelial type II cells in vitro. Experiments run in
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conjunction with Amersham Biosciences (Dr Murphy, 2003) (chapter 4) confirmed 
that low-level exposure to whole PMio induced cellular changes indicative of 
apoptosis within the primary cell cultures. Thus the present study used a low-level 
exposure (CD20) to whole PMio to identify whether these cellular changes resulted in 
consistent genetic changes associated with exposure.
5.2 Materials
5.2.1 Materials and Suppliers
RNeasy™ Mini kit (74104) containing all appropriate buffers, solutions and vials and 
Deoxyribonuclease I, QIA™ shredder (79654) purchased from Qiagen. 
(3-Mercaptoethanol (436022 A) was obtained from BDH Biochemical Laboratory 
Supplies, Poole. Ultra-pure (HPLC) Grade Ethanol (95% v/v) (CAS 64-17-5) was 
bought from Fisher Life Sciences.
Tri-reagent ™ solution (T-9424), Isopropanol (>99% v/v) (I 9516) and Chloroform 
(>99% v/v, containing no iso-amyl alcohol or additives) (C 2432) were purchased 
from Sigma -  Aldrich.
QuickPrep® Micro mRNA Purification kit was purchased from Pharmacia Biotech 
and all appropriate solutions provided.
Agarose (Type 1A)(A 0169), 20X TBE* (T 4415), Ethidium Bromide (lOmg/ml) (E 
1510) and Loading Dye (G 2526) were all purchased from Sigma -  Aldrich.
* Diluted to 0.5% v/v TBE in distilled water, prior to use.
The nylon Atlas™ Rat 1.2 array system (7854-1) was purchased from BD Biosciences 
(formerly Clontech). Each kit containing. Cot-1 DNA (1 mg/ml), 10 X Termination 
mix (0.1 M EDTA, 1 mg/ml MgCl2, pH8.0), Reaction buffer (250 mM Tris-HCl), 375 
mM KC1, 15 mM MgCl2, pH 8.3), 10 X dNTP mix (5 mM of each dNTP except 
dATP), DTT (100 mM), 10X CDS Primer mix, Powerscript MMLV Reverse 
Transcriptase and nucleospin™ extraction/purification columns and wash solutions.
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[a-32P]-d.ATP (10 /zCi/mmol, Cat No. PB 10204) was purchased from Amersham, 
UK. Sheared Salmon Testes DNA (D7656, 10 mg/ml) was bought from Sigma. 
Atlas™ Image 2.0 and Atlas™ Navigator (BD Biosciences) were used to interpret the 
array data. 20% w/v SDS solution (ultra pure) (EC 874) and 20% w/v SSC Solution 
(ultra pure) (EC-873) were purchased from National Diagnostics. The Kodak 
Phospho-imager screen (Kodak 118 8077) was purchased from Biorad.
5.3 Methods
5.3.1 Cell isolation, Culture and Exposure
Murine alveolar macrophages were isolated from the saline lung lavage of healthy, 
untreated animals as previously described (Section 4.3.1). Primary epithelial cells 
were isolated using trypsin digestion and Percoll™ purification from rat lung tissue as 
described by Oreffo et al., 1987), also described previously (Chapter 4, section 4.3.1). 
Alveolar macrophages were cultured in DCCM 1 media (2% v/v L Glutamine, 1% v/v 
Penicillin and streptomycin) on plastic for four hours (37°C, 5% CO2) prior to 
exposure. Epithelial cells were cultured until a well-spread, confluent culture was 
achieved and whole PM applied in fresh DCCM-1 media (2% v/v L-Glutamine, 1% 
v/v Penicillin and Streptomycin, 2% v/v Ultroser G). Cells were exposed under 
culture conditions to the total dose of whole PM that caused a total cell detachment of 
20% (CD20) of the cell culture (Chapter 4). A dose resulting in the detachment of 
20% of a cell culture relative to an untreated culture (CD20) (Chapter 4) was 
calculated (/zg/mm2 of culture substrata) for each PM sample and applied to cells. A 
single length of exposure was adopted for each cell type for all gene expression 
studies based on literature investigating cell toxicity (6 hour -  epithelial type II, 4 
hour- alveolar macrophage). Cells were removed from the culture substrata and 
pooled with unattached cells and were recovered by centrifugation from the cell 
culture media and stored (-80°C) prior to RNA isolation.
Control cells received fresh DCCM-1 media devoid of PM in lieu of exposure and 
were cultured under the same conditions alongside PM-exposed samples.
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5.3.2 R N A  E x tra c tio n  a n d  M a c ro a rra y  A nalysis
Total RNA was isolated and treated to remove any residual DNA contamination using 
the Qiagen RNeasy™ protocol (Chapter 4). Tri-reagent ™ (Sigma) was also 
investigated but more efficient collection and DNase treatment was achieved using 
the Qiagen method.
Expression profiling on the isolated total RNA from exposed and control samples of 
alveolar macrophage and epithelial cells were completed in accordance with protocols 
previously described in full (Chapter 3). In brief, radio labelled cDNA probes were 
purified using column filtration and centrifugation and hybridised to the nylon arrays 
overnight with constant agitation. Any unbound probe was removed using wash 
solution 1 (0.1 % v/v SSC, 0.5 % v/v SDS) until the radioactivity counts detectable on 
the membrane had fallen to 10-15 dps. The membrane was sealed and exposed to a 
phosphoimage screen (Kodak) and left for 5-7 days depending on the final radioactive 
counts. The screen was subsequently scanned using a phosphoimager (Kodak) and 
visualised using Atlas™ image 2.01a (BD Biosciences), as previously described.
To ensure that all array analyses were similar, all variables were set as equal. The 
ratio signal threshold was reduced on all aligned arrays to 50% and all genes were 
reported to an excel worksheet, all analyses were therefore conducted on similar 
analysis outputs within the excel package.
The most appropriate method of gene analysis was investigated in chapter 3. In brief, 
logio transformation and normalisation of each control and exposed expression profile 
was completed to produce normally distributed data, allowing the application of 
statistical assumptions. The calculation of a mean sham-treated control and ±2 SD 
range in relative expression of each gene allowed the identification of genes with an 
expression outside of this range following PM exposure. A parametric students t-test 
was used to calculate statistically significant changes in gene expression. These 
indices were used to apply a degree of stringency to filtering the candidate genes 
involved in the genetic response to the PMio.
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5.4 Results
5.4.1 Iso la tion  a n d  P re p a ra tio n  o f  R N A  a n d  M a c ro a rra y  P ro ced u res
RNA preparations of superior yield and purity were isolated using the RNeasy RNA 
extraction kit (Qiagen). Type II epithelial cells and macrophages were disrupted and 
homogenised using both the QLA shredder and needle as outlined in the protocol to 
optimise RNA yield and RNA was isolated from as little as 6 million cells. RNA was 
isolated in accordance to the Qiagen technique, initial RT PCR analysis showed that 
the DNase treatment did reduce the yield of RNA from the preparation but the active 
enzyme was successfully removed from final preparation.
Production of quality RNA in significant quantity has proven extremely difficult from 
the primary isolates. There are a number of explanations for this, firstly, the yield and 
concentration of RNA from both cell types was highly variable and generally very 
low. This proved problematic because the Atlas™ nylon macroarray required large 
amounts of total RNA (2 fig) at high concentration (maximum 2-4 fi\). Secondly, 
particularly in PM-exposed cells were collected as a cell pellet prior to lysis. Thus, 
the cell lysate inevitably contained some particles, which have been shown to incite 
oxidative damage to DNA (Greenwell et al., 2003). Therefore, some loss of RNA and 
DNA may occur prior to RNA isolation. Alveolar macrophages also have an 
extensive array of digestive enzymes and so upon lysis, the activity of these molecules 
may further degrade and destroy the RNA. Whilst many of the particles were removed 
by centrifugation of the lysate prior to RNA isolation, it does not however remove any 
reactive soluble fraction from the preparation. Again oxidative bioavailable metals 
may be responsible for DNA and RNA losses prior to genetic analysis.
Many of the problems with the RNA and array procedures have been addressed, 
certainly for whole lung preparations, however, arrays using the primary isolates have 
proven to be, and still are, significantly less reliable. The low success rate of 
achieving suitable array images for the exposed primary isolates meant that the 
procedure was costly, both in terms of cell isolates from animals and PMio sample. 
Therefore expression profiling was only carried out successfully using the urban 
(Cardiff, CF 2)  P M i o  sample on epithelial type I I  cells (n=4) and industrial ( P T  1)  
P M i o  sample on alveolar macrophages (n=2). The low availability of RNA prevented
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confirmation of macroarray data using alternative techniques, and there were 
considerable differences in gene profiles between cell isolations from different 
animals.
There was a high incidence of non-specific hybridisation (background noise) on the 
arrays from primary cell isolates, at first attributed to lower quality starting RNA 
material and poor probe purification. The background noise became increasingly 
dependent on the batch of array membranes and reagents used and it became apparent 
that problems with certain batches of arrays membranes and consumables were a 
contributory factor.
5.4.2 Compilation of Candidate Genes- Epithelial Type II cell
Expression profiling epithelial type II cells in response to Cardiff (CF 2) PMio 
exposure (6 hours) were successfully completed (n=4) and compared to sham-treated 
controls (n=4). Images of each array from epithelial type II cells are included in 
Figure 5.1 and 5.2.
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Figure 5.1: Atlas™ Rat 1.2 nylon macro array images of the control (untreated) cultures of primary epithelial type II cells.
Figure 5.2: Atlas™ Rat 1.2 nylon macro array images of the cultures of primary epithelial type II cells following exposure (6hr) to a low dose (CD2o) of Cardiff (CF 2) PMi0
164
Following transformation and normalisation, candidate gene lists were compiled. The 
analytical approach confirmed by qPCR in chapter 3 was adopted for this experiment. 
The effect of increasing the stringency and adopting statistical (student t-test) and 
control±2SD range filtering is summarised in Table 5.1. A total of 12 genes were 
expressed outside a mean control±2SD following the low level exposure (CD20) to the 
PM sample. These genes were involved in xenobiotic metabolism (3), transporters 
and ion channels (2), cytokines and extracellular communication proteins (5) and 
receptor associated proteins/cell cycle controlling protein (1).
Table 5.1: Summary o f gene lists undergoing increased stringency o f  filtering to achieve a final list of 
candidate genes involved in the cellular response to an in vitro low exposure to Cardiff (CF 2) PM10 by 
primary cultures o f epithelial type II cells.
Stringency and parameters for screening for 
candidate genes (epithelial type n  cells)
Number of genes
Mean control±2SD
(n=4)
No minimum fold change 111 genes 3 genes up-regulated
> 2 fold change 12 genes 3 genes up regulated
Unpaired t-test only 
p<0.05
No minimum fold change 54 genes
> 2 fold change 11 genes All min.4 fold change
Mean control±2SD 
and
Unpaired t-test p<0.05
> 2 fold change 2 genes
3 genes (ifp<0.1)
2 genes up regulated 
1 gene down regulated
Two genes are deemed significantly altered by both the ± 2SD range and t-test 
(p<0.05), > 2 fold change parameters: Cytochrome P450 (VII) (BOlc, switched on, 
p=0.05) and Brain digoxin carrier (B02b, switched on, p=0.05). An additional gene 
may be included if the statistical significance is extended to p<0.1: Cytochrome P450 
(14) (BOlg, x3 fold down regulated, p=0.09). Both cytochromes are known to be 
involved in the metabolism of xenobiotics and can also be functionally classified as a 
proteins involved in the metabolism of complex lipids. Interestingly, the two 
Cytochrome P450 subunits undergo opposing directional changes following PMio 
exposure. Brain digoxin carrier (BOlb) is a facilitated diffusion protein integral to the 
plasma membrane linked to xenobiotic transportation. Closer examination of the 
function of candidate genes reveals a range of functions associated with each gene 
product that could contribute to the lung response in vivo. The two cytochrome P450 
proteins are known to be involved in the metabolism of cholesterol and detoxification
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of xenobiotics. BOlc (cholesterol P450 1A1) catalyses the rate determining reaction 
in the conversion of cholesterol to bile acids. In contrast, the down regulated 
cytochrome P450 51A1 is catalyses the biosynthesis of cholesterol. The third gene, 
brain digoxin carrier protein is a member of the organic anion transporter proteins 
(oatps) and functionally related to the multi drug resistance protein (BOln, Table 5.2). 
These gene products are known to be present in barriers such as the blood brain 
barrier in endothelial cells or epithelia, cells connected by highly regulated tight 
junctions and regulate the movement of waste products and xenobiotics across the 
barrier. These polyspecific organic anion transporters are part of the ATP binding 
cassette (ABC) super-family and are known to function in concert with the 
detoxification enzymes to protect the organism from potentially harmful compounds. 
They are known to be expressed, under normal physiological conditions, in cells and 
tissues that provide a barrier for the body towards toxicant entry, typical of the lung 
(Hagenbuch et al., 2002). Table 5.2 comprises a list of candidate genes (12) identified 
as significant (mean control ±2SD range and a minimum 2 fold alteration in 
expression). A total of eleven genes were identified as significantly altered (p<0.05) 
by a minimum of 2 fold following PM exposure but not outside a 2 SD range of the 
mean control expression. These genes are shown in Table 5.3. Both lists (Table 5.2 
and 5.3) contain genes involved in intracellular signalling and gated ion channels. 
Although these genes are not significant by both parameters (Mean control ±2SD 
range, p<0.05, minimum 2 fold alteration in expression) they represent an underlying 
cell response to these low level exposures.
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Table 5.2: The candidate genes (12) deemed significant (outside mean control ±2SD) and minimum of two fold change (no minimum statistical significance applied). Negative fold 
change indicates decrease in expression relative to untreated (control) cultures of primary pulmonary epithelial type II cells. Genes in red type indicate the 3 genes shortlisted (t-test 
p<0.1), minimum 2-fold change and outside mean control ±2SD. TRUE indicates the genes were expressed outside a mean control ±2SD range.
>2SD range
T test
Gene Functioncode Fold change (p value)
BOlc TRUE on 0.05 cytochrome P450 VII (CYP7) Xenobiotic metabolism Complex lipid metabolism
BOlg TRUE -3 0.09 cytochrome P-450 14 Xenobiotic transporter
BOln TRUE - 2 0.15 multidrug resistance protein 2 (MDR2) Drug resistance abc transporter
B02b TRUE on 0.05 Brain digoxin carrier protein Facilitated diffusion Xenobiotic transporter
B021 TRUE - 2 0.14 sulfonylurea receptor (SUR) Signalling
B031 TRUE - 2 0.15 purinergic receptor Ligand gated ion channel
B05e TRUE on 0.48 skeletal muscle Na+ channel protein alpha subunit Voltage gated ion channel
EOla TRUE - 2 0.14 insulin like growth factor II (IGF-II)
Growth factor, cytokine, chemokine
E02a TRUE - 2 0.11 neurotrophin 5, trk and trkb activating
E05a TRUE - 2 0.15 interleukin-2 (IL-2)
Signalling
E06c TRUE - 2 0.15 Neurexophilin 1 (NEUROPHILIN)
^  * Q* 4 O
E07a TRUE - 2 0.14 arrestin D Intracellular kinase
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Table 5.3: The candidate genes (11) deemed significantly altered (p<0.05) by a minimum of 2-fold change relative to untreated controls in primary cultures of epithelial type II cells. 
Genes in red type indicate the 2 genes shortlisted (t-test p<0.05), minimum 2-fold change and outside mean control ±2SD.
>2SD ranee
|T test
Fold chanee Gene Function
code (p-value)
BOlc TRUE On 0.05 cytochrome P450 VII (CYP7) Xenobiotic metabolism
B02b TRUE On 0.05 BRAIN DIGOXIN CARRIER PROTEIN Facilitated diffusion and Xenobiotic transporter
B03c FALSE 4.5 0.03 Cyclic nucleotide-activated channel Ligand gated ion channel
C02c FALSE 4.0 0.04 Type 1 hexokinase (HK1)
Metabolism
C03c FALSE 4.5 0.03 Alcohol dehydrogenase class 1
F02j FALSE 4.0 0.04 CaZ4-independent phospholipase A2 Phospholipase
F03j FALSE 4.5 0.03 Calbindin D28; Calcium binding protein
F04h FALSE 4.0 0.04 Putative protein kinase C regulatory protein Kinase activators, cell signalling
F05i FALSE 4.0 0.04 Frizzled-1 (FZ-1) dishevelled receptor Receptor protein
F061 FALSE 4.0 0.04 Secretogranin V Trafficking and targeting
F06n FALSE 4.4 0.04 elastase 2 precursor Serine protease
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5.4.3 C o m p ila tio n  o f  C a n d id a te  G enes- A lveolar M acro p h ag e  C ell
Expression profiling alveolar macrophages in response to Port Talbot (PT 1) PMio 
exposure (4 hours) were successfully completed (n=2) and compared to sham-treated 
controls (Figure 5.3). Low replicate numbers were a consequence of extremely 
unreliable isolation of sufficient high quality RNA for array analysis.
There was a high degree of variability in gene expression across both control and PM 
exposed cell cultures. Despite the low replicate numbers, analysis of the expression 
profiles did produce concise lists of candidate genes (Table 5.4). The high degree of 
variability in gene expression across the arrays resulted in no genes being expressed 
outside a mean control ±2SD range. A total of 15 genes, all up regulated, were 
deemed to be significantly (p<0.05) altered following exposure to PM (4 hours) by a 
minimum of two fold relative to sham-treated control cultures. These 15 genes (Table 
5.5) comprise: ion channels (8), facilitated diffusion proteins (3), xenobiotic 
transporters and metabolism (3) and transcription factors (1).
Table 5.4: Summary o f gene lists undergoing increased stringency o f  filtering to achieve a final list of 
candidate genes involved in the cellular response to in vitro exposure to Port Talbot (PT 1) PMi0.by 
primary cultures o f alveolar macrophage cells.
Stringency and param eters for screening for 
candidate genes (alveolar m acrophage)
N um ber of genes
Mean control±2SD
(n=2)
No minimum fold change
No genes
> 2 fold change
Unpaired t-test only 
p<0.05
No minimum fold change 21 genes 15 genes up regulated
> 2 fold change 15 genes All up regulated
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Figure 5.3 Atlas™ Rat 1.2 nylon macro array images of (a-b) control (untreated) cultures of primary alveolar macrophages (AMs) and (c-d) AMs following exposure (4hr) to 
a low dose (CD20) of Port Talbot (PT 1) PMi0
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Table 5.5: The candidate genes (15) deemed significant (outside mean control ±2SD) and minimum of two fold change in response to industrial PMi0 by primary cultures o f alveolar 
macrophages. The fold change indicates increase (all switched on) in expression relative to untreated (control) cultures.
Atlas Gene 
code
Fold
change
T-test 
(p  value)
Gene Function
AlOa on 0.02 Androgen binding protein Metabolism
A lla on 0.03 Fos-related antigen 1 (FOSL1; FRA1) Transcription factor
A llb on 0.02 P21; cipl; wafl cdk inhibitor
A14h on 0.01 Liver carboxyl esterase 10 precursor Metabolism inc. xenobiotic metabolism
BOlj on 0.02 Multi-specific organic anion transporter (OAT1) Xenobiotic transporter
B02f on 0.04 Fructose (glucose) transporter Facilitated diffusion protein
B03d on 0.01 Acetylcholine receptor gamma Facilitated diffusion protein 
Ligand gated ion channelB03e on 0.02 Acetylcholine receptor delta
B04i on 0.05 Sodium channel protein 6 (SCP6)
Voltage gated ion channel
B05d on 0.03 Voltage-gated potassium channel protein
B05e on 0.01 Skeletal muscle sodium channel protein alpha subunit (SCN4A)
B05f on 0.01 Voltage-dependent L-type calcium channel alpha ID subunit
B05g on 0.03 Voltage-dependent L-type calcium channel alpha 1C subunit
B06n on 0.02 Calcium channel, beta subunit, brain
B ile on 0.01 Urea transporter Facilitated diffusion protein
5.4.4 C o m p a riso n  o f  th e  T ype 11 a n d  A lveo lar M acro p h ag e  responses to  P M
E x p o su re
There appears to be some correlation between the alveolar macrophage and epithelial 
type II cell responses. A multi-specific organic anion transporter (oatp, BOlj) is up- 
regulated as a consequence of PM exposure in type II cells, a similar gene (B02b) is 
altered in a likewise manner in alveolar macrophages and may constitute part a 
general cell response to prevent cellular toxicity. In both candidate gene lists (type II 
cells and alveolar macrophages) the oatps are expressed alongside genes with 
products with established roles in detoxification (A14h in the alveolar macrophage 
candidate gene list). These gene products may work in concert to reduce entry of the 
toxic compound into the cell and to detoxify, preventing any overt cellular toxicity. 
In agreement with Stone (1998) three candidate genes appear to be voltage gated 
calcium channels (B05f, B05g, B06n). The role of calcium influx to drive the stress 
response in these cells has been established with experiments with PM or PM 
surrogates and the increase, at the RNA level reported by the arrays could form part of 
either the initial stress response or contribute to restoration of the cellular calcium 
levels following exposure. The presence o f potassium (B05d) and sodium channels 
(B04i) may contribute to the changes in the electrochemical gradient within the cell 
required to drive the cellular response following exposure.
5.5 Discussion
The objective for this study was to take a novel approach to identify changes in gene 
expression following PM exposure to primary cells in vitro. Firstly, it was anticipated 
that different cell types such as the alveolar macrophages would express different 
genes than those of epithelial type II cells that are largely concerned with surfactant 
secretion and xenobiotic metabolism. Secondly, it was hoped to determine if gene 
expression in either cell type could be linked to whole lung gene changes already 
recorded in the in vivo investigations (Chapter 3). Finally, it was intended to link any 
gene expression induced by PM in primary cells with those already noted by others 
using cell lines. The use of cell lines offers the chance of greater reproducibility and 
with a few limitations regarding availability of cells for study, offering more readily 
available and more efficient RNA isolation for macroarray investigations. However,
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as pointed out by Hetland (2003) cell lines may lack the receptors of some primary 
cells and respond quite differently to toxic substances.
Only limited success in achieving the aims was realised. Mostly this lack of success 
was due to the failure to consistently isolate sufficient concentrations of total RNA 
from control and PM exposed cell cultures. In brief, there are several possible 
explanations. Firstly, there could have been some degradation of the RNA from the 
cells by the PM, proven to have significant ability to cause oxidative damage to 
plasmid DNA Greenwell et al., 2003). Secondly, RNA degradation may have been 
carried out by the cells themselves. The Atlas™ nylon arrays required large amounts 
of RNA and proved suitable for tissue profiling (Chapter 3) when abundant source of 
RNA was available. This was not the case in the cell studies and it is therefore 
possible that commercially available microarray systems, requiring less RNA, would 
be better employed when RNA is available in only small quantities. The limited 
success in obtaining gene profiles could also be related to the use of primary cells and 
there are few, if any, reports in the literature related to their use in toxicogenomics. In 
contrast, the use of cell lines in many studies has provided a more reliable and low 
cost source of cells to study, but it has been highlighted that primary cells and many 
cell lines have different responses to toxic compounds (Hetland et al., 2003). This 
chapter was a novel approach to assessing the cellular response to characterised PMio 
and it was designed to incorporate primary cells rather than cell lines.
The expression profiling was completed on cells exposed to a dose that was shown to 
incite the detachment of 20% of the cell culture of freshly prepared whole PMio 
sample (CD20) As discussed previously, the exposure to this low dose and short 
exposure time (4hr alveolar macrophages, 6 hr -epithelial type II cells) was adopted 
based on previous research investigating the response of cultured cells (macrophages 
and epithelial cells) to toxins exposed in vitro (Li et al., 2000. Hetland et al., 2003. 
Monn et al., 2003). Previous studies (Chapter 4) had indicated that cell death was 
occurring at doses used in the CD50 experiments. The low dose used for the 
expression profiling (CD2o) was used in an attempt to achieve genetic profiling of the 
cellular response to a mild exposure rather than the genetic changes resulting in cell 
death. The candidate genes from studies of both cell types show that changes in cell 
detoxification/metabolism and transporter proteins may represent the early response 
to PMio.
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Expression profiling of the cells in isolation did not reveal any similar genes found to 
be expressed or repressed in the whole lung expression profiles (Chapter 3). This 
may be a consequence of the prominent role of cross talk between the large numbers 
of different cell types within the lung and which would be absent in a homogenous 
culture of primary isolates. However, the identification of key candidate genes, in 
both cell types examined, with known roles in cell signalling, detoxification and 
transport provided more details in the response of the cell to prevent toxicity 
following a mild toxicant challenge. Such candidate genes are therefore worthy of 
further investigation especially if further numbers of experiments provide 
reproducible data. Adapting the macroarray technology to isolated primary cells in 
vitro has not been easy but represents a start to studies that will become increasingly 
important in future pollutant research.
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6.0 General Discussion
6.1 Study Aims and Objectives
The aim of this study was to evaluate the toxicity of a characterised urban ambient 
PM 10 sample. The first investigation examined the biological responses of healthy 
male rats to a single intracheal instillation of urban PMio (0-10 mg)(Chapter 2). This 
assessment was carried out using established methods to examine the extent of 
oedema and inflammation arising as a direct consequence of the instillate. This 
instillation study also examined the contribution of equivalent doses (0-10 mg) of the 
different fractions of the ambient PMio (whole PM, washed durable fraction and water 
soluble fraction) towards the overall toxicity of the sample. The study was then 
extended to incorporate the novel application of gene profiling lung tissue samples 
from affected rats, to evaluate whether the observed changes at the lung surface could 
be attributed to detectable changes in gene expression. This investigation necessitated 
the development of methods of gene analysis to establish a suitable approach to 
identify candidate genes for the lung pathology and confirmation of the analysis 
methods using qPCR (Chapter 3). The study then progressed to examine the toxicity 
of the PM sample (urban and industrial) towards homogenous cultures of primary 
type II and alveolar macrophage cells (Chapter 4).
This chapter identified the contribution o f the different fractions to the overall toxicity 
in both cell systems and previous full chemical and morphological characterisation 
facilitated the correlation of observed toxicity to total metal content, source of sample 
and particle sizes. A small-scale investigation was then carried out using a new 
cellular imaging system, completed in conjunction with Amersham Biosciences. This 
approach used florescence labelling and laser analysis to identify subtle changes in 
cell and nuclei morphology following exposure to PM levels below those doses 
deemed cytotoxic in the cell detachment assay. This in vitro characterisation of the 
sample toxicity was extended to toxicogenomic analysis, with limited success. 
Failure to consistently isolate sufficient high quality RNA in concentrations and 
quantity required for the array analysis prevented obtaining a high number of
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replicates deemed necessary for meaningful analysis. Some analyses have been 
completed and suggest that although the approach is challenging, this method could 
produce a useful insight into the cellular mechanisms of defence, toxicity and repair 
within cells following such an exposure.
6.2 Overview of Results and Conclusions
Histological and biochemical analysis characterised the early (3-day) and longer-term 
(6 week) effects of instilled PMio in male healthy rats. The subtle dose dependant 
PM 10 induced changes in parameters including the lung to body weight ratio and total 
lung surface protein at 3 days were indicative of a mild pulmonary oedema at this 
time point. However, this event was transient, with no significant changes in lung to 
body weight ratio at 6 weeks post instillation. The more sensitive parameter, total 
lung surface protein indicated some retained effects at 6 weeks following the 
instillation of both particle-containing fractions (whole and washed particles) at the 
higher doses (5 mg, 10 mg). A dose dependant increase in total surface protein was 
observed following exposure to the water soluble fraction, but a significant change 
was only observed at 10 mg equivalent exposure (p<0.05). A statistically significant 
reduction in total lung surface protein was observed at 6 weeks (2.5 mg only) but no 
further trend was observed for this parameter. A dose dependent increase in lavage 
free cell numbers was also observed for both whole and washed PM fractions at 3 
days post instillation, although statistically significant changes were detectable only at 
the highest dose (10 mg whole particles), a consequence of a high degree of variation 
in different animals within the group (n=5). The fraction devoid of particles, the 
water soluble fraction, produced no significant changes in free cell number at either 3 
days or 6 weeks post instillation. There was no significant recruitment of neutrophils 
into the lung, a further indicator of a low bioreactive instillate. In conclusion, 
conventional assessment reported only minimal changes in lung to body weight ratio, 
total surface protein and lavage free cells, indicating a low response to the instilled 
PM and PM fractions. The whole PM and washed PM fraction elicited the most 
response, a low-level response was noted with the soluble fraction, illustrating that the 
presence of the soluble material had a pulmonary effect in vivo. Histological 
examination confirms this low-level response in the healthy rat whereby only small
176
focal regions of particle accumulation and a slight epithelial effect was apparent. A 
chiefly macrophage mediated lung event was detectable following both 5 mg and 
10 mg exposure. In contrast, water soluble (10 mg PM equivalent dose) exposed lung 
tissue presented regions of alveolar, capillary or interstitial thickening, with prominent 
collections of red blood cells.
Toxicogenomic analysis o f selected animals (n=3) from sham-treated controls; whole 
particle exposed (5 mg, 10 mg) and water soluble (equivalent dose of 10 mg whole 
PM) produced expression profiles of the lung responses. A critique of the macroarray 
method is provided later. The array profiling and subsequent analysis produced 
candidate gene lists that would be suitable for continued studies. The candidate genes 
following the exposure to whole and water soluble PM fractions were similar in terms 
of functionality but contained no similar genes, indicating a distinct lung response at 3 
days, as judged by histological assessment. A 3 day post instillation had been adopted 
for the early time point on the basis o f previous studies identifying this time as peak 
for oedema and lung damage in rat models, however, changes in heart rate and gene 
expression in the heart attributed to soluble metals have been identified within an hour 
of instillation. The peak of the lung response to the water soluble fraction may occur 
much sooner than this time point resulting in a stage of repair by the 72 hour time 
point. In contrast, gene changes as a consequence of on going particle-induced 
cellular damage may be detected following the instillation of whole and washed 
fractions. The low replicate number (n=3 for each treatment group) was adopted for 
this first expression profiling study, this is very low for strong statistical assumptions 
and increased replicates would be favoured in further studies. The expression 
profiling of a lower dose (5 mg) whole PM exposed proved unsuccessful, attributed, 
in part, to the use of different animals for each array producing very different 
expression profiles within the treatment group. Changes in gene expression for the 
other treatment groups were confirmed by qPCR, although more comprehensive 
confirmation of all candidate genes should be completed. The finalised candidate 
gene lists of each PM fraction exposure could be linked to the observed pathology and 
warrant further investigation.
The characterisation of the response towards two ambient PM samples: industrial 
(Port Talbot 1) and urban (Cardiff 2) in cell free assays have been completed by a
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former postgraduate within our laboratory (Greenwell et al., 2003). The present study 
investigated the toxicity within a cell system, and adopted two primary cell types for 
this purpose; the alveolar macrophage and epithelial type II cell. A simple 
detachment assay was enlisted to ascertain the relative toxicity of both the ambient 
PM samples and respective fractions towards the two cell types. The alveolar 
macrophage and epithelial type II cell were differentially affected by the two PM 
samples. The Port Talbot sample was more toxic towards the type II cells, whilst the 
alveolar macrophages were more affected by the urban sample. However, most 
reactivity of the sample was retained within the durable fraction in each cell type. 
Characterisation of the samples (Moreno et al., 2003) allowed correlation with metal 
content. The toxicity of the samples towards the alveolar macrophages was greatest 
with the finer particle dominated fraction (urban, PMio to PM2.5 ratio 2-8-4 2 
compared to the same ratio in the Port Talbot sample 1-2) and could be postulated to 
reflect greater particle numbers per mass to which these cells had been exposed. In 
contrast, the type II cells were more susceptible to the coarse particle dominated 
sample (industrial), a finding in agreement with Hetland (2003). Type II cell toxicity 
correlated well with total metal content of the samples, no such trend was apparent 
with the alveolar macrophages, however correlations did exist between specific 
metals with both cell types. Such correlations were generally weak, a reflection of 
low replicate numbers and sample numbers examined, however the results indicate 
trends that specific metals could dictate the cytotoxicity of the PM sample in different 
cell types. Cellular imaging of PM exposed type II cell cultures provided evidence 
that subtle cellular and nuclear changes were detectable at the doses used in the 
detachment assays. These results supported the use of a low PM exposure (CD20) for 
subsequent toxicogenomic profiling, the expression profiling of the cellular events 
leading up to increased apoptosis and cell death and damage rather than cellular 
signalling concerned with cell death itself. Limited success with cellular expression 
profiling was achieved. This may have been a consequence of poor cell and RNA 
availability associated with primary cells compared to cell lines. However this 
approach was favoured over the use of cell lines, toxicological studies have 
highlighted slight differences in cell morphology, biology and responses to toxicant 
challenge in cell lines compared to primary isolates. The macroarray system adopted 
for these studies required considerable (2 fig) total RNA. Microarrays, although 
more expensive, require only a fraction of the RNA and may be more appropriate for
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primary cell studies with limited amounts of RNA. The low replicate numbers 
realised in this study hampers the reliability of the conclusions, but the study is a 
useful preliminary investigation, addressing the problems with expression profiling of 
primary cells rather than lung tissue. Candidate gene lists of PM exposed epithelial 
type II cells (sham-treated control n=4, PM exposed n=4) produced candidate genes 
involved in the removal and detoxification of molecular species. Functional analysis 
of these candidate genes indicates genes associated with ion channels and calcium 
metabolism. Such changes can be linked to events postulated to be taking place 
within the lung (Donaldson et al., 2001) and known cellular events of stress and repair 
(Stone et al., 1998).
6.3 Critique of the Methods and Approaches Adopted
Conventional toxicological assessment, in conjunction with histological examination, 
was utilised to characterise the pulmonary responses to assess the bioreactivity of 
urban PM (CF 2) in the rat. However, the conventional analysis provided very little 
evidence of the cellular and molecular events leading up to the endpoints observed 
and no information regarding the different mode of toxicity between the different 
fractions, implied by the distinct histology of water soluble and whole PM exposed 
lung tissue. However, the conventional assessments alongside the toxicogenomic 
profiling, enabled identification of changes at the lung surface and provided the 
potential to link such with changes in gene expression.
The Atlas ™ macroarray system was adopted for the expression-profiling studies. 
This nylon array offered a versatile method that that did not require large amounts of 
specialist equipment. Previous experiments had used the smaller array from the rat 
array series (Rat stress array, BD Biosciences, 207 genes) with great success 
(Reynolds et al., 2001). The larger Rat 1.2 array (1176 genes) was considered 
superior because of the nature and scope of the genes examined. However, this 
change introduced significant problems, including background noise and non-specific 
binding to every cDNA spot. Despite increased measures to identify batches of faulty 
membranes and consumables, the overall efficiency of successful arrays was poor, 
particularly during the profiling of PM exposed cells, with very limited starting
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material. The macroarray proved generally successful with the tissue profiling, with 
more abundant high quality RNA, but repeated use of the nylon arrays did result in 
considerable distortion of the membranes. Alternative commercial microarray 
systems, including BD Biosciences and Affymetrix, require lower quantities of 
starting materials and use glass as a substrata rather than nylon. The microarray 
systems offer the potential to examine genome-wide changes in gene expression but 
require specialised equipment and are often only suitable for single use.
The design of the study was based around a large in vivo experiment involving short­
term exposure (3 days and 6 weeks post instillation) of several different doses (0 mg, 
2.5 mg, 5 mg and 10 mg) to whole PM, washed PM and water soluble component of 
PM. Three animals were selected on the basis of heightened pulmonary responses as 
judged by the conventional assessment. Triplicate expression profiles were 
considered sufficient, but upon development of the bio informatic analysis, it became 
apparent that this low number weakened any statistical assumption made. The use of 
three individual animals for profiling introduced another large degree of variation 
above that found in repeated tissue samples. It would be advisable, in a case such as 
this, to introduce more replication, not necessarily extending the number of animals, 
but in repeating the arrays using the same samples and analysing multiple arrays. 
Another challenge to the success of the array analyses was the highly heterogeneous 
level of pulmonary responses achieved following the exposure to the PM and 
respective fractions. The lung tissue histology resulting from the instillation 
identified a focal effect, with large regions of the tissue remaining unaffected. 
Confirmation of the array results using a different section of tissue, which may be 
either more or less affected than the tissue selected for array analysis, would 
jeopardise the consistency of such gene changes. This was an unforeseen error in the 
design of this study.
The cell detachment assay adopted to assess the in vitro toxicity of ambient PM 
samples was relatively non-specific. Further investigations into changes within the 
cell and nuclear morphology indicated that there were mild cell changes indicative of 
the onset of apoptosis that may provide a more subtle marker of cell stress than that of 
detachment, particularly in the epithelial type II cell cultures.
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In conclusion, this study has been successful in addressing the primary objective of 
characterisation of the bioreactivity of an ambient PM sample both in vivo and in 
vitro. The Cardiff PM sample used through out the study proved to have low 
bioreactivity compared to highly potent pulmonary toxicants such as silica used in 
other studies. The toxicity was retained chiefly in the fractions containing the 
particles themselves, although the water soluble component, chiefly water soluble 
metals did incite a low level effect. The toxicogenomic profiling of the whole lung 
tissue realised distinct lists of candidate genes worthy of further investigation, and 
highlighted the possibility of different times of effect, if not different mechanism of 
toxicity by the water soluble and particle containing fractions. None of the candidate 
genes identified could be attributed to the two cells examined in vitro, however. 
Expression profiling of these cells, although hampered by practical problems, has 
identified genes with functions that may be linked with known events at the lung 
surface and illustrated the potential of this technique as a possible approach to 
investigating the toxicity of PMio- The cell systems were successful to ascertain the 
in vitro toxicity of a characterised industrial and urban PM sample. The study 
highlighted that differences in particle characteristics and particularly the metal 
content were linked to overall toxicity.
The use of gene arrays, although introducing several problems, can successfully be 
used to identify genes that may be otherwise overlooked by other studies that may be 
important in the cellular and tissue responses towards PM and other pulmonary 
toxins.
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